Cystobactamide derivatives

Cystobactamide derivatives address the ineffectiveness of current antibiotics by enhancing activity against Gram-negative and Gram-positive bacteria, improving potency and spectrum coverage, and reducing metabolic instability and toxicity.

CA3071155CActive Publication Date: 2026-11-10HELMHOLTZ ZENTRUM FUER INFEKTIONSFORSCHUNG GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CA3071155
Authority / Receiving Office
CA · CA
Patent Type
Patents
Current Assignee / Owner
Priority Date
2017-08-23
Filing Date
2018-08-23
Publication Date
2026-11-10
Estimated Expiration
2038-08-23

AI Technical Summary

Technical Problem

Current antibiotics are ineffective against certain bacterial strains, particularly Gram-negative bacteria such as E. coli, P. aeruginosa, and A. baumannii, and there is a need for broad-spectrum antibiotics to combat both Gram-negative and Gram-positive bacteria.

Method used

Development of cystobactamide derivatives, which are novel compounds with enhanced antibiotic activity against selected Gram-negative bacteria and broad-spectrum activity against Gram-positive bacteria, including specific modifications to improve potency and spectrum coverage.

Benefits of technology

The cystobactamide derivatives exhibit improved efficacy against a range of pathogenic bacteria, including P. aeruginosa, K. pneumoniae, E. aerogenes, E. faecalis, S. epidermidis, S. pneumoniae, fluoroquinolone-resistant E. coli, and S. aureus, with reduced metabolic instability and toxicity concerns.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention relates to novel derivatives of cystobactamides of formula (lb) and the use thereof for the treatment or prophylaxis of bacterial infections [Image disponible dans le document PDF, Image available in the PDF document] (Ib) wherein E is a group of formula -L-C(=O)-NH-* or a group of formula -C(=O)-NH- (CH<com:Sub>2< / com:Sub>)<com:Sub>m< / com:Sub>-*, wherein * denotes the point of attachment to group Ar and wherein L is a bond or a - NH-, a C<com:Sub>1-6< / com:Sub> alkylene or a heteroalkylene group containing from 1 to 6 carbon atoms and 1, 2 or 3 heteroatoms selected from O, S and N, and wherein m is an integer of from 1 to 4.
Need to check novelty before this filing date? Find Prior Art

Description

CYSTOBACTAMIDE DERIVATIVES The present invention relates to novel derivatives of cystobactamides and the use thereof for the treatment or prophylaxis of bacterial infections. Cystobactamides are novel natural products that have been isolated from myxobacterium Cystobacter velatus (MCy8071; internal name: Cystobacter ferrugineus). Cystobactamides exhibit a good antibiotic activity, especially against selected Gram-negative bacteria, such as E. coli, P. aeruginosa, and A. baumannii, as well as a broad-spectrum activity against Gram- positive bacteria. Cystobactamides have been described in WO 2015 / 003816, WO2016 / 082934, Angew. Chem. Int. Ed. 2014, 53, 14605–14609 (doi:10.1002 / anie. 201409964), Angew. Chem. Int. Ed. 2017, 56 (doi:10.1002 / anie.201705913), and in Synlett 2015, 26(09), 1175-1178 (doi: 10.1055 / s-0034-1380509). Albicidin is a natural product produced by Xanthomonas albilineans possessing antibacterial activity. Albicidin and derivatives thereof are described in WO 2014 / 125075. Summary of the invention According to one particular aspect, the invention relates to a compound of formula (Ib): [Image disponible dans le document PDF, Image available in the PDF document] (Ib) wherein 1a <com:Math><semantics>R1<annotation encoding="application / x-tex">R^1< / annotation>< / semantics>< / com:Math> is a hydrogen atom or a group of formula -<com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl; <com:Math><semantics>R2<annotation encoding="application / x-tex">R^2< / annotation>< / semantics>< / com:Math> is a hydrogen atom, an OH group or a group of formula -O-<com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl; A is an alkynyl, a cycloalkyl, heterocycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, aryl, heteroaryl, aralkyl or heteroaralkyl group, all of which may optionally be substituted; Q is a group of formula -C(=O)-NH-, wherein the NH-group is bound to the phenyl group carrying <com:Math><semantics>R2<annotation encoding="application / x-tex">R^2< / annotation>< / semantics>< / com:Math>; Ar is a phenylene group which may optionally be substituted; Ar<com:Sup>1< / com:Sup> is a phenylene group which may optionally be substituted; E is a group of formula -L-C(=O)-NH-* or a group of formula -C(=O)-NH-(CH<com:Sub>2< / com:Sub>)<com:Sub>m< / com:Sub>-*, wherein * denotes the point of attachment to group Ar and wherein L is a bond or a - NH-, a C<com:Sub>1-6< / com:Sub> alkylene or a heteroalkylene group containing from 1 to 6 carbon atoms and 1, 2 or 3 heteroatoms selected from O, S and N, and wherein m is an integer of from 1 to 4; G is a phenyl group or a heteroaryl group containing 5 or 6 to 10 ring atoms selected from O, S, N and C or a heterocycloalkyl group containing 5 or 6 ring atoms selected from O, S, N and C; all of which groups are substituted by 1, 2, 3, 4 or 5 groups R<com:Sup>6< / com:Sup>; the groups R<com:Sup>6< / com:Sup> are independently from each other selected from a halogen atom, NO<com:Sub>2< / com:Sub>, N<com:Sub>3< / com:Sub>, OH, NH<com:Sub>2< / com:Sub>, SH, CN or an alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, hetero- cycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, aryl, heteroaryl, aralkyl or hetero- aralkyl group, all of which groups may optionally be substituted; or two groups R<com:Sup>6< / com:Sup> are linked together via an alkylene, alkenylene or heteroalkylene group, all of which may optionally be substituted; 1b wherein G is substituted by a -CN group; R<com:Sup>7< / com:Sup> is a hydrogen atom; and <com:Math><semantics>R8<annotation encoding="application / x-tex">R^8< / annotation>< / semantics>< / com:Math> is a group of formula -C(=O)-NH<com:Sub>2< / com:Sub>; or a pharmaceutically acceptable salt, solvate or hydrate thereof. According to another particular aspect, the invention relates to a pharmaceutical composition comprising a compound as defined herein, and one or more carrier substances and / or one or more adjuvants. According to another particular aspect, the invention relates to a compound or a pharmaceutical composition as defined herein, for use in the treatment or prophylaxis of bacterial infections. The present invention provides compounds of formula (Ib): [Image disponible dans le document PDF, Image available in the PDF document] (Ib) wherein <com:Math><semantics>R1<annotation encoding="application / x-tex">R^1< / annotation>< / semantics>< / com:Math> is a hydrogen atom or a group of formula -<com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl; <com:Math><semantics>R2<annotation encoding="application / x-tex">R^2< / annotation>< / semantics>< / com:Math> is a hydrogen atom, an OH group or a group of formula -O-C<com:Sub>1-6< / com:Sub> alkyl; A is an alkynyl, a cycloalkyl, heterocycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, aryl, heteroaryl, aralkyl or heteroaralkyl group, all of which may optionally be substituted; Q is a group of formula -C(=O)-NH-, wherein the NH-group is bound to the phenyl group carrying R<com:Sup>2< / com:Sup>, or an optionally substituted heteroaryl group containing 5 ring atoms selected from O, S, N and C, or an optionally substituted heterocycloalkyl group containing 5 ring atoms selected from O, S, N and C, or a group of formula -CO-heteroaryl wherein the heteroaryl group is optionally substituted and contains 5 ring atoms selected from O, S, N and C; Ar is a phenylene group or a naphthylene group or a heteroarylene group containing 5 or 6 to 10 ring atoms selected from O, S, N and C or a C<com:Sub>3-7< / com:Sub> cycloalkyl group or a heterocycloalkyl group containing from 3 to 7 ring atoms selected from C, O, S and N or a C<com:Sub>2-4< / com:Sub> alkynyl group; all of which groups may optionally be substituted; Ar<com:Sup>1< / com:Sup> is a phenylene group or a naphthylene group or a heteroarylene group containing 5 or 6 to 10 ring atoms selected from O, S, N and C or a C<com:Sub>3-7< / com:Sub> cycloalkyl group or a heterocycloalkyl group containing from 3 to 7 ring atoms selected from C, O, S and N or a C<com:Sub>2-4< / com:Sub> alkynyl group; all of which groups may optionally be substituted; E is a bond or a group of formula -C=C- or a heteroarylene group containing 5 ring atoms selected from O, S, N and C (preferably from C and N) or a group of formula -L-C(=O)-NH-* , <com:Math><semantics>−C(=O)−NH−(CH2)m−*<annotation encoding="application / x-tex">-C(=O)-NH-(CH_2)_m-*< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2−NH−(CH2)m−*<annotation encoding="application / x-tex">-SO_2-NH-(CH_2)_m-*< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−L−SO2−NH−*<annotation encoding="application / x-tex">-L-SO_2-NH-*< / annotation>< / semantics>< / com:Math> or <com:Math><semantics>−N=N−<annotation encoding="application / x-tex">-N=N-< / annotation>< / semantics>< / com:Math>, wherein * denotes the point of attachment to group Ar and wherein L is a bond or a -NH-, a C<com:Sub>1-6< / com:Sub> alkylene, a C<com:Sub>2-6< / com:Sub> alkenylene or a heteroalkylene group containing from 1 to 6 carbon atoms and 1, 2 or 3 heteroatoms selected from O, S and N, and wherein m is an integer of from 1 to 4; G is a phenyl group or a heteroaryl group containing 5 or 6 to 10 ring atoms selected from O, S, N and C or a heterocycloalkyl group containing 5 or 6 ring atoms selected from O, S, N and C; all of which groups may be unsubstituted or substituted by 1, 2, 3, 4 or 5 groups R<com:Sup>6< / com:Sup>; the groups R<com:Sup>6< / com:Sup> are independently from each other selected from a halogen atom, NO<com:Sub>2< / com:Sub>, N<com:Sub>3< / com:Sub>, OH, NH2, SH, CN or an alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, alkyl- cycloalkyl, heteroalkylcycloalkyl, aryl, heteroaryl, aralkyl or heteroaralkyl group, all of which groups may optionally be substituted; or two groups R<com:Sup>6< / com:Sup> are linked together via an alkylene, alkenylene or heteroalkylene group, all of which may optionally be substituted; R<com:Sup>7< / com:Sup> is a hydrogen atom, an OH group, a NH<com:Sub>2< / com:Sub> group, a C<com:Sub>1-6< / com:Sub> alkyl group, an -O-C<com:Sub>1-6< / com:Sub> alkyl group or an <com:Math><semantics>−O−C(=O)−C1−6<annotation encoding="application / x-tex">-O-C(=O)-C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl group; and R8 is an OH group, a SH group, a CN group, a C1-6 alkyl group, a -O-C1-6 alkyl group, a -S- C<com:Sub>1-6< / com:Sub> alkyl group, a phenyl group, a 4-hydroxyphenyl group or a heteroaryl group containing 5 or 6 ring atoms selected from O, S, N and C or a group of formula -C(=O)-N(R9)-R10; or R<com:Sup>7< / com:Sup> and R<com:Sup>8< / com:Sup> together with the carbon atom to which they are bound are part of an optionally substituted C<com:Sub>3-7< / com:Sub> cycloalkyl group or an optionally substituted heterocycloalkyl group containing 3, 4, 5, 6 or 7 ring atoms selected from O, S, N and C; R<com:Sup>9< / com:Sup> is a hydrogen atom or a C<com:Sub>1-6< / com:Sub> alkyl group; and <com:Math><semantics>R10<annotation encoding="application / x-tex">R^{10}< / annotation>< / semantics>< / com:Math> is a hydrogen atom, a <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl group or a <com:Math><semantics>C3−7<annotation encoding="application / x-tex">C_{3-7}< / annotation>< / semantics>< / com:Math> cycloalkyl group; or R<com:Sup>9< / com:Sup> and R<com:Sup>10< / com:Sup> together with the nitrogen atom to which they are bound are part of an optionally substituted heterocycloalkyl group containing 3, 4, 5, 6 or 7 ring atoms selected from O, S, N and C; or a pharmaceutically acceptable salt, solvate or hydrate or a pharmaceutically acceptable formulation thereof. Preferably, Ar<com:Sup>1< / com:Sup> is an optionally substituted phenylene group; further preferably an optionally substituted 1,4-phenylene group. Moreover preferably, Ar<com:Sup>1< / com:Sup> is unsubstituted. According to a preferred embodiment, the present invention provides compounds of formula (I): [Image disponible dans le document PDF, Image available in the PDF document] (I) wherein <com:Math><semantics>R1<annotation encoding="application / x-tex">R^1< / annotation>< / semantics>< / com:Math> is a hydrogen atom or a group of formula -<com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl; R<com:Sup>2< / com:Sup> is a hydrogen atom, an OH group or a group of formula -O-C<com:Sub>1-6< / com:Sub> alkyl; A is an alkynyl, a cycloalkyl, heterocycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, aryl, heteroaryl, aralkyl or heteroaralkyl group, all of which may optionally be substituted; Q is a group of formula -C(=O)-NH-, wherein the NH-group is bound to the phenyl group carrying R<com:Sup>2< / com:Sup>, or an optionally substituted heteroaryl group containing 5 ring atoms selected from O, S, N and C, or an optionally substituted heterocycloalkyl group containing 5 ring atoms selected from O, S, N and C, or a group of formula -CO-heteroaryl wherein the heteroaryl group is optionally substituted and contains 5 ring atoms selected from O, S, N and C; Ar is a phenylene group or a heteroarylene group containing 5 or 6 ring atoms selected from O, S, N and C or a C<com:Sub>3-7< / com:Sub> cycloalkyl group or a heterocycloalkyl group containing from 3 to 7 ring atoms selected from C, O, S and N or a C2-4 alkynyl group; all of which groups may optionally be substituted; E is a bond or a group of formula -C≡C- or a heteroarylene group containing 5 ring atoms selected from O, S, N and C (preferably from C and N) or a group of formula -L-C(=O)-NH-* , -C(=O)-NH-(CH<com:Sub>2< / com:Sub>)<com:Sub>m< / com:Sub>-*, -SO<com:Sub>2< / com:Sub>-NH-(CH<com:Sub>2< / com:Sub>)<com:Sub>m< / com:Sub>-*, -L-SO<com:Sub>2< / com:Sub>-NH-* or -N=N-, wherein * denotes the point of attachment to group Ar and wherein L is a bond or a -NH-, a C<com:Sub>1-6< / com:Sub> alkylene, a C<com:Sub>2-6< / com:Sub> alkenylene or a heteroalkylene group containing from 1 to 6 carbon atoms and 1, 2 or 3 heteroatoms selected from O, S and N, and wherein m is an integer of from 1 to 4; G is a phenyl group or a heteroaryl group containing 5 or 6 ring atoms selected from O, S, N and C or a heterocycloalkyl group containing 5 or 6 ring atoms selected from O, S, N and C; all of which groups may be unsubstituted or substituted by 1, 2, 3, 4 or 5 groups R<com:Sup>6< / com:Sup>; the groups R<com:Sup>6< / com:Sup> are independently from each other selected from a halogen atom, NO<com:Sub>2< / com:Sub>, N<com:Sub>3< / com:Sub>, OH, NH2, SH, CN or an alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, alkyl- cycloalkyl, heteroalkylcycloalkyl, aryl, heteroaryl, aralkyl or heteroaralkyl group, all of which groups may optionally be substituted; or two groups R<com:Sup>6< / com:Sup> are linked together via an alkylene, alkenylene or heteroalkylene group, all of which may optionally be substituted; R<com:Sup>7< / com:Sup> is a hydrogen atom, an OH group, a NH<com:Sub>2< / com:Sub> group, a C<com:Sub>1-6< / com:Sub> alkyl group, an -O-C<com:Sub>1-6< / com:Sub> alkyl group or an <com:Math><semantics>−O−C(=O)−C1−6<annotation encoding="application / x-tex">-O-C(=O)-C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl group; and R<com:Sup>8< / com:Sup> is an OH group, a SH group, a CN group, a C<com:Sub>1-6< / com:Sub> alkyl group, a -O-C<com:Sub>1-6< / com:Sub> alkyl group, a -S- C<com:Sub>1-6< / com:Sub> alkyl group, a phenyl group, a 4-hydroxyphenyl group or a group of formula -C(=O)- <com:Math><semantics>N(R9)−R10<annotation encoding="application / x-tex">N(R^9)-R^{10}< / annotation>< / semantics>< / com:Math>; or 6 R<com:Sup>7< / com:Sup> and R<com:Sup>8< / com:Sup> together with the carbon atom to which they are bound are part of an optionally substituted C<com:Sub>3-7< / com:Sub> cycloalkyl group or an optionally substituted heterocycloalkyl group containing 3, 4, 5, 6 or 7 ring atoms selected from O, S, N and C; R<com:Sup>9< / com:Sup> is a hydrogen atom or a C<com:Sub>1-6< / com:Sub> alkyl group; and R<com:Sup>10< / com:Sup> is a hydrogen atom, a C<com:Sub>1-6< / com:Sub> alkyl group or a C<com:Sub>3-7< / com:Sub> cycloalkyl group; or R<com:Sup>9< / com:Sup> and R<com:Sup>10< / com:Sup> together with the nitrogen atom to which they are bound are part of an optionally substituted heterocycloalkyl group containing 3, 4, 5, 6 or 7 ring atoms selected from O, S, N and C; or a pharmaceutically acceptable salt, solvate or hydrate or a pharmaceutically acceptable formulation thereof. Preferably, E is a group of formula -L-C(=O)-NH-*, -C(=O)-NH-(CH<com:Sub>2< / com:Sub>)<com:Sub>m< / com:Sub>-*, -SO<com:Sub>2< / com:Sub>-NH- (CH<com:Sub>2< / com:Sub>)<com:Sub>m< / com:Sub>-*, -L-SO<com:Sub>2< / com:Sub>-NH-* or -N=N-, wherein * denotes the point of attachment to group Ar and wherein L is a bond or a -NH-, a <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkylene, a <com:Math><semantics>C2−6<annotation encoding="application / x-tex">C_{2-6}< / annotation>< / semantics>< / com:Math> alkenylene or a heteroalkylene group containing from 1 to 6 carbon atoms and 1, 2 or 3 heteroatoms selected from O, S and N, and wherein m is an integer of from 1 to 4. According to a further preferred embodiment, the present invention provides compounds of formula (I) wherein <com:Math><semantics>R1<annotation encoding="application / x-tex">R^1< / annotation>< / semantics>< / com:Math> is a hydrogen atom or a group of formula -<com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl; <com:Math><semantics>R2<annotation encoding="application / x-tex">R^2< / annotation>< / semantics>< / com:Math> is a hydrogen atom, an OH group or a group of formula -O-C<com:Sub>1-6< / com:Sub> alkyl; A is an alkynyl, a cycloalkyl, heterocycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, aryl, heteroaryl, aralkyl or heteroaralkyl group, all of which may optionally be substituted; Q is a group of formula -C(=O)-NH-, wherein the NH-group is bound to the phenyl group carrying R<com:Sup>2< / com:Sup>, or an optionally substituted heteroaryl group containing 5 ring atoms selected from O, S, N and C, or an optionally substituted heterocycloalkyl group containing 5 ring atoms selected from O, S, N and C; Ar is a phenylene group or a heteroarylene group containing 5 or 6 ring atoms selected from O, S, N and C; all of which groups may optionally be substituted; E is a group of formula -L-C(=O)-NH-* , -C(=O)-NH-(CH<com:Sub>2< / com:Sub>)<com:Sub>m< / com:Sub>-*, -SO<com:Sub>2< / com:Sub>-NH-(CH<com:Sub>2< / com:Sub>)<com:Sub>m< / com:Sub>-*, -L-SO<com:Sub>2< / com:Sub>- NH-* or -N=N-, wherein * denotes the point of attachment to group Ar and wherein L is a bond or a -NH-, a C<com:Sub>1-6< / com:Sub> alkylene, a C<com:Sub>2-6< / com:Sub> alkenylene or a heteroalkylene group containing from 1 to 6 carbon atoms and 1, 2 or 3 heteroatoms selected from O, S and N, and wherein m is an integer of from 1 to 4; G is a phenyl group or a heteroaryl group containing 5 or 6 ring atoms selected from O, S, N and C or a heterocycloalkyl group containing 5 or 6 ring atoms selected from O, S, N and C; all of which groups may be unsubstituted or substituted by 1, 2, 3, 4 or 5 groups R<com:Sup>6< / com:Sup>; the groups R<com:Sup>6< / com:Sup> are independently from each other selected from a halogen atom, NO<com:Sub>2< / com:Sub>, N<com:Sub>3< / com:Sub>, OH, NH<com:Sub>2< / com:Sub>, SH, CN or an alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, alkyl- cycloalkyl, heteroalkylcycloalkyl, aryl, heteroaryl, aralkyl or heteroaralkyl group, all of which groups may optionally be substituted; or two groups R<com:Sup>6< / com:Sup> are linked together via an alkylene, alkenylene or heteroalkylene group, all of which may optionally be substituted; R<com:Sup>7< / com:Sup> is a hydrogen atom, an OH group, a NH<com:Sub>2< / com:Sub> group, a C<com:Sub>1-6< / com:Sub> alkyl group, an -O-C<com:Sub>1-6< / com:Sub> alkyl group or an <com:Math><semantics>−O−C(=O)−C1−6<annotation encoding="application / x-tex">-O-C(=O)-C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl group; and R<com:Sup>8< / com:Sup> is an OH group, a SH group, a CN group, a C<com:Sub>1-6< / com:Sub> alkyl group, a -O-C<com:Sub>1-6< / com:Sub> alkyl group, a -S- <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl group, a phenyl group, a 4-hydroxyphenyl group or a group of formula <com:Math><semantics>−C(=O)<annotation encoding="application / x-tex">-C(=O)< / annotation>< / semantics>< / com:Math>- <com:Math><semantics>N(R9)−R10<annotation encoding="application / x-tex">N(R^9)-R^{10}< / annotation>< / semantics>< / com:Math>; or R<com:Sup>7< / com:Sup> and R<com:Sup>8< / com:Sup> together with the carbon atom to which they are bound are part of an optionally substituted C<com:Sub>3-7< / com:Sub> cycloalkyl group or an optionally substituted heterocycloalkyl group containing 3, 4, 5, 6 or 7 ring atoms selected from O, S, N and C; <com:Math><semantics>R9<annotation encoding="application / x-tex">R^9< / annotation>< / semantics>< / com:Math> is a hydrogen atom or a <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl group; and R<com:Sup>10< / com:Sup> is a hydrogen atom, a C<com:Sub>1-6< / com:Sub> alkyl group or a C<com:Sub>3-7< / com:Sub> cycloalkyl group; or R<com:Sup>9< / com:Sup> and R<com:Sup>10< / com:Sup> together with the nitrogen atom to which they are bound are part of an optionally substituted heterocycloalkyl group containing 3, 4, 5, 6 or 7 ring atoms selected from O, S, N and C; or a pharmaceutically acceptable salt, solvate or hydrate or a pharmaceutically acceptable formulation thereof. Preferably, Q is a group of formula -C(=O)-NH-, wherein the NH-group is bound to the phenyl group carrying R<com:Sup>2< / com:Sup>. Further preferably, Q is an optionally substituted heteroaryl group containing 5 ring atoms selected from O, S, N and C. Moreover preferably, Q is selected from the following groups: [Image disponible dans le document PDF, Image available in the PDF document] wherein R<com:Sup>11< / com:Sup> is a hydrogen atom or an alkyl group (such as CH<com:Sub>3< / com:Sub> or CF<com:Sub>3< / com:Sub>) or an aryl group and R<com:Sup>12< / com:Sup> is a hydrogen atom or an alkyl group (such as CH<com:Sub>3< / com:Sub> or CF<com:Sub>3< / com:Sub>) or an aryl group. Preferably, the nitrogen atom of these preferred groups <com:Math><semantics>Q<annotation encoding="application / x-tex">Q< / annotation>< / semantics>< / com:Math> is bound to the phenyl group carrying <com:Math><semantics>R2<annotation encoding="application / x-tex">R^2< / annotation>< / semantics>< / com:Math>. Especially preferably, R<com:Sup>11< / com:Sup> is a hydrogen atom. According to a preferred embodiment, the present invention provides compounds of formula (Ia): [Image disponible dans le document PDF, Image available in the PDF document] (Ia) wherein <com:Math><semantics>R1<annotation encoding="application / x-tex">R^1< / annotation>< / semantics>< / com:Math> is a hydrogen atom or a group of formula -<com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl; 9 R<com:Sup>2< / com:Sup> is a hydrogen atom, an OH group or a group of formula -O-C<com:Sub>1-6< / com:Sub> alkyl; A is an alkynyl, a cycloalkyl, heterocycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, aryl, heteroaryl, aralkyl or heteroaralkyl group, all of which may optionally be substituted; Ar is a phenylene group or a heteroarylene group containing 5 or 6 ring atoms selected from O, S, N and C; all of which groups may optionally be substituted; E is a group of formula -L-C(=O)-NH-*, -C(=O)-NH-(CH<com:Sub>2< / com:Sub>)<com:Sub>m< / com:Sub>-*, -SO<com:Sub>2< / com:Sub>-NH-(CH<com:Sub>2< / com:Sub>)<com:Sub>m< / com:Sub>-*, -L-SO<com:Sub>2< / com:Sub>- NH-* or -N=N-, wherein * denotes the point of attachment to group Ar and wherein L is a bond or a -NH-, a C<com:Sub>1-6< / com:Sub> alkylene, a C<com:Sub>2-6< / com:Sub> alkenylene or a heteroalkylene group containing from 1 to 6 carbon atoms and 1, 2 or 3 heteroatoms selected from O, S and N, and wherein m is an integer of from 1 to 4; G is a phenyl group or a heteroaryl group containing 5 or 6 ring atoms selected from O, S, N and C; all of which groups may be unsubstituted or substituted by 1, 2, 3, 4 or 5 groups R<com:Sup>6< / com:Sup>; the groups R<com:Sup>6< / com:Sup> are independently from each other selected from a halogen atom, NO<com:Sub>2< / com:Sub>, N<com:Sub>3< / com:Sub>, OH, NH2, SH, CN or an alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, alkyl- cycloalkyl, heteroalkylcycloalkyl, aryl, heteroaryl, aralkyl or heteroaralkyl group, all of which groups may optionally be substituted; or two groups R<com:Sup>6< / com:Sup> are linked together via an alkylene, alkenylene or heteroalkylene group, all of which may optionally be substituted; R<com:Sup>7< / com:Sup> is a hydrogen atom, an OH group, a NH<com:Sub>2< / com:Sub> group, a C<com:Sub>1-6< / com:Sub> alkyl group, an -O-C<com:Sub>1-6< / com:Sub> alkyl group or an <com:Math><semantics>−O−C(=O)−C1−6<annotation encoding="application / x-tex">-O-C(=O)-C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl group; and R<com:Sup>8< / com:Sup> is an OH group, a SH group, a CN group, a C<com:Sub>1-6< / com:Sub> alkyl group, a -O-C<com:Sub>1-6< / com:Sub> alkyl group, a -S- C<com:Sub>1-6< / com:Sub> alkyl group, a phenyl group, a 4-hydroxyphenyl group or a group of formula -C(=O)- <com:Math><semantics>N(R9)−R10<annotation encoding="application / x-tex">N(R^9)-R^{10}< / annotation>< / semantics>< / com:Math>; or 10 R<com:Sup>7< / com:Sup> and R<com:Sup>8< / com:Sup> together with the carbon atom to which they are bound are part of an optionally substituted C<com:Sub>3-7< / com:Sub> cycloalkyl group or an optionally substituted heterocycloalkyl group containing 3, 4, 5, 6 or 7 ring atoms selected from O, S, N and C; <com:Math><semantics>R9<annotation encoding="application / x-tex">R^9< / annotation>< / semantics>< / com:Math> is a hydrogen atom or a <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl group; and R<com:Sup>10< / com:Sup> is a hydrogen atom, a C<com:Sub>1-6< / com:Sub> alkyl group or a C<com:Sub>3-7< / com:Sub> cycloalkyl group; or R<com:Sup>9< / com:Sup> and R<com:Sup>10< / com:Sup> together with the nitrogen atom to which they are bound are part of an optionally substituted heterocycloalkyl group containing 3, 4, 5, 6 or 7 ring atoms selected from O, S, N and C; or a pharmaceutically acceptable salt, solvate or hydrate or a pharmaceutically acceptable formulation thereof. Preferably, Ar is a phenylene group or a pyridylene group, both of which may be substituted. Further preferably, Ar is an unsubstituted phenylene group or an unsubstituted pyridylene group. Especially preferably, Ar is an unsubstituted phenylene group; especially preferably an unsubstituted 1,4 phenylene group. Moreover preferably, Ar is a cyclohexylene group or a group of formula -CH₂-C≡C- or -C≡C- CH<com:Sub>2< / com:Sub>-. Further preferably, R<com:Sup>7< / com:Sup> is a hydrogen atom. Moreover preferably, R<com:Sup>7< / com:Sup> is an -OMe group. Further preferably, <com:Math><semantics>R7<annotation encoding="application / x-tex">R^7< / annotation>< / semantics>< / com:Math> is an <com:Math><semantics>−O−C1−6<annotation encoding="application / x-tex">-O-C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl group. Moreover preferably, <com:Math><semantics>R7<annotation encoding="application / x-tex">R^7< / annotation>< / semantics>< / com:Math> is an <com:Math><semantics>−O−C(=O)−C1−6<annotation encoding="application / x-tex">-O-C(=O)-C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl group. Further Preferably, <com:Math><semantics>R8<annotation encoding="application / x-tex">R^8< / annotation>< / semantics>< / com:Math> is a group of formula <com:Math><semantics>−C(=O)−NH2<annotation encoding="application / x-tex">-C(=O)-NH_2< / annotation>< / semantics>< / com:Math>. Moreover preferably, R<com:Sup>8< / com:Sup> is a CN group. Further Preferably, R<com:Sup>8< / com:Sup> is a CN group and R<com:Sup>7< / com:Sup> is an -OMe group. Moreover Preferably, R<com:Sup>8< / com:Sup> is a heteroaryl group containing 5 ring atoms selected from C and N. Further preferably, R<com:Sup>7< / com:Sup> and R<com:Sup>8< / com:Sup> together with the carbon atom to which they are bound are part of a heterocycloalkyl group containing 5 ring atoms selected from O, N and C which may be substituted by an =O group. Especially preferably, <com:Math><semantics>R7<annotation encoding="application / x-tex">R^7< / annotation>< / semantics>< / com:Math> is a hydrogen atom and <com:Math><semantics>R8<annotation encoding="application / x-tex">R^8< / annotation>< / semantics>< / com:Math> is a group of formula -CONH<com:Sub>2< / com:Sub>. Moreover preferably, if R<com:Sup>7< / com:Sup> is an -OMe group, G is substituted by a -CN group. Especially preferably, R<com:Sup>7< / com:Sup> is an -OMe group and R<com:Sup>8< / com:Sup> is a group of formula -CONH<com:Sub>2< / com:Sub> and G is substituted by a -CN group. Preferably, the present invention provides compounds of formula (II): [Image disponible dans le document PDF, Image available in the PDF document] (II) wherein R<com:Sup>1< / com:Sup>, R<com:Sup>2< / com:Sup>, A, E and G are as defined above, or a pharmaceutically acceptable salt, solvate or hydrate or a pharmaceutically acceptable formulation thereof. Preferably, <com:Math><semantics>R1<annotation encoding="application / x-tex">R^1< / annotation>< / semantics>< / com:Math> is a <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> alkyl group. Further preferably, R<com:Sup>1< / com:Sup> is a group of formula -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub> or -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>; especially preferably a group of formula -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>. Further preferably, R<com:Sup>2< / com:Sup> is a hydrogen atom or an OH group; especially preferably an OH group. Moreover preferably, A is an optionally substituted phenyl group; an optionally substituted heteroaryl group containing 5 or 6 ring atoms selected from O, S, N and C; an optionally substituted cycloalkyl group containing from 3 to 7 ring atoms; or an optionally substituted heterocycloalkyl group containing from 3 to 7 ring atoms selected from O, S, N and C; or an optionally substituted acetylenyl group (e.g. a group of formula −C≡C-COOH). Further preferably, A is a group of formula -CH<com:Sub>2< / com:Sub>-A' or NH-A', wherein A' is an optionally substituted phenyl group; an optionally substituted heteroaryl group containing 5 or 6 ring atoms selected from O, S, N and C; an optionally substituted cycloalkyl group containing from 3 to 7 ring atoms; or an optionally substituted heterocycloalkyl group containing from 3 to 7 ring atoms selected from O, S, N and C; or an optionally substituted acetylenyl group (e.g. a group of formula <com:Math><semantics>−C≡C−COOH<annotation encoding="application / x-tex">-C \equiv C - COOH< / annotation>< / semantics>< / com:Math>). Especially preferably, A is an optionally substituted phenyl group. Preferably, A is substituted by 1, 2 or 3 substituents which are independently selected from a halogen atom, COOH, SO<com:Sub>2< / com:Sub>NH<com:Sub>2< / com:Sub>, OH, -B(OH)<com:Sub>2< / com:Sub>, CH<com:Sub>2< / com:Sub>COOH, -O-C<com:Sub>1-6< / com:Sub> alkyl, SO<com:Sub>3< / com:Sub>H and C<com:Sub>1-6< / com:Sub> alkyl or a group of the following formula: [Image disponible dans le document PDF, Image available in the PDF document] Moreover preferably, A is a group of the following formula: [Image disponible dans le document PDF, Image available in the PDF document] wherein R<com:Sup>3< / com:Sup> is a hydrogen atom, a halogen atom, an OH group, a C<com:Sub>1-6< / com:Sub> alkyl group or a group of formula -O-C<com:Sub>1-6< / com:Sub> alkyl; R<com:Sup>4< / com:Sup> is a hydrogen atom, a halogen atom, an OH group, a C<com:Sub>1-6< / com:Sub> alkyl group or a group of formula -O-C<com:Sub>1-6< / com:Sub> alkyl; and R<com:Sup>5< / com:Sup> is an OH group or a NH<com:Sub>2< / com:Sub> group; especially preferably, R<com:Sup>3< / com:Sup> is a hydrogen atom or a group of formula -O-C<com:Sub>1-4< / com:Sub> alkyl (especially a group of formula -O-CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>), R<com:Sup>4< / com:Sup> is a hydrogen atom or an OH group and R<com:Sup>5< / com:Sup> is an OH group. Further preferably, A is selected from the following groups: [Image disponible dans le document PDF, Image available in the PDF document] Moreover preferably, A is selected from the following groups: [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] Wherein Hal is a halogen atom. Further preferably, A is selected from the following groups: [Image disponible dans le document PDF, Image available in the PDF document] Especially preferably, A is selected from the following groups: [Image disponible dans le document PDF, Image available in the PDF document] • Moreover preferably, E is selected from the following groups: -C(=O)-NH-*, -CH=C(CH<com:Sub>3< / com:Sub>)- <com:Math><semantics>C(=O)−NH−*<annotation encoding="application / x-tex">C(=O)-NH-*< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−O−CH(CH3)−C(=O)−NH−*<annotation encoding="application / x-tex">-O-CH(CH_3)-C(=O)-NH-*< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S−CH(CH3)−C(=O)−NH−*<annotation encoding="application / x-tex">-S-CH(CH_3)-C(=O)-NH-*< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2−C(=O)−NH−*<annotation encoding="application / x-tex">-CH_2-C(=O)-NH-*< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2−CH2−C(=O)−NH−*,−C(=O)−NH−CH2−*,−C(=O)−NH−CH2−CH2−*,−SO2−NH−*or−N=N−,−N=N−+,−N=N−++++++++++++++++++++++++++++++++++<annotation encoding="application / x-tex">-CH_2-CH_2-C(=O)-NH-*, \ -C(=O)-NH-CH_2-*, \ -C(=O)-NH-CH_2-CH_2-*, \ -SO_2-NH-* or \ -N=N-, \ -N=N-+, \ -N=N-++++++++++++++++++++++++++++++++++< / annotation>< / semantics>< / com:Math> wherein * denotes the point of attachment to group Ar; especially preferably, E is selected from -C(=O)-NH-* or -CH=C(CH<com:Sub>3< / com:Sub>)-C(=O)-NH-*. Especially preferably, E is a group of formula: -C(=O)-NH-*, wherein * denotes the point of attachment to group Ar. Further preferably, G is an optionally substituted phenyl group or an optionally substituted heteroaryl group containing 5 or 6 ring atoms selected from C, N, O and S. Moreover preferably, G is a phenyl group which is unsubstituted or substituted by 1, 2 or 3 groups <com:Math><semantics>R6<annotation encoding="application / x-tex">R^6< / annotation>< / semantics>< / com:Math>. Especially preferably, G is substituted by a -CN group. The presence of a CN group at group G has the advantage of broadening of the spectrum coverage against relevant pathogenic bacteria such as P. aeruginosa DSM-46316, K. pneumoniae DSM-30104 and E. aerogenes DSM-30053, and of significantly increasing the potency against relevant pathogenic bacteria such as E. faecalis ATCC-29212, S. epidermidis DSM-28765, S. pneumoniae DSM-20566, fluoroquinolone resistant E. coli WT-3 [gyrA(S83L,D87G)] and E. coli WT-III [marRΔ74bp], S. aureus. Moreover, nitro groups are prone to metabolic instability from which potential toxicity problems might arise whereas a cyano group is less likely to give these issues. (see e.g.: Nitroaromatic compounds: Environmental toxicity, carcinogenicity, mutagenicity, therapy and mechanism, Peter Kovacica* and Ratnasamy Somanathana, J. Appl. Toxicol. 2014; 34: 810–824). Further preferably, the groups R<com:Sup>6< / com:Sup> are independently selected from -F, -Cl, -Br, -NO<com:Sub>2< / com:Sub>, -OH, -O-C<com:Sub>1-6< / com:Sub> alkyl (especially -OMe or -O-CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>), -NH<com:Sub>2< / com:Sub>, -CN, -Me, -N<com:Sub>3< / com:Sub>, -CF<com:Sub>3< / com:Sub>, NHAc, -NHMe, -NMe<com:Sub>2< / com:Sub>, -NHCONH<com:Sub>2< / com:Sub> and -SO<com:Sub>2< / com:Sub>Me; or wherein two groups R<com:Sup>6< / com:Sup> together form a group of the formula -CH<com:Sub>2< / com:Sub>-O-C(=O)-, -NH-N=N- or -CH=CH-CH=N-. Moreover preferably, G is a group of the following formula: [Image disponible dans le document PDF, Image available in the PDF document] wherein R<com:Sup>6a< / com:Sup> is -H, -NO<com:Sub>2< / com:Sub>, -F, -NHAc, -N<com:Sub>3< / com:Sub>, -NMe<com:Sub>2< / com:Sub>, -CN, -OH, -NH<com:Sub>2< / com:Sub>, -CF<com:Sub>3< / com:Sub>, -NHCONH<com:Sub>2< / com:Sub> or - SO<com:Sub>2< / com:Sub>Me; R<com:Sup>6b< / com:Sup> is -H, -NO<com:Sub>2< / com:Sub>, -OMe, -Cl, -Br, -NH<com:Sub>2< / com:Sub>, -O-CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -F or -Me; and R<com:Sup>6c< / com:Sup> is -H, -F, - NO<com:Sub>2< / com:Sub>, -NH<com:Sub>2< / com:Sub> -OH or -Me; or wherein R<com:Sup>6c< / com:Sup> is -H and R<com:Sup>6a< / com:Sup> and R<com:Sup>b< / com:Sup> together form a group of the formula <com:Math><semantics>−CH2−O−C(=O)−<annotation encoding="application / x-tex">-CH_2-O-C(=O)-< / annotation>< / semantics>< / com:Math>. Especially preferably, R<com:Sup>6a< / com:Sup> is CN. More preferably, <com:Math><semantics>R6a<annotation encoding="application / x-tex">R^{6a}< / annotation>< / semantics>< / com:Math> is CN and <com:Math><semantics>R6b<annotation encoding="application / x-tex">R^{6b}< / annotation>< / semantics>< / com:Math> and <com:Math><semantics>R6c<annotation encoding="application / x-tex">R^{6c}< / annotation>< / semantics>< / com:Math> are both hydrogen atoms. Further preferably, R<com:Sup>6a< / com:Sup> is a NO<com:Sub>2< / com:Sub> group. More preferably, R<com:Sup>6a< / com:Sup> is NO<com:Sub>2< / com:Sub> and R<com:Sup>6b< / com:Sup> and R<com:Sup>6c< / com:Sup> are both hydrogen atoms. Further preferably, G-E together are selected from the following groups: [Image disponible dans le document PDF, Image available in the PDF document] • 4 . [Image disponible dans le document PDF, Image available in the PDF document] Moreover preferably, G-E together are selected from the following groups: [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] Especially preferably, G-E are selected from the following groups: - [Image disponible dans le document PDF, Image available in the PDF document] Moreover, especially preferably, G-E are selected from the following groups: [Image disponible dans le document PDF, Image available in the PDF document] Further preferred are compounds of formula (III): [Image disponible dans le document PDF, Image available in the PDF document] (III) wherein R<com:Sup>1< / com:Sup>, R<com:Sup>2< / com:Sup>, R<com:Sup>3< / com:Sup>, R<com:Sup>4< / com:Sup>, R<com:Sup>5< / com:Sup>, R<com:Sup>6< / com:Sup> and L are as defined above and a is 0, 1, 2, 3, 4 or 5, or a pharmaceutically acceptable salt, solvate or hydrate or a pharmaceutically acceptable formulation thereof. Especially preferred are compounds of formula (III) wherein <com:Math><semantics>R1<annotation encoding="application / x-tex">R^1< / annotation>< / semantics>< / com:Math> is a hydrogen atom or a group of formula -<com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl; R<com:Sup>2< / com:Sup> is a hydrogen atom, an OH group or a group of formula -O-C<com:Sub>1-6< / com:Sub> alkyl; R<com:Sup>3< / com:Sup> is a hydrogen atom, an OH group or a group of formula -O-C<com:Sub>1-6< / com:Sub> alkyl; R<com:Sup>4< / com:Sup> is a hydrogen atom, an OH group or a group of formula -O-C<com:Sub>1-6< / com:Sub> alkyl; R<com:Sup>5< / com:Sup> is an OH group or a NH<com:Sub>2< / com:Sub> group; the groups R<com:Sup>6< / com:Sup> are independently from each other selected from -F, -NO<com:Sub>2< / com:Sub>, -OH, -O-C<com:Sub>1-6< / com:Sub> alkyl (especially -O-CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>), -NH<com:Sub>2< / com:Sub>, -CN, -Me, -CF<com:Sub>3< / com:Sub>, NHAc, -NHCONH<com:Sub>2< / com:Sub> and -SO<com:Sub>2< / com:Sub>Me; or wherein two groups <com:Math><semantics>R6<annotation encoding="application / x-tex">R^6< / annotation>< / semantics>< / com:Math> together form a group of the formula -CH<com:Sub>2< / com:Sub>-O-C(=O)-. a is 0, 1, 2 or 3; and L is a bond or a -NH-, a C<com:Sub>1-6< / com:Sub> alkylene, a C<com:Sub>2-6< / com:Sub> alkenylene or a heteroalkylene group containing from 1 to 6 carbon atoms and 1, 2 or 3 heteroatoms selected from O, S and N; or a pharmaceutically acceptable salt, solvate or hydrate or a pharmaceutically acceptable formulation thereof. Further preferably, L is a bond or a group of formula -CH=C(CH<com:Sub>3< / com:Sub>)-, -O-CH(CH<com:Sub>3< / com:Sub>)-, -S- <com:Math><semantics>C(CH3)<annotation encoding="application / x-tex">C(CH_3)< / annotation>< / semantics>< / com:Math>-, <com:Math><semantics>−CH2<annotation encoding="application / x-tex">-CH_2< / annotation>< / semantics>< / com:Math>- or <com:Math><semantics>−CH2<annotation encoding="application / x-tex">-CH_2< / annotation>< / semantics>< / com:Math>-<com:Math><semantics>CH2<annotation encoding="application / x-tex">CH_2< / annotation>< / semantics>< / com:Math>-. Especially preferably, L is a bond or a group of formula -<com:Math><semantics>CH=C(CH3)<annotation encoding="application / x-tex">CH=C(CH_3)< / annotation>< / semantics>< / com:Math>-. Further preferably, L is a bond. Moreover preferably, one of <com:Math><semantics>R6<annotation encoding="application / x-tex">R^6< / annotation>< / semantics>< / com:Math>, if present, is in para position to group L. Further preferred are compounds of formula (IV): [Image disponible dans le document PDF, Image available in the PDF document] (IV) wherein R<com:Sup>1< / com:Sup> is a C<com:Sub>1-4< / com:Sub> alkyl group (preferably a group of formula CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>); R<com:Sup>3< / com:Sup> is hydrogen or a -O-C<com:Sub>1-4< / com:Sub> alkyl group (preferably hydrogen or a group of formula -O- <com:Math><semantics>CH(CH3)2);<annotation encoding="application / x-tex">CH(CH_3)_2);< / annotation>< / semantics>< / com:Math> R<com:Sup>4< / com:Sup> is hydrogen or an OH group; and G and E are defined as above; or a pharmaceutically acceptable salt, solvate or hydrate or a pharmaceutically acceptable formulation thereof. Moreover preferred are compounds of formula (V): [Image disponible dans le document PDF, Image available in the PDF document] (V) wherein R<com:Sup>1< / com:Sup> is a C<com:Sub>1-4< / com:Sub> alkyl group (preferably a group of formula CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>); R<com:Sup>3< / com:Sup> is hydrogen or a -O-C<com:Sub>1-4< / com:Sub> alkyl group (preferably hydrogen or a group of formula -O- <com:Math><semantics>CH(CH3)2);<annotation encoding="application / x-tex">CH(CH_3)_2);< / annotation>< / semantics>< / com:Math> R<com:Sup>4< / com:Sup> is hydrogen or an OH group; and G and E are defined as above; or a pharmaceutically acceptable salt, solvate or hydrate or a pharmaceutically acceptable formulation thereof. Especially preferred are compounds of formula (IV) or (V), wherein R<com:Sup>3< / com:Sup> and R<com:Sup>4< / com:Sup> are both hydrogen or wherein R<com:Sup>3< / com:Sup> is a group of formula -O-CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub> and R<com:Sup>4< / com:Sup> is an OH group. The most preferred compounds of the present invention are the compounds disclosed in the examples or a pharmaceutically acceptable salt, solvate or hydrate or a pharmaceutically acceptable formulation thereof. The expression alkyl refers to a saturated, straight-chain or branched hydrocarbon group that contains from 1 to 20 carbon atoms, preferably from 1 to 15 carbon atoms, especially from 1 to 10 (e.g. 1, 2, 3 or 4) carbon atoms, for example a methyl, ethyl, propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, n-pentyl, iso-pentyl, n-hexyl, 2,2-dimethylbutyl or n-octyl group. The expression C<com:Sub>1-6< / com:Sub> alkyl refers to a saturated, straight-chain or branched hydrocarbon group that contains from 1 to 6 carbon atoms. The expression C<com:Sub>1-4< / com:Sub> alkyl refers to a saturated, straight-chain or branched hydrocarbon group that contains from 1 to 4 carbon atoms. Examples are a methyl (Me), CF<com:Sub>3< / com:Sub>, ethyl, propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl or tert-butyl group. The expressions alkenyl and alkynyl refer to at least partially unsaturated, straight-chain or branched hydrocarbon groups that contain from 2 to 20 carbon atoms, preferably from 2 to 15 carbon atoms, especially from 2 to 10 (e.g. 2, 3 or 4) carbon atoms, for example an ethenyl (vinyl), propenyl (allyl), iso-propenyl, butenyl, ethinyl, propinyl, butinyl, acetylenyl, propargyl, isoprenyl or hex-2-enyl group. Preferably, alkenyl groups have one or two (especially preferably one) double bond(s), and alkynyl groups have one or two (especially preferably one) triple bond(s). Furthermore, the terms alkyl, alkenyl and alkynyl refer to groups in which one or more hydrogen atoms have been replaced by a halogen atom (preferably F or Cl) such as, for example, a 2,2,2-trichloroethyl or a trifluoromethyl group. The expression heteroalkyl refers to an alkyl, alkenyl or alkynyl group in which one or more (preferably 1 to 8; especially preferably 1, 2, 3 or 4) carbon atoms have been replaced by an oxygen, nitrogen, phosphorus, boron, selenium, silicon or sulfur atom (preferably by an oxygen, sulfur or nitrogen atom) or by a SO or a SO<com:Sub>2< / com:Sub> group. The expression heteroalkyl furthermore refers to a carboxylic acid or to a group derived from a carboxylic acid, such as, for example, acyl, acylalkyl, alkoxycarbonyl, acyloxy, acyloxyalkyl, carboxyalkylamide or alkoxycarbonyloxy. Preferably, a heteroalkyl group contains from 1 to 12 carbon atoms and from 1 to 8 heteroatoms selected from oxygen, nitrogen and sulphur (especially oxygen and nitrogen). Especially preferably, a heteroalkyl group contains from 1 to 6 (e.g. 1, 2, 3 or 4) carbon atoms and 1, 2, 3 or 4 (especially 1, 2 or 3) heteroatoms selected from oxygen, nitrogen and sulphur (especially oxygen and nitrogen). The term <com:Math><semantics>C1<annotation encoding="application / x-tex">C_1< / annotation>< / semantics>< / com:Math>-<com:Math><semantics>C6<annotation encoding="application / x-tex">C_6< / annotation>< / semantics>< / com:Math> heteroalkyl refers to a heteroalkyl group containing from 1 to 6 carbon atoms and 1, 2 or 3 heteroatoms selected from O, S and / or N (especially O and / or N). The term C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub> heteroalkyl refers to a heteroalkyl group containing from 1 to 4 carbon atoms and 1, 2 or 3 heteroatoms selected from O, S and / or N (especially O and / or N). Furthermore, the term heteroalkyl refers to groups in which one or more hydrogen atoms have been replaced by a halogen atom (preferably F or Cl). Especially preferably, the expression heteroalkyl refers to an alkyl group as defined above (straight-chain or branched) in which one or more (preferably 1 to 6; especially preferably 1, 2, 3 or 4) carbon atoms have been replaced by an oxygen, sulfur or nitrogen atom; this group preferably contains from 1 to 6 (e.g. 1, 2, 3 or 4) carbon atoms and 1, 2, 3 or 4 (especially 1, 2 or 3) heteroatoms selected from oxygen, nitrogen and sulphur (especially oxygen and nitrogen); this group may preferably be substituted by one or more (preferably 1 to 6; especially preferably 1, 2, 3 or 4) fluorine, chlorine, bromine or iodine atoms or OH, =O, SH, <com:Math><semantics>=<annotation encoding="application / x-tex">=< / annotation>< / semantics>< / com:Math>S, NH<com:Sub>2< / com:Sub>, <com:Math><semantics>=<annotation encoding="application / x-tex">=< / annotation>< / semantics>< / com:Math>NH, N<com:Sub>3< / com:Sub>, CN or NO<com:Sub>2< / com:Sub> groups. Examples of heteroalkyl groups are groups of formulae: Ra-O-Ya-, Ra-S-Ya-, Ra-SO-Ya-, <com:Math><semantics>Ra−SO2−Ya−<annotation encoding="application / x-tex">R^{a}-SO_{2}-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−N(Rb)−Ya−<annotation encoding="application / x-tex">R^{a}-N(R^{b})-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−CO−Ya−<annotation encoding="application / x-tex">R^{a}-CO-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−CO−Ya−<annotation encoding="application / x-tex">R^{a}-CO-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−CO−Ya−<annotation encoding="application / x-tex">R^{a}-CO-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−CO−Ya−<annotation encoding="application / x-tex">R^{a}-CO-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−CO−Ya−<annotation encoding="application / x-tex">R^{a}-CO-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−CO−Ya−<annotation encoding="application / x-tex">R^{a}-CO-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−CO−Ya−<annotation encoding="application / x-tex">R^{a}-CO-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−CO−Ya−<annotation encoding="application / x-tex">R^{a}-CO-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−CO−Ya−<annotation encoding="application / x-tex">R^{a}-CO-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>R<annotation encoding="application / x-tex">R< / annotation>< / semantics>< / com:Math> <com:Math><semantics>Ra−N(Rb)−CO−Ya−<annotation encoding="application / x-tex">R^{a}-N(R^{b})-CO-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−O−CO−N(Rb)−Ya−<annotation encoding="application / x-tex">R^{a}-O-CO-N(R^{b})-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−N(Rb)−CO−O−Ya−<annotation encoding="application / x-tex">R^{a}-N(R^{b})-CO-O-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−N(Rb)−CO−N(Rc)−Ya−<annotation encoding="application / x-tex">R^{a}-N(R^{b})-CO-N(R^{c})-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra<annotation encoding="application / x-tex">R^{a}< / annotation>< / semantics>< / com:Math>-O-CO-O-Y<com:Sup>a< / com:Sup>-, <com:Math><semantics>Ra<annotation encoding="application / x-tex">R^{a}< / annotation>< / semantics>< / com:Math>-N(<com:Math><semantics>Rb<annotation encoding="application / x-tex">R^{b}< / annotation>< / semantics>< / com:Math>)-C(=NR<com:Sup>d< / com:Sup>)-N(<com:Math><semantics>Rc<annotation encoding="application / x-tex">R^{c}< / annotation>< / semantics>< / com:Math>)-Y<com:Sup>a< / com:Sup>-, <com:Math><semantics>Ra<annotation encoding="application / x-tex">R^{a}< / annotation>< / semantics>< / com:Math>-CS-Y<com:Sup>a< / com:Sup>-, <com:Math><semantics>Ra<annotation encoding="application / x-tex">R^{a}< / annotation>< / semantics>< / com:Math>-O-CS-Y<com:Sup>a< / com:Sup>-, <com:Math><semantics>Ra<annotation encoding="application / x-tex">R^{a}< / annotation>< / semantics>< / com:Math>-CS-O-Y<com:Sup>a< / com:Sup>-, <com:Math><semantics>Ra−CS−N(Rb)−Ya−<annotation encoding="application / x-tex">R^{a}-CS-N(R^{b})-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−N(Rb)−CS−Ya−<annotation encoding="application / x-tex">R^{a}-N(R^{b})-CS-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−O−CS−N(Rb)−Ya−<annotation encoding="application / x-tex">R^{a}-O-CS-N(R^{b})-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−N(Rb)−CS−O−Ya−<annotation encoding="application / x-tex">R^{a}-N(R^{b})-CS-O-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−N(Rb)−CS−N(Rc)−Ya−<annotation encoding="application / x-tex">R^{a}-N(R^{b})-CS-N(R^{c})-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−O−CS−O−Ya−<annotation encoding="application / x-tex">R^{a}-O-CS-O-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−S−CO−Ya−<annotation encoding="application / x-tex">R^{a}-S-CO-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−CO−S−Ya−<annotation encoding="application / x-tex">R^{a}-CO-S-Y^{a}-< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>Ra−S−CO−N(Rb)−Ya−<annotation encoding="application / x-tex">R^{a}-S-CO-N(R^{b})-Y^{a}-< / annotation>< / semantics>< / com:Math>, Ra-N(Rb)-CO-S-Ya-, Ra-S-CO-O-Ya-, Ra-O-CO-S-Ya-, Ra-S-CO-S-Ya-, Ra-S-CS-Ya-, Ra-CS-S-Ya-, Ra-S-CS-N(Rb)-Ya-, Ra-N(Rb)-CS-S-Ya-, Ra-S-CS-O-Ya-, Ra-O-CS-S-Ya-, wherein R<com:Sup>a< / com:Sup> being a hydrogen atom, a C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub> alkyl, a C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub> alkenyl or a C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub> alkynyl group; R<com:Sup>b< / com:Sup> being a hydrogen atom, a C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub> alkyl, a C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub> alkenyl or a C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub> alkynyl group; R<com:Sup>c< / com:Sup> being a hydrogen atom, a C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub> alkyl, a C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub> alkenyl or a C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub> alkynyl group; R<com:Sup>d< / com:Sup> being a hydrogen atom, a C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub> alkyl, a C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub> alkenyl or a C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub> alkynyl group and Y<com:Sup>a< / com:Sup> being a bond, a C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub> alkylene, a C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub> alkenylene or a C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub> alkynylene group, wherein each heteroalkyl group contains at least one carbon atom and one or more hydrogen atoms may be replaced by fluorine or chlorine atoms. Specific examples of heteroalkyl groups are methoxy, trifluoromethoxy, ethoxy, n-propyloxy, isopropyloxy, butoxy, tert-butyloxy, methoxymethyl, ethoxymethyl, -CH<com:Sub>2< / com:Sub>CH<com:Sub>2< / com:Sub>OH, -CH<com:Sub>2< / com:Sub>OH, -SO<com:Sub>2< / com:Sub>Me, -COOH, -NHCONH<com:Sub>2< / com:Sub>, -NHAc, methoxyethyl, 1-methoxyethyl, 1-ethoxyethyl, 2- methoxyethyl or 2-ethoxyethyl, methylamino, ethylamino, propylamino, isopropylamino, dimethylamino, diethylamino, isopropylethylamino, methylamino methyl, ethylamino methyl, diisopropylamino ethyl, methylthio, ethylthio, isopropylthio, enol ether, dimethylamino methyl, dimethylamino ethyl, acetyl, propionyl, butyryloxy, acetyloxy, methoxycarbonyl, ethoxycarbonyl, propionyloxy, acetylamino or propionylamino, carboxymethyl, carboxyethyl or carboxypropyl, N-ethyl-N-methylcarbamoyl or N-methylcarbamoyl. Further examples of heteroalkyl groups are nitrile (-CN), isonitrile, cyanate, thiocyanate, isocyanate, isothiocyanate and alkylnitrile groups. The expression alkylene group refers to a divalent alkyl group; the expression alkenylene group refers to a divalent alkenyl group (e.g. a group of formula -CH=C(CH<com:Sub>3< / com:Sub>)-); and the expression heteroalkylene group refers to a divalent heteroalkyl group (e.g. a group of formula <com:Math><semantics>−O−CH(CH3)−<annotation encoding="application / x-tex">-O-CH(CH_3)-< / annotation>< / semantics>< / com:Math> or <com:Math><semantics>−CO−O−CH2−<annotation encoding="application / x-tex">-CO-O-CH_2-< / annotation>< / semantics>< / com:Math>). The expression cycloalkyl refers to a saturated or partially unsaturated (for example, a cycloalkenyl group) cyclic group that contains one or more rings (preferably 1 or 2), and contains from 3 to 14 ring carbon atoms, preferably from 3 to 10 (especially 3, 4, 5, 6 or 7) ring carbon atoms. The expression cycloalkyl refers furthermore to groups in which one or more hydrogen atoms have been replaced by fluorine, chlorine, bromine or iodine atoms or by OH, =O, SH, =S, NH<com:Sub>2< / com:Sub>, =NH, N<com:Sub>3< / com:Sub> or NO<com:Sub>2< / com:Sub> groups, thus, for example, cyclic ketones such as, for example, cyclohexanone, 2-cyclohexenone or cyclopentanone. Further specific examples of cycloalkyl groups are a cyclopropyl, cyclobutyl, cyclopentyl, spiro[4,5]decanyl, norbornyl, cyclohexyl, cyclopentenyl, cyclohexadienyl, decalinyl, bicyclo[4.3.0]nonyl, tetraline, cyclopentylcyclohexyl, fluorocyclohexyl or cyclohex-2-enyl group. The expression heterocycloalkyl refers to a cycloalkyl group as defined above in which one or more (preferably 1, 2 or 3) ring carbon atoms have been replaced by an oxygen, nitrogen, silicon, selenium, phosphorus or sulfur atom (preferably by an oxygen, sulfur or nitrogen atom) or a SO group or a SO<com:Sub>2< / com:Sub> group. A heterocycloalkyl group has preferably 1 or 2 ring(s) containing from 3 to 10 (especially 3, 4, 5, 6 or 7) ring atoms (preferably selected from C, O, N and S). The expression heterocycloalkyl refers furthermore to groups that are substituted by fluorine, chlorine, bromine or iodine atoms or by OH, =O, SH, =S, NH<com:Sub>2< / com:Sub>, =NH, N<com:Sub>3< / com:Sub> or NO<com:Sub>2< / com:Sub> groups. Examples are a piperidyl, prolinyl, imidazolidinyl, piperazinyl, morpholinyl, urotro- pinyl, pyrrolidinyl, tetrahydrothiophenyl, tetrahydropyranyl, tetrahydrofuryl or 2-pyrazolinyl group and also lactames, lactones, cyclic imides and cyclic anhydrides. The expression alkylcycloalkyl refers to groups that contain both cycloalkyl and also alkyl, alkenyl or alkynyl groups in accordance with the above definitions, for example alkylcyclo- alkyl, cycloalkylalkyl, alkylcycloalkenyl, alkenylcycloalkyl and alkynylcycloalkyl groups. An alkylcycloalkyl group preferably contains a cycloalkyl group that contains one or two rings having from 3 to 10 (especially 3, 4, 5, 6 or 7) ring carbon atoms, and one or two alkyl, alkenyl or alkynyl groups (especially alkyl groups) having 1 or 2 to 6 carbon atoms. The expression heteroalkylcycloalkyl refers to alkylcycloalkyl groups as defined above in which one or more (preferably 1, 2 or 3) carbon atoms have been replaced by an oxygen, nitrogen, silicon, selenium, phosphorus or sulfur atom (preferably by an oxygen, sulfur or nitrogen atom) or a SO group or a SO<com:Sub>2< / com:Sub> group. A heteroalkylcycloalkyl group preferably contains 1 or 2 rings having from 3 to 10 (especially 3, 4, 5, 6 or 7) ring atoms, and one or two alkyl, alkenyl, alkynyl or heteroalkyl groups (especially alkyl or heteroalkyl groups) having from 1 or 2 to 6 carbon atoms. Examples of such groups are alkylheterocycloalkyl, alkylheterocycloalkenyl, alkenylheterocycloalkyl, alkynylheterocycloalkyl, hetero- alkylcycloalkyl, heteroalkylheterocycloalkyl and heteroalkylheterocycloalkenyl, the cyclic groups being saturated or mono-, di- or tri-unsaturated. The expression aryl refers to an aromatic group that contains one or more rings containing from 6 to 14 ring carbon atoms, preferably from 6 to 10 (especially 6) ring carbon atoms. The expression aryl refers furthermore to groups that are substituted by fluorine, chlorine, bromine or iodine atoms or by OH, SH, NH2, N3 or NO2 groups. Examples are the phenyl, naphthyl, biphenyl, 2-fluorophenyl, anilinyl, 3-nitrophenyl or 4-hydroxyphenyl group. The expression heteroaryl refers to an aromatic group that contains one or more rings containing from 5 to 14 ring atoms, preferably from 5 to 10 (especially 5 or 6 or 9 or 10) ring atoms, comprising one or more (preferably 1, 2, 3 or 4) oxygen, nitrogen, phosphorus or sulfur ring atoms (preferably O, S or N). The expression heteroaryl refers furthermore to groups that are substituted by fluorine, chlorine, bromine or iodine atoms or by OH, SH, N<com:Sub>3< / com:Sub>, NH<com:Sub>2< / com:Sub> or NO<com:Sub>2< / com:Sub> groups. Examples are pyridyl (e.g. 4-pyridyl), imidazolyl (e.g. 2-imidazolyl), phenylpyrrolyl (e.g. 3-phenylpyrrolyl), thiazolyl, isothiazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl, oxadiazolyl, thiadiazolyl, indolyl, indazolyl, tetrazolyl, pyrazinyl, pyrimidinyl, pyridazinyl, 4- hydroxypyridyl (4-pyridonyl), 3,4-hydroxypyridyl (3,4-pyridonyl), oxazolyl, isoxazolyl, triazolyl, tetrazolyl, isoxazolyl, indazolyl, indolyl, benzimidazolyl, benzoxazolyl, benz- isoxazolyl, benzthiazolyl, pyridazinyl, quinolinyl, isoquinolinyl, pyrrolyl, purinyl, carbazolyl, acridinyl, pyrimidyl, 2,3'-bifuryl, pyrazolyl (e.g. 3-pyrazolyl) and isoquinolinyl groups. The expression aralkyl refers to groups containing both aryl and also alkyl, alkenyl, alkynyl and / or cycloalkyl groups in accordance with the above definitions, such as, for example, aryl- alkyl, arylalkenyl, arylalkynyl, arylcycloalkyl, arylcycloalkenyl, alkylarylcycloalkyl and alkylarylcycloalkenyl groups. Specific examples of aralkyls are toluene, xylene, mesitylene, styrene, benzyl chloride, o-fluorotoluene, 1H-indene, tetraline, dihydronaphthalene, indanone, phenylcyclopentyl, cumene, cyclohexylphenyl, fluorene and indane. An aralkyl group preferably contains one or two aromatic ring systems (especially 1 or 2 rings), each containing from 6 to 10 carbon atoms and one or two alkyl, alkenyl and / or alkynyl groups containing from 1 or 2 to 6 carbon atoms and / or a cycloalkyl group containing 5 or 6 ring carbon atoms. The expression heteroaralkyl refers to groups containing both aryl and / or heteroaryl groups and also alkyl, alkenyl, alkynyl and / or heteroalkyl and / or cycloalkyl and / or heterocycloalkyl groups in accordance with the above definitions. A heteroaralkyl group preferably contains one or two aromatic ring systems (especially 1 or 2 rings), each containing from 5 or 6 to 9 or 10 ring atoms (preferably selected from C, N, O and S) and one or two alkyl, alkenyl and / or alkynyl groups containing 1 or 2 to 6 carbon atoms and / or one or two heteroalkyl groups containing 1 to 6 carbon atoms and 1, 2 or 3 heteroatoms selected from O, S and N and / or one or two cycloalkyl groups each containing 5 or 6 ring carbon atoms and / or one or two heterocycloalkyl groups, each containing 5 or 6 ring atoms comprising 1, 2, 3 or 4 oxygen, sulfur or nitrogen atoms. Examples are arylheteroalkyl, arylheterocycloalkyl, arylheterocycloalkenyl, arylalkyl- heterocycloalkyl, arylalkenylheterocycloalkyl, arylalkynylheterocycloalkyl, arylalkylhetero- cycloalkenyl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, heteroarylheteroalkyl, heteroarylcycloalkyl, heteroarylcycloalkenyl, heteroarylheterocycloalkyl, hetero- arylheterocycloalkenyl, heteroarylalkylcycloalkyl, heteroarylalkylheterocycloalkenyl, hetero- arylheteroalkylcycloalkyl, heteroarylheteroalkylcycloalkenyl and heteroarylheteroalkylhetero- cycloalkyl groups, the cyclic groups being saturated or mono-, di- or tri-unsaturated. Specific examples are a tetrahydroisoquinolinyl, benzoyl, phthalidyl, 2- or 3-ethylindolyl, 4-methyl- pyridino, 2-, 3- or 4-methoxyphenyl, 4-ethoxyphenyl, 2-, 3- or 4-carboxyphenylalkyl group. As already stated above, the expressions cycloalkyl, heterocycloalkyl, alkylcycloalkyl, hetero- alkylcycloalkyl, aryl, heteroaryl, aralkyl and heteroaralkyl also refer to groups that are substituted by fluorine, chlorine, bromine or iodine atoms or by OH, =O, SH, =S, NH<com:Sub>2< / com:Sub>, =NH, N<com:Sub>3< / com:Sub> or NO<com:Sub>2< / com:Sub> groups. The expression "optionally substituted" especially refers to groups that are optionally substituted by fluorine, chlorine, bromine or iodine atoms or by OH, =O, SH, =S, NH<com:Sub>2< / com:Sub>, =NH, -SO<com:Sub>3< / com:Sub>H<com:Sub>1< / com:Sub>, -SO<com:Sub>2< / com:Sub>NH<com:Sub>2< / com:Sub>, -COOH<com:Sub>1< / com:Sub>, -CONH<com:Sub>2< / com:Sub>, -CN<com:Sub>1< / com:Sub>, -NHCONH<com:Sub>2< / com:Sub>, N<com:Sub>3< / com:Sub> or NO<com:Sub>2< / com:Sub> groups. This expression refers furthermore especially to groups that may be substituted by one, two, three or more (preferably unsubstituted) C<com:Sub>1< / com:Sub>-C<com:Sub>10< / com:Sub> alkyl, C<com:Sub>2< / com:Sub>-C<com:Sub>10< / com:Sub> alkenyl, C<com:Sub>2< / com:Sub>-C<com:Sub>10< / com:Sub> alkynyl, C<com:Sub>1< / com:Sub>-C<com:Sub>10< / com:Sub> heteroalkyl, <com:Math><semantics>C3<annotation encoding="application / x-tex">C_{3}< / annotation>< / semantics>< / com:Math>-<com:Math><semantics>C18<annotation encoding="application / x-tex">C_{18}< / annotation>< / semantics>< / com:Math> cycloalkyl, C<com:Sub>2< / com:Sub>-C<com:Sub>17< / com:Sub> heterocycloalkyl, C<com:Sub>4< / com:Sub>-C<com:Sub>20< / com:Sub> alkylcycloalkyl, <com:Math><semantics>C2<annotation encoding="application / x-tex">C_2< / annotation>< / semantics>< / com:Math>-<com:Math><semantics>C19<annotation encoding="application / x-tex">C_{19}< / annotation>< / semantics>< / com:Math> heteroalkylcycloalkyl, C<com:Sub>6< / com:Sub>-C<com:Sub>18< / com:Sub> aryl, C<com:Sub>1< / com:Sub>-C<com:Sub>17< / com:Sub> heteroaryl, C<com:Sub>7< / com:Sub>-C<com:Sub>20< / com:Sub> aralkyl or C<com:Sub>2< / com:Sub>-C<com:Sub>19< / com:Sub> heteroaralkyl groups. This expression refers furthermore especially to groups that may be substituted by one, two, three or more (preferably unsubstituted) C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub> alkyl, C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub> alkenyl, C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub> alkynyl, C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub> heteroalkyl, C<com:Sub>3< / com:Sub>-C<com:Sub>10< / com:Sub> cycloalkyl, C<com:Sub>2< / com:Sub>-C<com:Sub>9< / com:Sub> heterocycloalkyl, C<com:Sub>7< / com:Sub>-C<com:Sub>12< / com:Sub> alkylcycloalkyl, C<com:Sub>2< / com:Sub>-C<com:Sub>11< / com:Sub> heteroalkylcycloalkyl, C<com:Sub>6< / com:Sub>-C<com:Sub>10< / com:Sub> aryl, C<com:Sub>1< / com:Sub>-C<com:Sub>9< / com:Sub> heteroaryl, C<com:Sub>7< / com:Sub>-C<com:Sub>12< / com:Sub> aralkyl or C<com:Sub>2< / com:Sub>-C<com:Sub>11< / com:Sub> heteroaralkyl groups. Preferred substituents are: halogen atoms (e.g. F, Cl, Br), groups of formula -OH, -O-C<com:Sub>1-6< / com:Sub> alkyl (e.g. -OMe, -OEt, -O-nPr, -O-iPr, -O-nBu, -O-iBu or -O-tBu), -NH2, -NHC1-6 alkyl, - <com:Math><semantics>N(C1−6 alkyl)2<annotation encoding="application / x-tex">N(C_{1-6} \text{ alkyl})_2< / annotation>< / semantics>< / com:Math>, -COOH, -SO<com:Sub>3< / com:Sub>H, =O, -SO<com:Sub>2< / com:Sub>NH<com:Sub>2< / com:Sub>, -CONH<com:Sub>2< / com:Sub>, -CN, -C<com:Sub>1-6< / com:Sub> alkyl (e.g. -Me, -Et, -nPr, - iPr, -nBu, -iBu, -tBu or -CF<com:Sub>3< / com:Sub>), -SH, -S-C<com:Sub>1-6< / com:Sub> alkyl, NHAc, -NO<com:Sub>2< / com:Sub>, -C≡CH, -NHCONH<com:Sub>2< / com:Sub>, - SO<com:Sub>2< / com:Sub>Me, cyclopropyl and a group of the following formulas: [Image disponible dans le document PDF, Image available in the PDF document] The term halogen refers to F, Cl, Br or I. According to a preferred embodiment, all alkyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, aralkyl and heteroaralkyl groups described herein may independently of each other optionally be substituted. When an aryl, heteroaryl, cycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, heterocycloalkyl, aralkyl or heteroaralkyl group contains more than one ring, these rings may be bonded to each other via a single or double bond or these rings may be annulated. Owing to their substitution, the compounds of the present invention may contain one or more centers of chirality. The present invention therefore includes both all pure enantiomers and all pure diastereoisomers and also mixtures thereof in any mixing ratio. The present invention moreover also includes all cis / trans-isomers of the compounds of the present invention and also mixtures thereof. The present invention moreover includes all tautomeric forms of the compounds of the present invention. The present invention further provides pharmaceutical compositions comprising one or more compounds described herein or a pharmaceutically acceptable salt, solvate or hydrate thereof, optionally in combination with one or more carrier substances and / or one or more adjuvants. The present invention furthermore provides compounds or pharmaceutical compositions as described herein for use in the treatment and / or prophylaxis of bacterial infections, especially caused by E. coli, P. aeruginosa, A. baumannii, other Gram-negative bacteria, and Gram- positive bacteria. Moreover preferably, the present invention provides compounds for use in the treatment and / or prophylaxis of bacterial infections, especially caused by Pseudomonas aeruginosa and other Gram-negative bacteria. Further preferably, the present invention provides compounds for use in the treatment and / or prophylaxis of bacterial infections caused by K. pneumoniae. Moreover preferably, the present invention provides compounds for use in the treatment and / or prophylaxis of bacterial infections, especially caused by S. aureus, S. epidermidis and E. faecalis. It is a further object of the present invention to provide a compound as described herein or a pharmaceutical composition as defined herein for the preparation of a medicament for the treatment and / or prophylaxis of bacterial infections, especially caused by selected Gram- negative bacteria and Gram-positive bacteria. Examples of pharmacologically acceptable salts of sufficiently basic compounds are salts of physiologically acceptable mineral acids like hydrochloric, hydrobromic, sulfuric and phosphoric acid; or salts of organic acids like methanesulfonic, p-toluenesulfonic, lactic, acetic, trifluoroacetic, citric, succinic, fumaric, maleic and salicylic acid. Further, a sufficiently acidic compound may form alkali or earth alkali metal salts, for example sodium, potassium, lithium, calcium or magnesium salts; ammonium salts; or organic base salts, for example methylamine, dimethylamine, trimethylamine, triethylamine, ethylenediamine, ethanolamine, choline hydroxide, meglumin, piperidine, morpholine, tris-(2- hydroxyethyl)amine, lysine or arginine salts; all of which are also further examples of salts of the compounds described herein. Preferred pharmacologically acceptable salts are ammonium salts. The compounds described herein may be solvated, especially hydrated. The hydratization / hydration may occur during the process of production or as a consequence of the hygroscopic nature of the initially water free compounds. The solvates and / or hydrates may e.g. be present in solid or liquid form. The therapeutic use of the compounds described herein, their pharmacologically acceptable salts, solvates and hydrates, respectively, as well as formulations and pharmaceutical compositions also lie within the scope of the present invention. The pharmaceutical compositions according to the present invention comprise at least one compound described herein and, optionally, one or more carrier substances and / or adjuvants. As mentioned above, therapeutically useful agents that contain compounds described herein, their solvates, salts or formulations are also comprised in the scope of the present invention. In general, the compounds described herein will be administered by using the known and acceptable modes known in the art, either alone or in combination with any other therapeutic agent. For oral administration such therapeutically useful agents can be administered by one of the following routes: oral, e.g. as tablets, dragees, coated tablets, pills, semisolids, soft or hard capsules, for example soft and hard gelatine capsules, aqueous or oily solutions, emulsions, suspensions or syrups, parenteral including intravenous, intramuscular and subcutaneous injection, e.g. as an injectable solution or suspension, rectal as suppositories, by inhalation or insufflation, e.g. as a powder formulation, as microcrystals or as a spray (e.g. liquid aerosol), transdermal, for example via an transdermal delivery system (TDS) such as a plaster containing the active ingredient or intranasal. For the production of such tablets, pills, semisolids, coated tablets, dragees and hard, e.g. gelatine, capsules the therapeutically useful product may be mixed with pharmaceutically inert, inorganic or organic excipients as are e.g. lactose, sucrose, glucose, gelatine, malt, silica gel, starch or derivatives thereof, talc, stearinic acid or their salts, dried skim milk, and the like. For the production of soft capsules one may use excipients as are e.g. vegetable, petroleum, animal or synthetic oils, wax, fat, and polyols. For the production of liquid solutions, emulsions or suspensions or syrups one may use as excipients e.g. water, alcohols, aqueous saline, aqueous dextrose, polyols, glycerin, lipids, phospholipids, cyclodextrins, vegetable, petroleum, animal or synthetic oils. Especially preferred are lipids and more preferred are phospholipids (preferred of natural origin; especially preferred with a particle size between 300 to 350 nm) preferred in phosphate buffered saline (pH = 7 to 8, preferred 7.4). For suppositories one may use excipients as are e.g. vegetable, petroleum, animal or synthetic oils, wax, fat and polyols. For aerosol formulations one may use compressed gases suitable for this purpose, as are e.g. oxygen, nitrogen and carbon dioxide. The pharmaceutically useful agents may also contain additives for conservation, stabilization, e.g. UV stabilizers, emulsifiers, sweetener, aromatizers, salts to change the osmotic pressure, buffers, coating additives and antioxidants. In general, in the case of oral or parenteral administration to adult humans weighing approximately 80 kg, a daily dosage of about 1 mg to about 10,000 mg, preferably from about 5 mg to about 1,000 mg, should be appropriate, although the upper limit may be exceeded when indicated. The daily dosage can be administered as a single dose or in divided doses, or for parenteral administration, it may be given as continuous infusion or subcutaneous injection. EXAMPLES 1. GENERAL All commercial chemicals and solvents were reagent grade and were used without further purification. Reaction progress was monitored by TLC on pre-coated silica gel 60 F254 plates (Merck) and visualization was accomplished with UV light (254 nm) and with potassium permanganate staining solution (Dissolve 1.5 g of KMnO<com:Sub>4< / com:Sub>, 10 g K<com:Sub>2< / com:Sub>CO<com:Sub>3< / com:Sub>, and 1.25 mL 10% NaOH in 200 mL water) and LCMS with the following instruments: LC (Agilent technologies 1260 Infinity II<com:Sup>TM< / com:Sup>) coupled to MS (Agilent technologies 6130 quadrupole LC / MS) using an Agilent poroshell<com:Sup>TM< / com:Sup> 120 SB-C18 2.7 µm 2.1x30 mm column and LCMS (API150EX, Applied Biosystems) using a YMC Pack J'sphere<com:Sup>TM< / com:Sup> H80, 33x2.1 mm JH 085040302 QC column. LCMS analyses, analytical data were recorded with LC (Agilent technologies 1200 series) coupled to amaZon SL<com:Sup>TM< / com:Sup> using a Gemini-NX<com:Sup>TM< / com:Sup> 3u C18 110A 50x2.0 mm column. <com:Sup>1< / com:Sup>H and <com:Sup>13< / com:Sup>C NMR spectra were recorded on Bruker AVANCE<com:Sup>TM< / com:Sup> III 500 and 700 spectrometers. Chemical shifts are reported as <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> values in parts per million (ppm) and referenced to residual solvent peak as internal reference (CDCl3, DMSO-d6); J values were given in Hz. When peak multiplicities are given the following abbreviations are used: s, singlet; d, doublet; t, triplet; q, quartet; hept, heptet; m, multiplet; br, broadened signal. RevelerisX2<com:Sup>TM< / com:Sup> flash chromatography system was used for purification of the compounds (GraceResolv<com:Sup>TM< / com:Sup> cartridges), alternatively, silica gel 60M MACHEREY-NAGEL<com:Sup>TM< / com:Sup> (0.040- 0.063 mm; 230–400 mesh) was used for column chromatography. Preparative reversed phase (RP) HPLC was carried out using a Thermo Scientific Dionex (UltiMate 3000<com:Sup>TM< / com:Sup> HPLC system) with a Phenomenex Luna<com:Sup>TM< / com:Sup> C18(2) (250 mm × 21.2 mm) column. For microwave assisted reaction, Biotage® Initiator+ was used. Purity and identity of the compounds were assayed by means of TLC (Merck F-254 silica gel), LCMS (API150EX, Applied Biosystems), HRMS (maxis HD, Bruker), IR and NMR analyses. Solvents and chemicals abbreviation: Pet. Et.= petrolether EA= ethyl acetate DCM= dichloromethane THF= tetrahydrofuran DMSO= dimethyl sulfoxide TEA= trimethylamine DiPEA= diisopropylethylamin CH<com:Sub>3< / com:Sub>CN= acetonitrile TFA= Trifluoroacetic acid EDC= <com:Math><semantics>N<annotation encoding="application / x-tex">N< / annotation>< / semantics>< / com:Math>-(3-Dimethylaminopropyl)-<com:Math><semantics>N<annotation encoding="application / x-tex">N< / annotation>< / semantics>< / com:Math>'-ethylcarbodiimide hydrochloride DCC= Dicyclohexylcarbodiimid HBTU= 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate HOAt= 1-Hydroxy-7-azabenzotriazole BTC= Bis(trichloromethyl) carbonate Tips= Triisopropylsilane AcOH= acetic acid 1.1 Marfey assay Sample (5 µmol) treated with HCl 6N at 110 °C for 6 h.. Sample dried via Freeze-drying, residue treated with NaHCO3 saturated solution (100 µL) and a solution 1% of Marfey reagent (FDAA) in acetone (200 μL). Reaction stirred at 40 °C for 1 h and quenched with HCl 1 N (100 μL). Sample analyzed by LCMS. (column, Gemini-NX 3u C18 110 A 50.0x2.0 mm) Results are given in % of the two diasteroisomers formed upon derivatization. The method itself, presumably during the hydrolysis step, entails partial racemization, which was quantified in around 5%. 2. SYNTHESIS 1 2.1 Retrosynthetic disconnection . [Image disponible dans le document PDF, Image available in the PDF document] fragmets In the above formula A1, groups <com:Math><semantics>X<annotation encoding="application / x-tex">X< / annotation>< / semantics>< / com:Math> and <com:Math><semantics>Y<annotation encoding="application / x-tex">Y< / annotation>< / semantics>< / com:Math> independently represent <com:Math><semantics>H<annotation encoding="application / x-tex">H< / annotation>< / semantics>< / com:Math> or <com:Math><semantics>R6<annotation encoding="application / x-tex">R^6< / annotation>< / semantics>< / com:Math>. 2.2 Building blocks synthesis a. Fragments A1 Carboxylic acids synthesized: [Image disponible dans le document PDF, Image available in the PDF document] 4-(4-nitrobenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] 4-Aminobenzoic acid (800 mg; 5.84 mmol) was dissolved in THF (4.0 mL) and NaHCO<com:Sub>3< / com:Sub> saturated solution (4.0 mL), to it 4-nitrobenzoyl chloride (1.08 g; 5.84 mmol) was added at 0 °C. Reaction stirred for 2 hours, precipitate collected by filtration, washed with water and THF, dried under high vacuum to give 1.30 g of a solid (4.55 mmol; <com:Math><semantics>y=77%<annotation encoding="application / x-tex">y=77\%< / annotation>< / semantics>< / com:Math>). <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 12.80 (br, 1H), 10.83 (s, 1H), 8.43 – 8.35 (m, 2H), 8.25 – 8.14 <com:Math><semantics>(m,2H),7.99−7.94(m,2H),7.94−7.90(m,2H).<annotation encoding="application / x-tex">(m, 2H), 7.99 - 7.94 (m, 2H), 7.94 - 7.90 (m, 2H).< / annotation>< / semantics>< / com:Math> <com:Sup>13< / com:Sup>C NMR (126 MHz, DMSO) δ 166.9, 164.3, 149.3, 142.8, 140.3, 130.3, 129.4, 126.0, 123.6, 119.7. HRMS (ESI) calculated for C14H9N2O5 (M-H) 285.0517, found 285.0536. (E)-3-(4-(allyloxy)phenyl)-2-methylacrylic acid [Image disponible dans le document PDF, Image available in the PDF document] See: Angew. Chem. Int. Ed. 2014, 53, <com:Math><semantics>1−6<annotation encoding="application / x-tex">1-6< / annotation>< / semantics>< / com:Math> <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 12.35 (br, 1H), 7.54 (d, <com:Math><semantics>J=1.1<annotation encoding="application / x-tex">J = 1.1< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.46 – 7.42 (m, 2H), <com:Math><semantics>7.03−6.99<annotation encoding="application / x-tex">7.03 - 6.99< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>6.05<annotation encoding="application / x-tex">6.05< / annotation>< / semantics>< / com:Math> (ddt, <com:Math><semantics>J=17.3<annotation encoding="application / x-tex">J = 17.3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>10.5<annotation encoding="application / x-tex">10.5< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>5.2<annotation encoding="application / x-tex">5.2< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>5.40<annotation encoding="application / x-tex">5.40< / annotation>< / semantics>< / com:Math> (dq, <com:Math><semantics>J=17.3<annotation encoding="application / x-tex">J = 17.3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>1.7<annotation encoding="application / x-tex">1.7< / annotation>< / semantics>< / com:Math> Hz, 1H), 5.27 (dq, <com:Math><semantics>J=10.5<annotation encoding="application / x-tex">J = 10.5< / annotation>< / semantics>< / com:Math>, 1.5 Hz, 1H), 4.61 (dt, <com:Math><semantics>J=5.3<annotation encoding="application / x-tex">J = 5.3< / annotation>< / semantics>< / com:Math>, 1.5 Hz, 2H), 2.03 (d, <com:Math><semantics>J=1.5<annotation encoding="application / x-tex">J = 1.5< / annotation>< / semantics>< / com:Math> Hz, 3H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 169.6, 158.3, 137.4, 133.5, 131.4, 128.1, 126.2, 117.6, 114.7, 68.2, 13.9. HRMS (ESI) calculated for C13H13O3 (M-H) 217.0870, found 217.0873. 4-acetamidobenzoic acid [Image disponible dans le document PDF, Image available in the PDF document] 31 See: J. Org. Chem. 2013, 78, 11765 – 11771. <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 12.67 (br, 1H), 10.23 (s, 1H), 7.90 – 7.84 (m, 2H), 7.68 (d, <com:Math><semantics>J=<annotation encoding="application / x-tex">J =< / annotation>< / semantics>< / com:Math> 8.7 Hz, 2H), 2.08 (s, 3H). <com:Sup>13< / com:Sup>C NMR (126 MHz, DMSO) δ 168.8, 166.9, 143.3, 130.4, 124.9, 118.1, 24.1. HRMS (ESI) calculated for C9H8NO3 (M-H) 178.0510, found 178.0510. 2-(allyloxy)-3-isopropoxy-4-nitrobenzoic acid [Image disponible dans le document PDF, Image available in the PDF document] See synthesis of building bock C1 (section 2.2c). [Image disponible dans le document PDF, Image available in the PDF document] 32 33 methyl 4-ureidobenzoate [Image disponible dans le document PDF, Image available in the PDF document] A solution of methyl 4-aminobenzoate (500 mg; 3.31 mmol) and DiPEA (0.86 mL; 4.97 mmol) in DCM (10 mL) was added dropwise at 0 °C to a solution of BTC (328 mg; 1.10 mmol) in DCM (20 mL). Reaction stirred at 0 °C for 2 h. Solvent reduced under vacuum, residue dissolved in 5 mL of DCM and added to a cooled solution of NH<com:Sub>4< / com:Sub>OH conc.. The mixture was stirred for 2 hours, the solid was collected by filtration, washed with water and twice with Et<com:Sub>2< / com:Sub>O, dried under high vacuum to give 410 mg of a white powder (2.11 mmol; y= 64%). <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 8.98 (s, 1H), 7.87 – 7.79 (m, 2H), 7.57 – 7.48 (m, 2H), 6.05 (s, 2H), 3.79 (s, 3H). <com:Sup>13< / com:Sup>C NMR (126 MHz, DMSO) δ 166.0, 155.6, 145.3, 130.3, 121.6, 116.8, 51.7. HRMS (ESI) calculated for C9H11N2O3 (M+H) 195.0764, found 195.0766. 4-ureidobenzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Methyl 4-ureidobenzoate (150 mg; 0.77 mmol) was suspended in THF (4 mL) and water (2 mL). A solution of LiOH (185 mg; 7.7 mmol) in water (2 mL) was added to the suspension at 0 °C. Reaction stirred overnight, pH adjusted to 1, the precipitate was collected by filtration washed with water and three times with Et<com:Sub>2< / com:Sub>O, dried at high vacuum to give 80 mg of a white powder <com:Math><semantics>(0.44 mmol;y=58%)<annotation encoding="application / x-tex">(0.44 \text{ mmol}; y= 58\%)< / annotation>< / semantics>< / com:Math>. <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 12.50 (br, 1H), 8.90 (s, 1H), 7.84 – 7.77 (m, 2H), 7.54 – 7.45 (m, 2H), 6.02 (s, 1H). <com:Sup>13< / com:Sup>C NMR (126 MHz, DMSO) δ 167.1, 155.6, 144.9, 130.4, 122.9, 116.7. HRMS (ESI) calculated for C8H7N2O3 (M-H) 179.0462, found 179.0470. ethyl (E)-3-(4-cyanophenyl)-2-methylacrylate 4-hydroxybenzaldehyd (500 mg; 3.82 mmol) was dissolved in DCM (3.0 mL) at rt, ethyl-2- (triphenylphosphoranylidene) propionate (1.06 g; 2.94 mmol) was added. The mixture was stirred overnight at 37°C then concentrated under reduced pressure. The crude was purified on silica gel with a gradient 1-50%EA in Pet. Et. to give 570 mg of white solid (2.65 mmol; y= 90%). <com:Sup>1< / com:Sup>H NMR (500 MHz, CDCl<com:Sub>3< / com:Sub>) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 7.70 – 7.66 (m, 2H), 7.64 (s, 1H), 7.47 (d, <com:Math><semantics>J=8.2<annotation encoding="application / x-tex">J = 8.2< / annotation>< / semantics>< / com:Math> Hz, 2H), 4.29 (q, <com:Math><semantics>J=7.1<annotation encoding="application / x-tex">J = 7.1< / annotation>< / semantics>< / com:Math> Hz, 2H), 2.10 (d, <com:Math><semantics>J=1.5<annotation encoding="application / x-tex">J = 1.5< / annotation>< / semantics>< / com:Math> Hz, 3H), 1.35 (t, <com:Math><semantics>J=7.1<annotation encoding="application / x-tex">J = 7.1< / annotation>< / semantics>< / com:Math> Hz, 3H). <com:Sup>13< / com:Sup>C NMR (126 MHz, CDCl<com:Sub>3< / com:Sub>) δ 167.9, 140.6, 136.4, 132.1, 131.8, 130.0, 118.6, 111.7, 61.3, 14.3, 14.2. HRMS (ESI) calculated for C13H14NO2 (M+H) 216.1019, found 216.1014. (E)-3-(4-cyanophenyl)-2-methylacrylic acid (35) [Image disponible dans le document PDF, Image available in the PDF document] Ethyl (E)-3-(4-cyanophenyl)-2-methylacrylate (150 mg; 0.67 mmol) was dissolved in THF (3.35 mL) and water (1.68 mL), solution cooled to 0 C and a mixture of LiOH (167 mg; 6.98 mmol) in water (1.68 mL) added to it. Reaction stirred at 0 C for 10 min. then to r.t. overnight. Reaction quenched adjusting pH to 1, then diluted with EA (20 mL) and HCl 1 N (20 mL), organic solvent washed with brine and dried over sodium sulphate. Solvent reduce under vacuum to afford 125 mg of a white solid (0.67 mmol; y=q.). <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 7.91 – 7.87 (m, 2H), 7.65 (d, <com:Math><semantics>J<annotation encoding="application / x-tex">J< / annotation>< / semantics>< / com:Math> = 8.2 Hz, 2H), 7.61 (s, 1H), <com:Math><semantics>2.02(d,J=1.5Hz,3H).<annotation encoding="application / x-tex">2.02 (d, J = 1.5 Hz, 3H).< / annotation>< / semantics>< / com:Math> <com:Sup>13< / com:Sup>C NMR (126 MHz, DMSO) δ 168.9, 140.4, 135.8, 132.3, 130.3, 127.6, 118.7, 110.6, 14.0. HRMS (ESI) calculated for C11H10NO2 (M+H) 188.0706, found 188.0709. 4,5-bis(allyloxy)picolinic acid [Image disponible dans le document PDF, Image available in the PDF document] Synthesized following modified experimental procedures reported in "WO 2010070523 and J. Med. Chem., 2013, 56 (13), pp 5541–5552". Allyl Bromide was used instead of benzyl bromide. <com:Sup>1< / com:Sup>H NMR (500 MHz, MeOD) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 8.16 (s, 1H), 7.82 (s, 1H), 6.11 (m, 2H), 5.54 – 5.44 (m, 2H), 5.36 (m, 2H), 4.86 (dt, <com:Math><semantics>J=5.3<annotation encoding="application / x-tex">J = 5.3< / annotation>< / semantics>< / com:Math>, 1.5 Hz, 2H), 4.77 (dt, <com:Math><semantics>J=5.3<annotation encoding="application / x-tex">J = 5.3< / annotation>< / semantics>< / com:Math>, 1.5 Hz, 2H). <com:Math><semantics>13<annotation encoding="application / x-tex">^{13}< / annotation>< / semantics>< / com:Math>C NMR (126 MHz, MeOD) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 165.4, 159.9, 149.2, 144.4, 133.6, 132.9, 131.0, 119.5, 119.2, 110.5, 72.0, 71.5. HRMS (ESI) calculated for C12H14NO4 (M+H) 236.0917, found 236.0922. b. Fragments B1 Synthesis: [Image disponible dans le document PDF, Image available in the PDF document] methyl (S)-4-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-oxo-4- (tritylamino)butanamido)benzoate [Image disponible dans le document PDF, Image available in the PDF document] See: J. Org. Chem. (2012), 77, 6948-6958 POCl<com:Sub>3< / com:Sub> (2.22 mL; 23.84 mmol) was added at 0 °C under N<com:Sub>2< / com:Sub> atmosphere to a stirred solution of Fmoc-Asn(Trt)OH (14.22 g; 23.84 mmol), TEA (5.51 mL; 39.74 mmol) and methyl 4- aminobenzoate (3.00 g; 19.87 mmol) in DCM (330 mL). Reaction stirred at 0 C for 2 hours, quenched with HCl 1N and ice. Organic phase washed with HCL 1 N (300 mL), brine (330 mL) and dried over sodium sulphate. The solvent was removed under reduced pressure, the residue thus obtained was chromatographed on silica gel with a gradient 0-10% EA in DCM to give 13.97 g of a white solid(19.16 mmol; <com:Math><semantics>y=96%<annotation encoding="application / x-tex">y=96\%< / annotation>< / semantics>< / com:Math>). <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.44 (s, 1H), 8.62 (s, 1H), 7.91 (dd, <com:Math><semantics>J=15.9<annotation encoding="application / x-tex">J = 15.9< / annotation>< / semantics>< / com:Math>, 8.2 Hz, 4H), 7.80 (d, <com:Math><semantics>J=7.9<annotation encoding="application / x-tex">J = 7.9< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>7.78−7.72<annotation encoding="application / x-tex">7.78 - 7.72< / annotation>< / semantics>< / com:Math> (m, 4H), <com:Math><semantics>7.41<annotation encoding="application / x-tex">7.41< / annotation>< / semantics>< / com:Math> (q, <com:Math><semantics>J=7.6<annotation encoding="application / x-tex">J = 7.6< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>7.30<annotation encoding="application / x-tex">7.30< / annotation>< / semantics>< / com:Math> (dt, <com:Math><semantics>J=22.8<annotation encoding="application / x-tex">J = 22.8< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>7.3<annotation encoding="application / x-tex">7.3< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>7.23−7.15<annotation encoding="application / x-tex">7.23 - 7.15< / annotation>< / semantics>< / com:Math> (m, 15H), <com:Math><semantics>4.48−4.43<annotation encoding="application / x-tex">4.48 - 4.43< / annotation>< / semantics>< / com:Math> (m, 1H), <com:Math><semantics>4.36<annotation encoding="application / x-tex">4.36< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=10.6<annotation encoding="application / x-tex">J = 10.6< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>7.1<annotation encoding="application / x-tex">7.1< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>4.30<annotation encoding="application / x-tex">4.30< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=10.5,7.1 Hz,1H<annotation encoding="application / x-tex">J = 10.5, 7.1 \text{ Hz}, 1\text{H}< / annotation>< / semantics>< / com:Math>), 4.23 (t, <com:Math><semantics>J=7.0 Hz,1H<annotation encoding="application / x-tex">J = 7.0 \text{ Hz}, 1\text{H}< / annotation>< / semantics>< / com:Math>), 2.75 (dd, <com:Math><semantics>J=14.6,9.8 Hz,1H<annotation encoding="application / x-tex">J = 14.6, 9.8 \text{ Hz}, 1\text{H}< / annotation>< / semantics>< / com:Math>), 2.62 (dd, <com:Math><semantics>J=10.5,7.1 Hz<annotation encoding="application / x-tex">J = 10.5, 7.1 \text{ Hz}< / annotation>< / semantics>< / com:Math>), 2.62 (dd, <com:Math><semantics>J=10.5,7.1 Hz<annotation encoding="application / x-tex">J = 10.5, 7.1 \text{ Hz}< / annotation>< / semantics>< / com:Math>), 4.23 (t, <com:Math><semantics>J=7.0 Hz<annotation encoding="application / x-tex">J = 7.0 \text{ Hz}< / annotation>< / semantics>< / com:Math>), 1H), 2.75 (dd, 14.6, 5.0 Hz, 1H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 170.9, 168.4, 165.8, 155.8, 144.7, 143.8, 143.8, 143.4, 140.7, 130.2, 128.6, 127.6, 127.4, 127.1, 126.3, 125.3, 125.2, 124.0, 120.1, 118.7, 69.4, 65.8, 52.9, 51.9, 46.7, 38.3, 20.8. HRMS (ESI) calculated for C46H40N3O6 (M+H<com:Sup>+< / com:Sup>) 730.2912, found 730.2925. Marfey: 96.5% S enantiomer, 3.5% R enantiomer methyl (S)-4-(2-(4-nitrobenzamido)-4-oxo-4-(tritylamino)butanamido)benzoate [Image disponible dans le document PDF, Image available in the PDF document] Methyl (S)-4-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-oxo-4-(tritylamino)butan- amido)benzoate (12.26 g; 16.82 mmol) was dissolved in a 20% solution of diethylamine in acetonitrile (195 mL), solution stirred for 30 min. The solvent was removed under reduced pressure, the residue was dissolved in CH<com:Sub>3< / com:Sub>CN and evaporated twice. The pale yellow gum and 4-Nitrobenzoic acid (3.09 g; 18.5 mmol) were suspended in CH<com:Sub>3< / com:Sub>CN (140 mL), HBTU (7.02 g; 18.5 mmol) followed by DiPEA (6.754 mL, 38.85 mmol) were added at 0 C. The reaction mixture was stirred for 3 hours and quenched with NaHCO3 saturated solution. The solvent was partially evaporated under reduced pressure, the residue was dissolved in EA (300 mL). Organic phase washed with NaHCO<com:Sub>3< / com:Sub> saturated solution (300 mL), HCl 1 N (300 mL), brine (300 mL) dried over sodium sulphate and evaporated under vacuum. The residue thus obtained was triturated with Pet. Et. and chromatographed on silica gel with a gradient 0- 10% EA in DCM to give 8.64 g of a yellow solid (13.17 mmol; <com:Math><semantics>y=78%<annotation encoding="application / x-tex">y=78\%< / annotation>< / semantics>< / com:Math>). <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.57 (s, 1H), 9.20 (d, <com:Math><semantics>J=7.6<annotation encoding="application / x-tex">J = 7.6< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.68 (s, 1H), 8.41 – <com:Math><semantics>8.35 (m, 2H),8.18−8.13 (m, 2H),7.95−7.90 (m, 2H),7.80−7.75 (m, 2H),7.23−7.13 (m, 2H)<annotation encoding="application / x-tex">8.35 \text{ (m, 2H)}, 8.18 - 8.13 \text{ (m, 2H)}, 7.95 - 7.90 \text{ (m, 2H)}, 7.80 - 7.75 \text{ (m, 2H)}, 7.23 - 7.13 \text{ (m, 2H)}< / annotation>< / semantics>< / com:Math> 15H), 4.93 (m, 1H), 3.82 (s, 3H), 2.98 (dd, <com:Math><semantics>J=14.9<annotation encoding="application / x-tex">J = 14.9< / annotation>< / semantics>< / com:Math>, 10.5 Hz, 1H), 2.75 (dd, <com:Math><semantics>J=14.8<annotation encoding="application / x-tex">J = 14.8< / annotation>< / semantics>< / com:Math>, 4.6 Hz, 1H). <com:Sup>13< / com:Sup>C NMR (126 MHz, DMSO) δ 170.5, 168.3, 165.8, 164.6, 149.2, 144.7, 143.3, 139.3, 130.2, 129.0, 128.5, 127.4, 126.4, 124.1, 123.6, 118.8, 69.4, 52.1, 51.9, 37.9. HRMS (ESI) calculated for C38H33N4O7 (M+H<com:Sup>+< / com:Sup>) 657.2344, found 657.2348. Marfey: 94.2% S enantiomer, 5.8% R enantiomer (S)-4-(2-(4-nitrobenzamido)-4-oxo-4-(tritylamino)butanamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] See: J. Org. Chem., 2016, 81 (3), pp 1137–1150 Methyl (S)-4-(2-(4-nitrobenzamido)-4-oxo-4-(tritylamino)butanamido)benzoate (5.7 g; 8.69 mmol) and lithium iodide (9.32 g; 69.52 mmol) were mixed in EA (80 mL) and heated to 90 °C for 5 days. After cooling, mixture diluted with EA (200 mL) and HCl 1 N (200 mL), organic phase washed with water (2x 200 mL), brine (200 mL), dried over sodium sulphate and reduced under vacuum. The residue was chromatographed on silica gel with a gradient 0- 20% MeOH in DCM to give 5.39 g of yellow solid (7.44 mmol; y= 86%). <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 12.72 (s, 1H), 10.52 (s, 1H), 9.19 (d, <com:Math><semantics>J=7.6<annotation encoding="application / x-tex">J = 7.6< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.67 (s, 1H), <com:Math><semantics>8.40−8.36<annotation encoding="application / x-tex">8.40 - 8.36< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>8.17−8.13<annotation encoding="application / x-tex">8.17 - 8.13< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>7.91−7.88<annotation encoding="application / x-tex">7.91 - 7.88< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>7.76−7.72<annotation encoding="application / x-tex">7.76 - 7.72< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>7.22<annotation encoding="application / x-tex">7.22< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−7.14<annotation encoding="application / x-tex">-7.14< / annotation>< / semantics>< / com:Math> (m, 15H), 4.93 (m, 1H), 2.98 (dd, <com:Math><semantics>J=14.9<annotation encoding="application / x-tex">J = 14.9< / annotation>< / semantics>< / com:Math>, 10.6 Hz, 1H), 2.75 (dd, <com:Math><semantics>J=14.9<annotation encoding="application / x-tex">J = 14.9< / annotation>< / semantics>< / com:Math>, 4.5 Hz, 1H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 170.4, 168.3, 166.9, 164.6, 149.2, 144.7, 142.9, 139.3, 130.3, 129.0, 128.5, 127.4, 126.4, 123.6, 118.6, 69.4, 66.3, 52.0, 38.0. <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 170.4, 168.3, 166.9, 164.6, 149.2, 144.7, 142.9, 139.3, 130.3, 129.0, 128.5, 127.4, 126.4, 123.6, 118.6, 69.4, 52.0, 38.0. HRMS (ESI) calculated for C37H29N4O7 (M-H) 641.2041, found 641.2045. Marfey: 94.0 % S enantiomer, 6.0% R enantiomer c. Fragments C1-4 *** Fragment C1 [Image disponible dans le document PDF, Image available in the PDF document] Synthesis: [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] [Image disponible dans le document PDF, Image available in the PDF document] 2-hydroxy-3-isopropoxybenzaldehyde [Image disponible dans le document PDF, Image available in the PDF document] See: Angew. Chem. Int. Ed. 2011, 50, 1101 –1104 A solution of 2,3-dihydroxybenzaldehyde (20 g; 145 mmol) in DMSO (100 mL) was added dropwise, keeping low the temperature with an ice bath, to a previously prepared suspension of NaH (7.0 g; 292 mmol) in DMSO (250 mL). The mixture stirred at r.t. for two hours, then 2-Bromopropane (13.6 mL; 145 mmol) was added slowly keeping low the temperature. The reaction mixture was stirred for 36 hours, quenched with HCl followed by NH<com:Sub>4< / com:Sub>Cl until pH 5 reached. Work up done in several portions as follows: 300 mL of the mixture were further diluted with H2O (1200 mL) and extracted with Et2O (3x 200 mL). Organic phases dried over Na2SO4 and reduced under pressure to give 30 g of dark oil. Crude residue chromatographed on silica gel, isocratic condition (Pet. Et. DCM 7:3) to give 9.78 g of a yellow oil (54 mmol, <com:Math><semantics>y=37%<annotation encoding="application / x-tex">y=37\%< / annotation>< / semantics>< / com:Math>). <com:Sup>1< / com:Sup>H NMR (500 MHz, CDCl<com:Sub>3< / com:Sub>) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.96 (s, 1H), 9.92 (s, 1H), 7.19 (dd, <com:Math><semantics>J=7.8<annotation encoding="application / x-tex">J = 7.8< / annotation>< / semantics>< / com:Math>, 1.5 Hz, 1H), 7.15 <com:Math><semantics>(dd,J=8.0,1.2 Hz,1H),6.94(t,J=7.9 Hz,1H),4.59(m,J=6.1 Hz,1H),1.39(d,J=6.1 Hz)<annotation encoding="application / x-tex">(dd, J = 8.0, 1.2 \text{ Hz}, 1\text{H}), 6.94 (t, J = 7.9 \text{ Hz}, 1\text{H}), 4.59 (m, J = 6.1 \text{ Hz}, 1\text{H}), 1.39 (d, J = 6.1 \text{ Hz})< / annotation>< / semantics>< / com:Math> Hz, 1H). <com:Sup>13< / com:Sup>C NMR (126 MHz, CDCl<com:Sub>3< / com:Sub>) δ 196.4, 153.0, 146.4, 125.3, 122.7, 121.3, 119.5, 72.1, 22.0. HRMS (ESI) calculated for C10H13O3 (M+H<com:Sup>+< / com:Sup>) 181.0859, found 181.0858. 2-formyl-6-isopropoxyphenyl acetate [Image disponible dans le document PDF, Image available in the PDF document] Acetyl chloride (4.25 mL; 59.76 mmol) was added dropwise to a stirred solution of 2- hydroxy-3-isopropoxybenzaldehyde (9.78 g; 54.33 mmol) and pyridine (9.65 mL; 119.53 mmol) in DCM (540 mL) at 0 C. Reaction stirred for 5 min. at 0 °C then temperature raised to r.t. Stirring prolonged for 1 h. Reaction quenched with HCl 1 N, organic phase partially reduced under vacuum, washed with HCl 1 N (200 mL), brine (200 mL), dried over sodium sulphate and reduced under vacuum to give 12.2 g of a yellow oil, which was chromatographed on silica gel with a gradient 2-10% EA in Pet. Et, to give 8.89 g of a pale yellow oil (<com:Math><semantics>40.04 mmol<annotation encoding="application / x-tex">40.04 \text{ mmol}< / annotation>< / semantics>< / com:Math>; y= <com:Math><semantics>74%<annotation encoding="application / x-tex">74\%< / annotation>< / semantics>< / com:Math>). <com:Sup>1< / com:Sup>H NMR (700 MHz, CDCl<com:Sub>3< / com:Sub>) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.14 (s, 1H), 7.44 (dd, <com:Math><semantics>J<annotation encoding="application / x-tex">J< / annotation>< / semantics>< / com:Math> = 7.8, 1.5 Hz, 1H), 7.30 (t, <com:Math><semantics>J<annotation encoding="application / x-tex">J< / annotation>< / semantics>< / com:Math> = 8.0 Hz, 1H), 7.21 (dd, <com:Math><semantics>J=8.3<annotation encoding="application / x-tex">J = 8.3< / annotation>< / semantics>< / com:Math>, 1.3 Hz, 1H), 4.59 – 4.53 (m, 1H), 2.39 (s, 3H), 1.34 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, CDCl<com:Sub>3< / com:Sub>) δ 188.8, 168.7, 150.2, 142.9, 129.5, 126.6, 121.0, 120.6, 71.9, 22.0, 20.5. HRMS (ESI) calculated for C12H15O4 (M+H<com:Sup>+< / com:Sup>) 223.0965, found 223.0968. 6-formyl-2-isopropoxy-3-nitrophenyl acetate [Image disponible dans le document PDF, Image available in the PDF document] Fuming nitric acid (17.5 mL, 420 mmol) was cooled to -40 °C under a nitrogen atmosphere. A solution of 2-formyl-6-isopropoxyphenyl acetate (6.50 g, 29.3 mmol) in 40 mL of dry DCM was added dropwise while the mixture was vigorously stirred and kept at -40 °C. The solution was stirred for an additional 1.5 hours before being poured into 150 mL of ice water. The mixture was then extracted with DCM (<com:Math><semantics>4×50<annotation encoding="application / x-tex">4 \times 50< / annotation>< / semantics>< / com:Math> mL) and the combined organic extracts were dried over sodium sulphate. The solvent was removed under vacuum to afford the desired compound as an orange oil (7.59 g, 28.4 mmol, y= 97%), containing around 17% of deactylated product. <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.10 (d, <com:Math><semantics>J=0.5<annotation encoding="application / x-tex">J = 0.5< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.00 (dd, <com:Math><semantics>J=8.5<annotation encoding="application / x-tex">J = 8.5< / annotation>< / semantics>< / com:Math>, 0.4 Hz, 1H), 7.81 <com:Math><semantics>(d,J=8.5 Hz,1H),4.46 (hept, J=6.1 Hz,1H),2.44 (s, 3H),1.22 (d, J=6.1 Hz,6H).<annotation encoding="application / x-tex">(d, J = 8.5 \text{ Hz}, 1\text{H}), 4.46 \text{ (hept, } J = 6.1 \text{ Hz}, 1\text{H}), 2.44 \text{ (s, 3H)}, 1.22 \text{ (d, } J = 6.1 \text{ Hz}, 6\text{H}).< / annotation>< / semantics>< / com:Math> <com:Sup>13< / com:Sup>C NMR (126 MHz, DMSO) δ 189.4, 168.3, 148.4, 145.5, 143.1, 131.8, 125.4, 122.0, 78.9, 22.1, 20.4. HRMS (ESI) calculated for C12H14NO6 (M+H<com:Sup>+< / com:Sup>) 268.0816, found 268.0811. 2-(allyloxy)-3-isopropoxy-4-nitrobenzaldehyde [Image disponible dans le document PDF, Image available in the PDF document] 6-formyl-2-isopropoxy-3-nitrophenyl acetate (2.10 g; 7.9 mmol) was dissolved in THF (40 mL) and water (20 mL), then LiOH (1.89 g; 79.0 mmol) dissolved in water (20 mL) was added at 0 C, reaction stirred overnight. In the morning, pH adjusted to 1, solvent partially reduced under vacuum and watery phase extracted with CHCl3 (150 mL) three times, combined organic phases dried over sodium sulphate and reduced under vacuum to give a yellow oil, which was used in the next step without further purification. Residue was dissolved in DMF (20 mL), K<com:Sub>2< / com:Sub>CO<com:Sub>3< / com:Sub> (2.18 g; 15.8 mmol) followed by allyl bromide (1.026 mL; 11.85 mmol) were added, reaction stirred 24 h at r.t.. Reaction diluted with water (200 mL) and EA (200 mL), aqueous phase extracted with EA (150 mL). Combined organic phases washed with brine (300 mL), dried over sodium sulphate and reduced under vacuum to give 4 g of a crude material, which was chromatographed on silica gel with a gradient 0-10% EA in Pet. Et. to give 1.69 g a yellow oil (6.37 mmol; y= 81%). <com:Sup>1< / com:Sup>H NMR (500 MHz, CDCl<com:Sub>3< / com:Sub>) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.39 (d, <com:Math><semantics>J=0.9<annotation encoding="application / x-tex">J = 0.9< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.64 (d, <com:Math><semantics>J=8.5<annotation encoding="application / x-tex">J = 8.5< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.51 (dd, <com:Math><semantics>J=0.5<annotation encoding="application / x-tex">J = 0.5< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.51 (dd, <com:Math><semantics>J=0.5<annotation encoding="application / x-tex">J = 0.5< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.51 (dd, <com:Math><semantics>J=0.5<annotation encoding="application / x-tex">J = 0.5< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.51 (dd, <com:Math><semantics>J=0.5<annotation encoding="application / x-tex">J = 0.5< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.51 (dd, <com:Math><semantics>J=0<annotation encoding="application / x-tex">J = 0< / annotation>< / semantics>< / com:Math> <com:Math><semantics>=8.5,0.9 Hz,1H,6.05 (m, J=17.1,10.3,6.1 Hz,1H),5.40 (pseudo dq, J=17.1,1.4 Hz,<annotation encoding="application / x-tex">= 8.5, 0.9 \text{ Hz}, 1\text{H}, 6.05 \text{ (m, } J = 17.1, 10.3, 6.1 \text{ Hz}, 1\text{H}), 5.40 \text{ (pseudo dq, } J = 17.1, 1.4 \text{ Hz},< / annotation>< / semantics>< / com:Math> 1H), 5.33 (pseudo dq, <com:Math><semantics>J=10.3<annotation encoding="application / x-tex">J = 10.3< / annotation>< / semantics>< / com:Math>, 2.2, 1.0 Hz, 1H), 4.74 – 4.72 (m, 1H), 4.68 (m, 1H), 1.32 (d, <com:Math><semantics>J<annotation encoding="application / x-tex">J< / annotation>< / semantics>< / com:Math> <com:Math><semantics>=6.2 Hz,1H<annotation encoding="application / x-tex">= 6.2 \text{ Hz}, 1 \text{H}< / annotation>< / semantics>< / com:Math>). <com:Sup>13< / com:Sup>C NMR (126 MHz, CDCl<com:Sub>3< / com:Sub>) δ 188.7, 156.3, 150.0, 145.1, 133.0, 132.0, 122.3, 120.3, 119.5, 78.3, 75.7, 22.4. HRMS (ESI) calculated for C13H15NO5Na (M+Na<com:Sup>+< / com:Sup>) 288.0842, found 288.0839. 2-(allyloxy)-3-isopropoxy-4-nitrobenzoic acid [Image disponible dans le document PDF, Image available in the PDF document] See: J. AM. CHEM. SOC. 2004, 126, 8396-8398 and J. Org. Chem. 2015, 80, 6076-6082 2-(allyloxy)-3-isopropoxy-4-nitrobenzaldehyde (1.69 g; 6.38 mmol) and 2-Methyl-2-butene (7.2 mL; 70 mmol) were dissolved in t-BuOH (48 mL). Then a solution of NaClO<com:Sub>2< / com:Sub> 80% (0.87 g; 7.65 mmol) in Monosodium phosphate monohydrate solution 1 N (7.2 mL) was added dropwise to the solution. Reaction stirred for 1 h, t hen quenched by adding a solution of Na<com:Sub>2< / com:Sub>SO<com:Sub>3< / com:Sub> (14.0 mmol in 10 mL). Mixture partially reduced under vacuum, diluted with EA (100 mL) and HCl 1 N (100 mL), aqueous phase extracted again with EA (50 mL), organic phases reunited washed with brine (150 mL) and dried over sodium sulphate. Solvent reduced under vacuum to give 1.9 g (6.38 mmol; y= q.) of a dark residue, which was used in the next step without further purification. allyl 4-nitrobenzoate [Image disponible dans le document PDF, Image available in the PDF document] K<com:Sub>2< / com:Sub>CO<com:Sub>3< / com:Sub> (2.5 g, 17.95 mmol) was added to a stirred mixture of 4-Nitrobenzoic acid (5.0 g; 30.0 mmol) and Allyl bromide (2.9 mL; 33.0 mmol) in DMF (50 mL). Reaction was stirred for 24 hours. Et<com:Sub>2< / com:Sub>O (500 mL) and water (500 mL) were added, the organic phase washed then with NaHCO<com:Sub>3< / com:Sub> satured solution twice (400 mL) and once with brine (400 mL), dried over sodium sulphate, evaporated under reduced pressure to obtain 6.1 g (30.0 mmol; y= q.) of a yellow oil. Product was used in the next step without further purification. allyl 4-aminobenzoate [Image disponible dans le document PDF, Image available in the PDF document] Zinc powder (27 g; 541 mmol) was added over 30 min to a solution of allyl 4- nitrobenzoate(5.6 g; 27 mmol) in acetic acid (100 mL). Reaction stirred overnight at r.t.. It was quenched with NaHCO3, watery phase extracted twice with EA, washed again with NaHCO3 and brine, dried over sodium sulphate and reduced under vacuum to give around 4.5 g of a crude residue, which was chromatographed on silica gel with a gradient 5-30% EA in Pet. Et. to afford 3.42 g (19 mmol; y= 71%) of a white solid. <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 7.74 – 7.55 (m, 2H), 6.62 – 6.51 (m, 2H), 6.00 (m, 3H), 5.34 (pseudo dq, <com:Math><semantics>J=17.2<annotation encoding="application / x-tex">J = 17.2< / annotation>< / semantics>< / com:Math>, 1.7 Hz, 1H), 5.22 (pseudo dq, <com:Math><semantics>J=10.5<annotation encoding="application / x-tex">J = 10.5< / annotation>< / semantics>< / com:Math>, 1.4 Hz, 1H), 4.68 (dt, <com:Math><semantics>J=5.3<annotation encoding="application / x-tex">J = 5.3< / annotation>< / semantics>< / com:Math>, 1.5 Hz, 2H). <com:Sup>13< / com:Sup>C NMR (126 MHz, DMSO) δ 165.5, 153.6, 133.3, 131.1, 117.2, 115.6, 112.6, 64.0. HRMS (ESI) calculated for C10H12NO2 (M+H<com:Sup>+< / com:Sup>) 178.0863, found 178.0867. allyl 4-(2-(allyloxy)-3-isopropoxy-4-nitrobenzamido)benzoate [Image disponible dans le document PDF, Image available in the PDF document] . - POCl<com:Sub>3< / com:Sub> (0.68 mL; 7.32 mmol) was added at 0 °C to a stirred solution of 2-(allyloxy)-3- isopropoxy-4-nitrobenzoic acid (7.32 mmol, crude), TEA (1.7 mL; 12.20 mmol) and allyl 4- aminobenzoate (1.08 g; 6.10 mmol) in DCM (100 mL) under nitrogen. Reaction stirred for 3 h, then quenched with NaHCO<com:Sub>3< / com:Sub> saturated solution, solvent partially reduced under vacuum, then diluted with EA (150 mL) and water (150 mL), aqueous phase extracted again twice with EA (2x 100 mL), organic phases reun ited washed with HCl 1 N (300 mL) and brine (300 mL), dried over sodium sulphate and reduced under vacuum to give a crude material, which was chromatographed on silica gel with a gradient 5-30% to give 2.22 g (5.04 mmol; y= 83%) of a yellow oil. <com:Sup>1< / com:Sup>H NMR (500 MHz, CDCl<com:Sub>3< / com:Sub>) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.17 (s, 1H), 8.08 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 3H), 7.74 (d, <com:Math><semantics>J=8.6<annotation encoding="application / x-tex">J = 8.6< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.63 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 1H), 6.24 – 5.87 (m, 2H), 5.55 – 5.22 (m, 4H), 4.80 (dd, <com:Math><semantics>J=20.6<annotation encoding="application / x-tex">J = 20.6< / annotation>< / semantics>< / com:Math>, 5.9 Hz, 4H), 4.64 (hept, <com:Math><semantics>J=12.4<annotation encoding="application / x-tex">J = 12.4< / annotation>< / semantics>< / com:Math>, 6.3 Hz, 1H), 1.34 (d, <com:Math><semantics>J=6.2<annotation encoding="application / x-tex">J = 6.2< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, CDCl<com:Sub>3< / com:Sub>) δ 165.7, 161.1, 151.5, 148.2, 144.7, 141.9, 132.3, 131.5, 131.0, 130.5, 126.2, 126.1, 121.1, 120.0, 119.4, 118.3, 78.7, 75.7, 65.5, 22.4. HRMS (ESI) calculated for C23H25N2O7 (M+H<com:Sup>+< / com:Sup>) 441.1656, found 441.1654 allyl 4-(2-(allyloxy)-4-amino-3-isopropoxybenzamido)benzoate [Image disponible dans le document PDF, Image available in the PDF document] Tin(II) chloride dehydrate (4.3 g; 19.09 mmol), allyl 4-(2-(allyloxy)-3-isopropoxy-4- nitrobenzamido)benzoate (1.4 g; 3.18 mmol) were dissolved in EtOH (32 mL), the solution was stirred at r.t. overnight. The solvent was removed under vacuum, NaHCO3 saturated solution (300 mL) and EA (300 mL) were added to the residue. The aqueous phase extracted again with EA (200 mL). The organic phases reunited were washed with brine (400 mL), dried over sodium sulphate and reduced under vacuum. The crude residue thus obtained was chromatographed on silica gel with a gradient EA 10-40% in Pet. Et. to give 1.22 g (2.98 mmol; 95%)of a yellow oil. <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.26 (s, 1H), <com:Math><semantics>8.01−7.86<annotation encoding="application / x-tex">8.01 - 7.86< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>7.86−7.74<annotation encoding="application / x-tex">7.86 - 7.74< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>7.39<annotation encoding="application / x-tex">7.39< / annotation>< / semantics>< / com:Math> <Formule mathématique disponible dans le document PDF, Math available in the PDF document>(d, J = 8.6 \text{ Hz}, 1\text{H}), 6.56 (d, J = 8.6 \text{ Hz}, 1\text{H}), 6.26 - 5.93 (m, 2\text{H}), 5.59 (s, 2\text{H}), 5.48 - 5.35 (m, 2\text{H}), 5.59 (s, 2\text{H}), 5.48 - 5.35 (m, 2\text{H}), 5.59 (s, 2\text{H}), 5.48 - 5.35 (m, 2\text{H}), 5.59 (s, 2\text{ 2H), 5.30- 5.20 (m, 2H) 4.78 (dt, <com:Math><semantics>J=5.4<annotation encoding="application / x-tex">J = 5.4< / annotation>< / semantics>< / com:Math>, 1.5 Hz, 2H), 4.61 (dt, <com:Math><semantics>J=5.6<annotation encoding="application / x-tex">J = 5.6< / annotation>< / semantics>< / com:Math>, 1.4 Hz, 2H), 4.46 (hept, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 1H), 1.26 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (126 MHz, DMSO) δ 165.0, 163.9, 150.6, 147.8, 143.7, 135.3, 133.6, 132.8, 130.3, 126.1, 123.6, 118.8, 118.1, 117.7, 114.6, 109.9, 74.4, 73.7, 64.8, 40.1, 40.0, 39.9, 39.8, 39.8, 39.7, 39.6, 39.5, 39.3, 39.2, 39.0, 22.2. HRMS (ESI) calculated for C23H27N2O5 (M+H<com:Sup>+< / com:Sup>) 411.1914, found 411.1900 Fragment C2 ( ) O О‱ЙН O٠, NH<com:Sub>2< / com:Sub> Synthesis: [Image disponible dans le document PDF, Image available in the PDF document] 12 13 allyl 2-(allyloxy)-3-isopropoxy-4-nitrobenzoate [Image disponible dans le document PDF, Image available in the PDF document] 6-formyl-2-isopropoxy-3-nitrophenyl acetate (0.9 g; 3.37 mmol) was dissolved in THF (17 mL) and water (8.5 mL), then LiOH (0.81 g; 33.70 mmol) dissolved in water (8.5 mL) was added at 0 C, reaction stirred overnight. pH adjusted to 1, solvent partially reduced under vacuum and watery phase extracted with CHCl3 (100 mL) three times, combined organic phases dried over sodium sulphate and reduced under vacuum to give a yellow oil. Which was dissolved with 2-Methyl-2-butene (3.75 mL; 35.39 mmol) in t-BuOH (25 mL). Then a solution of NaClO<com:Sub>2< / com:Sub> 80% (0.46 g; 4.04 mmol) in Monosodium phosphate monohydrate solution 1 N (3.75 mL) was added dropwise to the solution. Reaction stirred for 1 h, t hen quenched by adding a solution of Na<com:Sub>2< / com:Sub>SO<com:Sub>3< / com:Sub> (8.0 mmol in 5 mL). Mixture partially reduced under vacuum, diluted with EA (100 mL) and HCl 1 N (100 mL), aqueous phase extracted again with EA (50 mL), organic phases reunited washed with brine (150 mL) and dried over sodium sulphate. Solvent removed under vacuum, the residue was dissolved in DMF (9.0 mL), K<com:Sub>2< / com:Sub>CO<com:Sub>3< / com:Sub> (1.40 g; 10.11 mmol) followed by allyl bromide (0.73 mL; 8.43 mmol) were added, reaction stirred 24 h at r.t.. Reaction diluted with water (100 mL) and EA (100 mL), aqueous phase extracted with EA (50 mL). Combined organic phases washed with brine (100 mL), dried over sodium sulphate and reduced under vacuum, the crude material was chromatographed on silica gel with a gradient 0-10% EA in Pet. Et. to give 0.84 g a yellow oil <com:Math><semantics>(2.63 mmol;y=79%).<annotation encoding="application / x-tex">(2.63 \text{ mmol}; y=79\%).< / annotation>< / semantics>< / com:Math> <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 7.70 (d, <com:Math><semantics>J=8.5<annotation encoding="application / x-tex">J = 8.5< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.57 (d, <com:Math><semantics>J=8.5<annotation encoding="application / x-tex">J = 8.5< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 6.08 – 5.97 (m, 2H), 5.40 (m, 2H), 5.28 (m, 2H), 4.81 (dt, <com:Math><semantics>J=5.6<annotation encoding="application / x-tex">J = 5.6< / annotation>< / semantics>< / com:Math>, 1.4 Hz, 2H), 4.64 (dt, <com:Math><semantics>J=12.3<annotation encoding="application / x-tex">J = 12.3< / annotation>< / semantics>< / com:Math>, 6.1 Hz, 1H), <com:Math><semantics>4.56<annotation encoding="application / x-tex">4.56< / annotation>< / semantics>< / com:Math> (dt, <com:Math><semantics>J=5.8<annotation encoding="application / x-tex">J = 5.8< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>1.4<annotation encoding="application / x-tex">1.4< / annotation>< / semantics>< / com:Math> Hz, <com:Math><semantics>2H<annotation encoding="application / x-tex">2H< / annotation>< / semantics>< / com:Math>), <com:Math><semantics>1.20<annotation encoding="application / x-tex">1.20< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, <com:Math><semantics>6H<annotation encoding="application / x-tex">6H< / annotation>< / semantics>< / com:Math>). <com:Sup>13< / com:Sup>C NMR (126 MHz, DMSO) δ 164.1, 151.7, 147.8, 143.8, 133.2, 132.1, 130.4, 124.8, 119.1, 118.7, 118.5, 77.2, 74.8, 66.0, 22.0. HRMS (ESI) calculated for C16H19NNaO6 (M+Na) 344.1105, found 344.1105. allyl 2-(allyloxy)-4-amino-3-isopropoxybenzoate [Image disponible dans le document PDF, Image available in the PDF document] allyl 2-(allyloxy)-3-isopropoxy-4-nitrobenzoate 700 mg; 2.17 mmol) was dissolved in EtOH (19.8 mL) and AcOH (2.2 mL), the solution was cooled to 0 °C and to it Zn dust (1.42 g; 21.7 mmol) was added portion wise. Reaction stirred at r.t. for 4 hours then mixture filtered over a pad of celite<com:Sup>TM< / com:Sup> and solvent reduced under vacuum, he residue was chromatographed on silica gel with a gradient 1-20% EA in Pet. Et. to afford 550 mg of desired compound (1.89 mmol; <com:Math><semantics>y=87%<annotation encoding="application / x-tex">y = 87\%< / annotation>< / semantics>< / com:Math>). <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 7.33 (d, <com:Math><semantics>J=8.6<annotation encoding="application / x-tex">J = 8.6< / annotation>< / semantics>< / com:Math> Hz, 1H), 6.46 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 1H), 6.10 – 5.94 <com:Math><semantics>(m,2H),5.62(s,2H),5.34(m,2H),5.20(m,2H),4.66(dt,<math>J=5.4,1.5Hz,2H),4.45−4.38<annotation encoding="application / x-tex">(m, 2H), 5.62 (s, 2H), 5.34 (m, 2H), 5.20 (m, 2H), 4.66 (dt, J = 5.4, 1.5 Hz, 2H), 4.45 - 4.38< / annotation>< / semantics>< / com:Math> (m, 3H), 1.21 (d, <com:Math><semantics>J=6.2<annotation encoding="application / x-tex">J = 6.2< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (126 MHz, DMSO) δ 164.6, 153.1, 148.5, 136.2, 134.6, 133.2, 127.2, 117.5, 116.8, 111.0, 109.2, 74.1, 73.6, 64.2, 40.0, 39.9, 39.8, 39.8, 39.7, 39.5, 39.3, 39.2, 39.0, 22.1. HRMS (ESI) calculated for C16H22NO4 (M+H) 292.1543, found 292.1541. allyl 2-(allyloxy)-4-(2-(allyloxy)-3-isopropoxy-4-nitrobenzamido)-3-isopropoxybenzoate [Image disponible dans le document PDF, Image available in the PDF document] Collidine (1.44 mL; 11.00 mmol) was added dropwise at 0 °C to a solution of 2-(allyloxy)-3- isopropoxy-4-nitrobenzoic acid (579 mg; 2.06 mmol) and Bis(trichloromethyl) carbonate (204 mg; 0.69 mmol) in THF (13 mL). Reaction stirred at r.t. for 20 min then added to a cooled solution of allyl 2-(allyloxy)-4-amino-3-isopropoxybenzoate (400 mg; 1.37 mmol) and DiPEA (2.38 mL; 13.7 mmol) in THF (13 mL). Reaction stirred for 20 hours at r.t., quenche with water and solvent partially reduced under vacuum, mixture disluted with Et<com:Sub>2< / com:Sub>O (50 mL) and HCl 1N (50 mL), watery phase extracted again with Et<com:Sub>2< / com:Sub>O (50 mL). The combined organic phases were washed with brine (100 mL), dried over sodium sulphate and reduced under vacuum. The crude was chromatographed on silica gel with a gradient 1-20% EA in Pet. Et. to give 535 mg of desired product (0.97 mmol; y= 70%). <com:Sup>1< / com:Sup>H NMR (500 MHz, CDCl<com:Sub>3< / com:Sub>) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.73 (s, 1H), 8.42 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.02 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.68 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.62 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 1H), 6.18 – 6.00 (m, 3H), 5.45 – 5.35 (m, 2H), <com:Math><semantics>5.34−5.27<annotation encoding="application / x-tex">5.34 - 5.27< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>5.26<annotation encoding="application / x-tex">5.26< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>4.83−4.76<annotation encoding="application / x-tex">4.83 - 4.76< / annotation>< / semantics>< / com:Math> (m, 5H), <com:Math><semantics>4.65<annotation encoding="application / x-tex">4.65< / annotation>< / semantics>< / com:Math> (dt, <com:Math><semantics>J=12.3<annotation encoding="application / x-tex">J = 12.3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>6.2<annotation encoding="application / x-tex">6.2< / annotation>< / semantics>< / com:Math> Hz, 1H), 4.58 (dt, <com:Math><semantics>J=5.9<annotation encoding="application / x-tex">J = 5.9< / annotation>< / semantics>< / com:Math>, 1.3 Hz, 2H), 1.37 (d, <com:Math><semantics>J=6.2<annotation encoding="application / x-tex">J = 6.2< / annotation>< / semantics>< / com:Math> Hz, 6H), 1.28 (d, <com:Math><semantics>J=6.2<annotation encoding="application / x-tex">J = 6.2< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (126 MHz, CDCl<com:Sub>3< / com:Sub>) δ 165.0, 161.3, 151.8, 151.2, 147.9, 145.0, 140.4, 137.4, 133.8, 132.2, 131.7, 131.6, 127.0, 125.9, 121.8, 121.1, 119.9, 118.5, 118.0, 115.1, 78.7, 76.3, 76.2, 74.9, 65.6, 22.5, 22.4. HRMS (ESI) calculated for C29H35N2O9 (M+H) 555.2337, found 555.2335. allyl 2-(allyloxy)-4-(2-(allyloxy)-4-amino-3-isopropoxybenzamido)-3-isopropoxybenzoate [Image disponible dans le document PDF, Image available in the PDF document] Allyl 2-(allyloxy)-4-(2-(allyloxy)-3-isopropoxy-4-nitrobenzamido)-3-isopropoxybenzoate (250 mg; 0.45 mmol) was dissolved in EtOH (9.0 mL) and AcOH (1.0 mL), the solution was cooled to 0 °C and to it Zn dust (295 mg; 4.50 mmol) was added portion wise. Reaction stirred at r.t. for 5 hours then mixture filtered over a pad of celite and solvent reduced under vacuum, residue dissolved in DCM (30 mL), organic phase washed with NaHCO<com:Sub>3< / com:Sub> saturated solution and dried over sodium sulphate. Solvent removed under reduced pressure to give 220 mg of desired product <com:Math><semantics>(0.42 mmol;y=93%)<annotation encoding="application / x-tex">(0.42 \text{ mmol}; y= 93\%)< / annotation>< / semantics>< / com:Math>. <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.75 (s, 1H), 8.34 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.55 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.53 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 1H), 6.58 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 1H), 6.12 – 5.98 (m, 3H), 5.70 (s, 2H), 5.43 <com:Math><semantics>−5.36<annotation encoding="application / x-tex">-5.36< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>5.31<annotation encoding="application / x-tex">5.31< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>5.27−5.19<annotation encoding="application / x-tex">5.27 - 5.19< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>4.75<annotation encoding="application / x-tex">4.75< / annotation>< / semantics>< / com:Math> (dt, <com:Math><semantics>J=5.5<annotation encoding="application / x-tex">J = 5.5< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>1.5<annotation encoding="application / x-tex">1.5< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>4.67<annotation encoding="application / x-tex">4.67< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=<annotation encoding="application / x-tex">J =< / annotation>< / semantics>< / com:Math> 6.5 Hz, 2H), <com:Math><semantics>4.61−4.55<annotation encoding="application / x-tex">4.61 - 4.55< / annotation>< / semantics>< / com:Math> (m, 1H), <com:Math><semantics>4.53<annotation encoding="application / x-tex">4.53< / annotation>< / semantics>< / com:Math> (dt, <com:Math><semantics>J=5.7<annotation encoding="application / x-tex">J = 5.7< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>1.4<annotation encoding="application / x-tex">1.4< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>4.45−4.39<annotation encoding="application / x-tex">4.45 - 4.39< / annotation>< / semantics>< / com:Math> (m, 1H), <com:Math><semantics>1.29<annotation encoding="application / x-tex">1.29< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=6.2 Hz,6H,1.23(d,J=6.2 Hz,6H).<annotation encoding="application / x-tex">J = 6.2 \text{ Hz}, 6\text{H}, 1.23 (d, J = 6.2 \text{ Hz}, 6\text{H}).< / annotation>< / semantics>< / com:Math> <com:Sup>13< / com:Sup>C NMR (126 MHz, DMSO) δ 164.5, 162.9, 151.2, 150.6, 148.3, 139.5, 138.5, 135.1, 134.0, 133.0, 132.7, 126.7, 126.2, 119.8, 119.3, 118.1, 117.5, 114.2, 113.1, 110.3, 75.7, 74.8, 74.2, 74.1, 65.0, 22.2, 22.0. HRMS (ESI) calculated for C29H37N2O7 (M+H) 525.2595, found 525.2591. Fragment C3 [Image disponible dans le document PDF, Image available in the PDF document] Synthesis: [Image disponible dans le document PDF, Image available in the PDF document] • • 2-hydroxy-3-isobutoxybenzaldehyde [Image disponible dans le document PDF, Image available in the PDF document] A solution of 2,3-dihydroxybenzaldehyde (15 g; 109 mmol) in DMSO (75 mL) was added drop wise, keeping low the temperature with an ice bath, to a previously prepared suspension . of NaH (8.72 g; 218 mmol) in DMSO (180 mL). The mixture stirred at r.t. for two hours, then Isobutyl bromide (11.9 mL; 109 mmol) was added slowly keeping low the temperature. The reaction mixture was stirred for 42 hours, quenched with HCl followed by NH<com:Sub>4< / com:Sub>Cl until pH 5 reached. Work up done in several portions as follows: 300 mL of the mixture were further diluted with H<com:Sub>2< / com:Sub>O (1200 mL) and extracted with Et<com:Sub>2< / com:Sub>O (3x 200 mL). Organic phases dried over Na<com:Sub>2< / com:Sub>SO<com:Sub>4< / com:Sub> and reduced under pressure to give 30 g of dark oil. Crude residue chromatographed on silica gel, isocratic condition (Pet. Et. DCM 7:3) to give 8.04 g of a yellow oil (41 mmol, <com:Math><semantics>y=38%<annotation encoding="application / x-tex">y=38\%< / annotation>< / semantics>< / com:Math>). <com:Sup>1< / com:Sup>H NMR (500 MHz, CDCl<com:Sub>3< / com:Sub>) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.98 (s, 1H), 9.92 (s, 1H), 7.17 (dd, <com:Math><semantics>J=7.8<annotation encoding="application / x-tex">J = 7.8< / annotation>< / semantics>< / com:Math>, 1.4 Hz, 1H), 7.11 <com:Math><semantics>(dd,J=8.0,1.2 Hz,1H),6.93(t,J=7.9 Hz,1H),3.81(d,J=6.7 Hz,2H),2.17(dp,J=13.3,1.2 Hz,1.2 Hz,1.2 Hz,1.2 Hz,1.2 Hz,1.2 Hz,1.2 Hz,1.2 Hz,1.2 Hz,1<annotation encoding="application / x-tex">(dd, J = 8.0, 1.2 \text{ Hz}, 1H), 6.93 (t, J = 7.9 \text{ Hz}, 1H), 3.81 (d, J = 6.7 \text{ Hz}, 2H), 2.17 (dp, J = 13.3, 1.2 \text{ Hz}, 1.2 \text{ Hz}, 1.2 \text{ Hz}, 1.2 \text{ Hz}, 1.2 \text{ Hz}, 1.2 \text{ Hz}, 1.2 \text{ Hz}, 1.2 \text{ Hz}, 1.2 \text{ Hz}, 1< / annotation>< / semantics>< / com:Math> <com:Math><semantics>6.7 Hz<annotation encoding="application / x-tex">6.7 \text{ Hz}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>1H<annotation encoding="application / x-tex">1\text{H}< / annotation>< / semantics>< / com:Math>), <com:Math><semantics>1.05 (d<annotation encoding="application / x-tex">1.05 \text{ (d}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>J=6.7 Hz<annotation encoding="application / x-tex">J = 6.7 \text{ Hz}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>6H<annotation encoding="application / x-tex">6\text{H}< / annotation>< / semantics>< / com:Math>). 2-formyl-6-isobutoxyphenyl acetate [Image disponible dans le document PDF, Image available in the PDF document] Acetyl chloride (5.93 mL; 55.2 mmol) was added dropwise to a stirred solution of 2-hydroxy- 3-isobutoxybenzaldehyde (7.15 g; 36.8 mmol) and pyridine (8.90 mL; 110.0 mmol) in DCM (340 mL) at 0 C. Reaction stirred for 5 min. at 0 °C then temperature raised to r.t. Stirring prolonged for 1 h. Reaction quenched with HCl 1 N, organic phase partially reduced under vacuum, washed with HCl 1 N (200 mL), brine (200 mL), dried over sodium sulphate and reduced under vacuum. The crude was chromatographed on silica gel with a gradient 2-10% EA in Pet. Et, to give 8.46 g of a pale yellow oil (35.85 mmol; <com:Math><semantics>y=97%<annotation encoding="application / x-tex">y=97\%< / annotation>< / semantics>< / com:Math>). <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.12 (s, 1H), 7.46 (dd, <com:Math><semantics>J=7.2<annotation encoding="application / x-tex">J = 7.2< / annotation>< / semantics>< / com:Math>, 2.5 Hz, 1H), 7.42 – 7.37 (m, 2H), 3.82 (d, <com:Math><semantics>J=6.3<annotation encoding="application / x-tex">J = 6.3< / annotation>< / semantics>< / com:Math> Hz, 2H), 2.34 (s, 3H), 2.00 (dp, <com:Math><semantics>J=13.2<annotation encoding="application / x-tex">J = 13.2< / annotation>< / semantics>< / com:Math>, 6.6 Hz, 1H), 0.96 (d, <com:Math><semantics>J=6.8<annotation encoding="application / x-tex">J = 6.8< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 190.0, 168.5, 150.9, 141.1, 128.9, 127.0, 120.4, 119.4, 74.6, 27.7, 20.2, 18.8. HRMS (ESI) calculated for C13H16NaO4 (M+Na) 259.0941, found 259.0943. 6-formyl-2-isobutoxy-3-nitrophenyl acetate [Image disponible dans le document PDF, Image available in the PDF document] Furning nitric acid (5.0 mL, 118.4 mmol) was cooled to -40 °C under a nitrogen atmosphere. A solution of 2-formyl-6-isobutoxyphenyl acetate (3.50 g, 14.8 mmol) in 8.0 mL of dry DCM was added dropwise while the mixture was vigorously stirred and kept at -40 °C. The solution was stirred for an additional 1.5 hours before being poured into 100 mL of ice water. The mixture was then extracted with DCM (<com:Math><semantics>4×50<annotation encoding="application / x-tex">4 \times 50< / annotation>< / semantics>< / com:Math> mL) and the combined organic extracts were dried over sodium sulphate. The solvent was removed under vacuum, the crude thus obtained was chromatographed on silica gel with a gradient 5-40% EA in Pet. Et. to afford 2.45 g of the desired compound (8.73 mmol, y= 97%). <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.13 – 10.09 (s 1H), 8.03 – 8.00 (m, 1H), 7.83 (d, <com:Math><semantics>J<annotation encoding="application / x-tex">J< / annotation>< / semantics>< / com:Math> = 8.5 Hz, 1H), 3.84 (d, <com:Math><semantics>J=6.2<annotation encoding="application / x-tex">J = 6.2< / annotation>< / semantics>< / com:Math> Hz, 2H), 2.44 (s, 3H), 2.01 – 1.93 (m, 1H), 0.94 (d, <com:Math><semantics>J=6.7<annotation encoding="application / x-tex">J = 6.7< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (126 MHz, DMSO) δ 189.4, 168.5, 147.5, 145.2, 144.7, 132.0, 125.5, 122.3, 81.5, 28.5, 20.4, 18.5. HRMS (ESI) calculated for C13H15NNaO6 (M+Na) 304.0792, found 304.0792. 2-(allyloxy)-3-isobutoxy-4-nitrobenzoic acid [Image disponible dans le document PDF, Image available in the PDF document] 6-formyl-2-isobutoxy-3-nitrophenyl acetate (4.10 g; 14.6 mmol) was dissolved in THF (70 mL) and water (35 mL), then LiOH (3.50 g; 146.0 mmol) dissolved in water (35 mL) was added at 0 C, reaction stirred overnight. In the morning, pH adjusted to 1, solvent partially reduced under vacuum and watery phase extracted with CHCl3 (150 mL) three times, combined organic phases dried over sodium sulphate and reduced under vacuum to give a yellow oil, which was used in the next step without further purification. Residue was dissolved in DMF (30 mL), K<com:Sub>2< / com:Sub>CO<com:Sub>3< / com:Sub> (4.03 g; 29.2 mmol) followed by allyl bromide (1.89 mL; 21.9 mmol) were added, reaction stirred 24 h at r.t.. Reaction diluted with water (200 mL) and EA (200 mL), aqueous phase extracted with EA (150 mL). Combined organic phases washed with brine (300 mL), dried over sodium sulphate and reduced under vacuum to give a crude material, which was dissolved with 2-Methyl-2-butene (15.5 mL; 146 mmol) in t-BuOH (100 mL). Then a solution of NaClO<com:Sub>2< / com:Sub> 80% (1.98 g; 17.52 mmol) in Monosodium phosphate monohydrate solution 1 N (16.2 mL) was added dropwise to the solution. Reaction stirred for 1 h, t hen quenched by adding a solution of Na<com:Sub>2< / com:Sub>SO<com:Sub>3< / com:Sub> (34.0 mmol in 10 mL). Mixture partially reduced under vacuum, diluted with EA (200 mL) and HCl 1 N (200 mL), aqueous phase extracted again with EA (100 mL), organic phases reunited washed with brine (250 mL) and dried over sodium sulphate. Solvent reduced under vacuum, crude chromatographed on silica gel with a gradient 0-10% MeOH in DCM to afford 3.01 g of the desired compound (10.22) mmol, <com:Math><semantics>y=70%<annotation encoding="application / x-tex">y = 70\%< / annotation>< / semantics>< / com:Math>). <com:Sup>1< / com:Sup>H NMR (500 MHz, CDCl<com:Sub>3< / com:Sub>) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 7.90 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.57 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 1H), 6.08 (m, 1H), 5.44 (dq, <com:Math><semantics>J=17.1<annotation encoding="application / x-tex">J = 17.1< / annotation>< / semantics>< / com:Math>, 1.3 Hz, 1H), 5.39 (ddd, <com:Math><semantics>J=10.3<annotation encoding="application / x-tex">J = 10.3< / annotation>< / semantics>< / com:Math>, 1.9, 0.9 Hz, 1H), 4.81 – 4.77 (m, 2H), 3.93 (d, <com:Math><semantics>J=6.5<annotation encoding="application / x-tex">J = 6.5< / annotation>< / semantics>< / com:Math> Hz, 2H), 2.12 (dp, <com:Math><semantics>J=13.3<annotation encoding="application / x-tex">J = 13.3< / annotation>< / semantics>< / com:Math>, 6.7 Hz, 1H), 1.03 (d, <com:Math><semantics>J=6.7<annotation encoding="application / x-tex">J = 6.7< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (126 MHz, CDCl<com:Sub>3< / com:Sub>) δ 165.0, 152.7, 148.2, 146.4, 131.1, 127.5, 126.8, 121.7, 119.8, 82.0, 76.5, 29.0, 19.0. HRMS (ESI) calculated for C14H16NO6 (M-H) 294.0983, found 294.0995. allyl 4-(2-(allyloxy)-3-isobutoxy-4-nitrobenzamido)benzoate [Image disponible dans le document PDF, Image available in the PDF document] To a stirred solution of 2-(allyloxy)-3-isobutoxy-4-nitrobenzoic acid (500 mg; 1.69 mmol), allyl 4-aminobenzoate (250 mg; 1.41 mmol) and TEA (0.38 mL; 2.82 mmol) in dry DCM (28 mL), POCl<com:Sub>3< / com:Sub> (0.16 mL; 1.69 mmol) was added drop wise at 0 °C. Reaction stirred for 4 hours then quenched by addition of NaHCO<com:Sub>3< / com:Sub> saturated solution, solvent partially reduced under vacuum and residue dissolved in EA (50 mL). Organic phase washed with NaHCO<com:Sub>3< / com:Sub> saturated solution (50 mL), HCl 1 N (50 mL), brine (50 mL), dried over sodium sulphate and reduced under vacuum. The crude thus obtained was purified on silica gel with a gradient 2-20% EA in Pet. Et. to give 400 mg of desired product (0.88 mmol; y= 62%). <com:Sup>1< / com:Sup>H NMR (500 MHz, CDCl<com:Sub>3< / com:Sub>) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.13 (s, 1H), 8.09 (m, 3H), 7.79 – 7.73 (m, 2H), 7.64 (d, <com:Math><semantics>J=<annotation encoding="application / x-tex">J =< / annotation>< / semantics>< / com:Math> 8.8 Hz, 1H), 6.08 (m, 2H), 5.48 (dq, <com:Math><semantics>J=17.1<annotation encoding="application / x-tex">J = 17.1< / annotation>< / semantics>< / com:Math>, 1.3 Hz, 1H), 5.45 – 5.39 (m, 2H), 5.30 (dq, <com:Math><semantics>J=17.1<annotation encoding="application / x-tex">J = 17.1< / annotation>< / semantics>< / com:Math>) 10.5, 1.3 Hz, 1H), 4.83 (dt, <com:Math><semantics>J=5.7<annotation encoding="application / x-tex">J = 5.7< / annotation>< / semantics>< / com:Math>, 1.4 Hz, 2H), 4.76 (dt, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math>, 1.0 Hz, 2H), 3.97 (d, <com:Math><semantics>J=6.5<annotation encoding="application / x-tex">J = 6.5< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>2.20−2.11<annotation encoding="application / x-tex">2.20 - 2.11< / annotation>< / semantics>< / com:Math> (m, 1H), <com:Math><semantics>1.06<annotation encoding="application / x-tex">1.06< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=6.7<annotation encoding="application / x-tex">J = 6.7< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (126 MHz, CDCl<com:Sub>3< / com:Sub>) δ 165.6, 161.1, 151.3, 147.3, 146.5, 141.8, 132.3, 131.5, 131.0, 130.8, 126.3, 126.1, 121.2, 120.1, 119.4, 118.3, 82.0, 76.2, 65.5, 29.1, 19.0. HRMS (ESI) calculated for C24H27N2O7 (M+H) 455.1813, found 455.1806. allyl 4-(2-(allyloxy)-4-amino-3-isobutoxybenzamido)benzoate [Image disponible dans le document PDF, Image available in the PDF document] Allyl 4-(2-(allyloxy)-3-isobutoxy-4-nitrobenzamido)benzoate (350 mg; 0.77 mmol) was dissolved in EtOH (13.5 mL) and AcOH (1.5 mL), the solution was cooled to 0 °C and to it Zn dust (500 mg; 7.70 mmol) was added portion wise. Reaction stirred at r.t. for 4 hours then mixture filtered over a pad of celite and solvent reduced under vacuum to afford 295 mg of desired compound (0.70 mmol; y= 90%). <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.24 (s, 1H), 7.98 – 7.90 (m, 2H), 7.84 – 7.78 (m, 2H), 7.41 – 7.36 (m, 1H), 6.58 (d, <com:Math><semantics>J=8.6<annotation encoding="application / x-tex">J = 8.6< / annotation>< / semantics>< / com:Math> Hz, 1H), 6.05 (m, 2H), 5.54 (s, 2H), 5.41 (ddq, <com:Math><semantics>J=17.1<annotation encoding="application / x-tex">J = 17.1< / annotation>< / semantics>< / com:Math>, 15.3, 1.6 Hz, 2H), 5.27 (m, 2H), 4.78 (dt, <com:Math><semantics>J=5.4<annotation encoding="application / x-tex">J = 5.4< / annotation>< / semantics>< / com:Math>, 1.5 Hz, 2H), 4.61 (dt, <com:Math><semantics>J=5.6<annotation encoding="application / x-tex">J = 5.6< / annotation>< / semantics>< / com:Math>, 1.3 Hz, 2H), 3.67 <com:Math><semantics>(d,J=6.5 Hz,2H),2.11 (tt, J=13.6,6.8 Hz,1H),1.01 (d, J=6.7 Hz,6H).<annotation encoding="application / x-tex">(d, J = 6.5 \text{ Hz}, 2H), 2.11 \text{ (tt, } J = 13.6, 6.8 \text{ Hz}, 1H), 1.01 \text{ (d, } J = 6.7 \text{ Hz}, 6H).< / annotation>< / semantics>< / com:Math> <com:Sup>13< / com:Sup>C NMR (126 MHz, DMSO) δ 165.0, 163.9, 150.4, 146.6, 143.6, 137.2, 133.5, 132.8, 130.3, 126.2, 123.7, 118.8, 118.3, 117.8, 114.8, 110.2, 78.5, 74.4, 64.8, 28.5, 19.2. HRMS (ESI) calculated for C24H27N2O5 (M-H) 423.1925, found 423.1933. - Fragment C4 [Image disponible dans le document PDF, Image available in the PDF document] Synthesis: [Image disponible dans le document PDF, Image available in the PDF document] methyl 3-hydroxy-4-nitrobenzoate [Image disponible dans le document PDF, Image available in the PDF document] 3-hydroxy-4-nitrobenzoic acid (2.5 g; 13.66 mmol) was dissolved in a MeOH (35.0 mL), Thionyl chloride (2.5 mL; 34.15mmol) was added dropwise at 0 °C, the solution was warmed to r.t. and then heated to 70 °C for 1 hour. The solvent was evaporated under reduced pressure, the residue was diluted with water (90 mL) and EA (90 mL), water again extracted twice with EA (2x90 mL). Combined organic phases washed with brine (150 mL), dried over sodium sulphate and evaporated under reduced pressure to give 2.64 g of a yellow solid. <com:Sup>1< / com:Sup>H NMR (700 MHz, CDCl<com:Sub>3< / com:Sub>) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.50 (s, 1H), 8.18 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.83 (d, <com:Math><semantics>J=1.8<annotation encoding="application / x-tex">J = 1.8< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.62 (dd, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math>, 1.8 Hz, 1H), 3.97 (s, 3H). <com:Sup>13< / com:Sup>C NMR (176 MHz, CDCl<com:Sub>3< / com:Sub>) δ 164.9, 154.7, 138.0, 135.8, 125.3, 121.7, 120.6, 53.0. HRMS (ESI) calculated for C8H6NO5 (M-H) 196.0251, found 196.0249. methyl 3-isopropoxy-4-nitrobenzoate [Image disponible dans le document PDF, Image available in the PDF document] Methyl 3-hydroxy-4-nitrobenzoate (1.94 g; 9.85 mmol) and K2CO3 (1.72 g; 11.82 mmol) were mixed in DMF (32 mL). 2-Bromopropane (1.55 mL; 15.76 mmol) was added and the mixture heated to 70 °C overnight. Reaction diluted with Et<com:Sub>2< / com:Sub>O (320 mL) and water (320 mL). Organic phase washed with brine (300 mL), dried over sodium sulphate and reduce under vacuum to give 2.25 g of a yellow oil. <com:Sup>1< / com:Sup>H NMR (700 MHz, CDCl<com:Sub>3< / com:Sub>) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 7.75 (d, <com:Math><semantics>J=8.3<annotation encoding="application / x-tex">J = 8.3< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.74 (d, <com:Math><semantics>J=1.6<annotation encoding="application / x-tex">J = 1.6< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.64 (dd, <com:Math><semantics>J=<annotation encoding="application / x-tex">J =< / annotation>< / semantics>< / com:Math> 8.3, 1.6 Hz, 1H), 4.77 (hept, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 1H), 3.96 (s, 3H), 1.41 (dd, <com:Math><semantics>J=6.0<annotation encoding="application / x-tex">J = 6.0< / annotation>< / semantics>< / com:Math>, 2.5 Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, CDCl<com:Sub>3< / com:Sub>) δ 165.4, 150.8, 143.8, 134.5, 125.1, 121.1, 117.0, 73.0, 52.8, 21.8. 3-isopropoxy-4-nitrobenzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Methyl 3-isopropoxy-4-nitrobenzoate (1.45 g; 6.07 mmol) was dissolved in THF (33 mL) and water (15 mL). To this mixture, a solution of LiOH (1.45 g; 60.70 mmol) in water (18 mL) was added. Reaction stirred at r.t. for 3 h., pH adjusted to 1 and solvent partially reduced under vacuum. The precipitate thus formed was collected by filtration and washed with Pet. Et. twice to give 1.36 g of a pale yellow solid. <com:Sup>1< / com:Sup>H NMR (500 MHz, CDCl<com:Sub>3< / com:Sub>) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 7.82 – 7.77 (m, 2H), 7.73 (dd, <com:Math><semantics>J<annotation encoding="application / x-tex">J< / annotation>< / semantics>< / com:Math> = 8.3, 1.5 Hz, 1H), 4.79 (hept, <com:Math><semantics>J=6.1 Hz,1H,1.43 (d, J=6.1 Hz, 6H).<annotation encoding="application / x-tex">J = 6.1 \text{ Hz}, 1\text{H}, 1.43 \text{ (d, } J = 6.1 \text{ Hz, 6H)}.< / annotation>< / semantics>< / com:Math> <com:Sup>13< / com:Sup>C NMR (126 MHz, CDCl<com:Sub>3< / com:Sub>) δ 169.4, 150.8, 133.3, 125.2, 121.8, 117.4, 73.2, 21.8. HRMS (ESI) calculated for C10H10NO5 (M-H) 224.0564, found 224.0565. methyl 4-(3-isopropoxy-4-nitrobenzamido)benzoate [Image disponible dans le document PDF, Image available in the PDF document] Methyl 4-aminobenzoate (79 mg; 0.52 mmol), 3-isopropoxy-4-nitrobenzoic acid (100 mg; 0.44) and HOAt (91; 0.67 mmol) were mixed together in DMF (1.2 mL). To this yellow solution, EDC (102 mg; 0.53 mmol) followed by lutidine (0.258 mL; 2.22 mmol) were added. Reaction stirred overnight, diluted with EA (20 mL) and HCl 1 N (20 mL), watery phase extracted again with EA (20 mL). Organic phases reunited dried over sodium sulphate and reduced under vacuum, the residue thus obtained chromatographed on silica gel with a gradient 3-40% EA in Pet. Et. to give 112 mg (0.31 mmol; y= 60%) of a pale yellow solid. <com:Sup>1< / com:Sup>H NMR (500 MHz, CDCl<com:Sub>3< / com:Sub>) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 8.11 – 8.06 (m, 2H), 7.98 (s, 1H), 7.83 (d, <com:Math><semantics>J<annotation encoding="application / x-tex">J< / annotation>< / semantics>< / com:Math> = 8.3 Hz, 1H), <com:Math><semantics>7.76−7.72<annotation encoding="application / x-tex">7.76 - 7.72< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>7.67<annotation encoding="application / x-tex">7.67< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=1.6<annotation encoding="application / x-tex">J = 1.6< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>7.36<annotation encoding="application / x-tex">7.36< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=8.3<annotation encoding="application / x-tex">J = 8.3< / annotation>< / semantics>< / com:Math>, 1.7 Hz, 1H), <com:Math><semantics>4.85−4.74<annotation encoding="application / x-tex">4.85 - 4.74< / annotation>< / semantics>< / com:Math> (m, 1H), 3.92 (s, 3H), 1.42 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (126 MHz, CDCl<com:Sub>3< / com:Sub>) δ 166.5, 163.9, 151.7, 143.1, 141.4, 139.2, 131.0, 126.6, 125.7, 119.5, 117.2, 115.8, 73.3, 52.2, 21.8. methyl 4-(4-amino-3-isopropoxybenzamido)benzoate [Image disponible dans le document PDF, Image available in the PDF document] Methyl 4-(3-isopropoxy-4-nitrobenzamido)benzoate (800 mg; 2.23 mmol) was dissolved in MeOH (24 mL). The solution was degassed with Argon for 10 min. Pd (80 mg) was added, reaction stirred under an H<com:Sub>2< / com:Sub> atmosphere overnight. Pd filtered out over a pad of celite and solvent evaporated under vacuum. The oil thus obtained was chromatographed on silica gel with a gradient 10-40% EA in Pet. Et.. to give 790 mg (2.40 mmol; y= 93%) of a white solid. <com:Sup>1< / com:Sup>H NMR (500 MHz, CDCl<com:Sub>3< / com:Sub>) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 8.08 – 8.03 (m, 1H), 8.03 – 7.98 (m, 2H), 7.78 – 7.71 (m, 2H), 7.46 (d, <com:Math><semantics>J=1.8<annotation encoding="application / x-tex">J = 1.8< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.28 (dd, <com:Math><semantics>J=8.2<annotation encoding="application / x-tex">J = 8.2< / annotation>< / semantics>< / com:Math>, 1.8 Hz, 1H), 6.80 (d, <com:Math><semantics>J=8.1<annotation encoding="application / x-tex">J = 8.1< / annotation>< / semantics>< / com:Math> Hz, 1H), 4.71 – 4.62 (m, 1H), 3.91 (s, 3H), 1.37 (d, <com:Math><semantics>J=6.0<annotation encoding="application / x-tex">J = 6.0< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (126 MHz, CDCl<com:Sub>3< / com:Sub>) δ 166.8, 165.5, 145.7, 142.7, 130.9, 125.4, 119.7, 119.0, 114.6, 112.9, 71.2, 52.1, 22.2. HRMS (ESI) calculated for C18H21N2O4 (M+H) 329.1496, found 329.1495. 2.3 Assembling a. General scheme depicting the final steps of the synthesis: [Image disponible dans le document PDF, Image available in the PDF document] In the above formulas, groups X and Y independently represent H or <com:Math><semantics>ℝ6<annotation encoding="application / x-tex">\mathbb{R}^6< / annotation>< / semantics>< / com:Math>. b. General procedures Coupling: The last aromatic ring was installed activating the carboxylic acid to acyl chloride or activated ester by means of: - A; BTC collidine - B; COCl via oxalyl chloride - C; EDC, HOAt Α. Collidine (8 eq.) added dropwise at 0 °C to a solution of desired carboxylic acid (3.5 eq.) and Bis(trichloromethyl) carbonate (1.05 eq.) in THF (M= 0.02). Reaction stirred at r.t. for 20 min then added to a solution of allyl (S)-2-(allyloxy)-4-(2-(allyloxy)-4-(4-(2-(4- aminobenzamido)-3-cyanopropanamido)benzamido)-3-methoxybenzamido)-3- methoxybenzoate (1 eq.) and DiPEA (10 eq.) in THF (M= 0.02). Reaction stirred for few hours then quenched with HCl 1 N and ice. Solvent partially reduced under vacuum, EA and HCl 1N were added, organic phase washed with NaHCO<com:Sub>3< / com:Sub> saturated solution, brine and dried over sodium sulphate. The solvent was removed under reduced pressure, the residue was purified on silica gel or directly used in the next step without further purification. B. Carboxylic acid activation: the desired carboxylic acid (1.0 eq.) is suspended in DCM (M= 0.5), oxalyl chloride (1.5 eq.) followed by catalytic DMF were added at 0 °C. Reaction stirred until all the carboxylic acid has reacted, reaction monitored by TLC. Solvent reduced under vacuum, residue dissolved again in DCM and evaporated twice. The desired carbonyl chloride (1.5 eq.) as a solution in THF (M= 0.08) was added at 0 °C to a stirred solution of allyl (S)-2-(allyloxy)-4-(2-(allyloxy)-4-(4-(2-(4-aminobenzamido)-3- cyanopropanamido)benzamido)-3-methoxybenzamido)-3-methoxybenzoate (1.0 eq.) and DiPEA (5 eq.) in THF (0.027 eq.), reaction stirred at 0 °C for 10 min then warmed to r.t., stirring prolonged for 1 h. Reaction quenched with HCl 1N / ice, solvent partially reduced under vacuum, mixture diluted with EA and HCl 1 N, organic phase washed with brine and dried over sodium sulphate. The residue thus obtained could be purified on silica gel or directly used in the next step without further purification. C. Carboxylic acid (3.0 eq.), EDC (3.0 eq), HOAt (3.5 eq.) were mixed together in DMF (M= 0.2), to this solution collidine was added (8.0 eq.), reaction stirred from 20 min then added to a solution of allyl (S)-2-(allyloxy)-4-(2-(allyloxy)-4-(4-(2-(4-aminobenzamido)-3- cyanopropanamido)benzamido)-3-methoxybenzamido)-3-methoxybenzoate (1.0 eq.) in DMF (M= 0.02). Reaction heated to 50 °C for several hours until no more amine starting material present. Reaction diluted with EA and HCl 1 N, organic phase washed with brine and dried over sodium sulphate, solvent reduced under vacuum, the residue was used in the next step without further purification. Final deprotection Phenyl silane (4.0 eq.) followed by Palladium-tetrakis(triphenylphosphine (0.25 eq.) was added to a solution of allyl protected cystobactamid derivative (1.0 eq.) in THF (M= 0.01). Reaction stirred overnight and purified by preparative HPLC using condition A or B. Condition A: gradient 20-95% CH<com:Sub>3< / com:Sub>CN + 0.1% HCOOH in water + 0.1% HCOOH in 40 min. Condition B: gradient 10-95% CH<com:Sub>3< / com:Sub>CN in water 10 mM NH<com:Sub>4< / com:Sub>HCO<com:Sub>3< / com:Sub> in 40 min. C. A1+B1+C1 Synthesis: [Image disponible dans le document PDF, Image available in the PDF document] allyl (S)-4-(2-(allyloxy)-3-isopropoxy-4-(4-(2-(4-nitrobenzamido)-4-oxo-4- (tritylamino)butanamido)benzamido)benzamido)benzoate [Image disponible dans le document PDF, Image available in the PDF document] POCl<com:Sub>3< / com:Sub> (3.20 mmol) as a solution in DCM (1:9) was added dropwise to a solution of allyl 4-(2- (allyloxy)-4-amino-3-isopropoxybenzamido)benzoate (0.53 g; 1.28 mmol) and (S)-4-(2-(4- nitrobenzamido)-4-oxo-4-(tritylamino)butanamido)benzoic acid (2.05 g, 3.20 mmol) in THF (13 mL) at 0 °C, followed by DiPEA (1.78 mL; 10.24 mmol) as a solution in DCM (1:1). Reaction stirred at r.t. for 6 h, quenched with HCl 1 N and ice, solvent partially reduced under vacuum and residue diluted with EA (250 mL) and HCl 1N (250 mL), organic phase washed with brine (250 mL) and dried over sodium sulphate. Solvent removed under vacuum, the crude residue was chromatographed on silica gel with a gradient EA 20-75% in Pet. Et to give 940 mg of a orange residue (0.95 mmol; 54%). <com:Sup>1< / com:Sup>H NMR (500 MHz, CDCl<com:Sub>3< / com:Sub>) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.20 (s, 1H), 9.63 (s, 1H), 8.74 (s, 1H), 8.50 (d, <com:Math><semantics>J=8.9<annotation encoding="application / x-tex">J = 8.9< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.47 (d, <com:Math><semantics>J=6.2<annotation encoding="application / x-tex">J = 6.2< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.29 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 2H), 8.07 (dd, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math>, 4.9 Hz, 3H), 7.96 (d, <com:Math><semantics>J=8.8 Hz<annotation encoding="application / x-tex">J = 8.8 \text{ Hz}< / annotation>< / semantics>< / com:Math>, 2H), 7.88 (d, <com:Math><semantics>J=8.7 Hz<annotation encoding="application / x-tex">J = 8.7 \text{ Hz}< / annotation>< / semantics>< / com:Math>, 2H), 7.77 (d, <com:Math><semantics>J=8.7 Hz<annotation encoding="application / x-tex">J = 8.7 \text{ Hz}< / annotation>< / semantics>< / com:Math>, 2H), 7.59 (d, <com:Math><semantics>J=8.7 Hz<annotation encoding="application / x-tex">J = 8.7 \text{ Hz}< / annotation>< / semantics>< / com:Math>, 2H), <com:Math><semantics>7.33−7.24<annotation encoding="application / x-tex">7.33 - 7.24< / annotation>< / semantics>< / com:Math> (m, 15H), <com:Math><semantics>7.15<annotation encoding="application / x-tex">7.15< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>6.15<annotation encoding="application / x-tex">6.15< / annotation>< / semantics>< / com:Math> (m, 1H), <com:Math><semantics>6.05<annotation encoding="application / x-tex">6.05< / annotation>< / semantics>< / com:Math> (m, 1H), <com:Math><semantics>5.50<annotation encoding="application / x-tex">5.50< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=17.1<annotation encoding="application / x-tex">J = 17.1< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>1.2<annotation encoding="application / x-tex">1.2< / annotation>< / semantics>< / com:Math> Hz, 1H), 5.43 (m, 2H), 5.30 (dd, <com:Math><semantics>J=10.4<annotation encoding="application / x-tex">J = 10.4< / annotation>< / semantics>< / com:Math>, 1.1 Hz, 1H), 5.07 (m, 1H), 4.82 (d, <com:Math><semantics>J=5.6<annotation encoding="application / x-tex">J = 5.6< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>4.76 (dt, J=12.3,6.2 Hz, 1H), 4.71 (d, J=5.9 Hz, 2H), 3.31 (dd, J=15.6,2.7 Hz, 1H), 2.76<annotation encoding="application / x-tex">4.76 \text{ (dt, } J = 12.3, 6.2 \text{ Hz, 1H), } 4.71 \text{ (d, } J = 5.9 \text{ Hz, 2H), } 3.31 \text{ (dd, } J = 15.6, 2.7 \text{ Hz, 1H), } 2.76< / annotation>< / semantics>< / com:Math> <com:Math><semantics>(dd,J=15.6,7.3Hz,1H),1.39(dd,J=6.1,3.9Hz,6H).<annotation encoding="application / x-tex">(dd, J = 15.6, 7.3 Hz, 1H), 1.39 (dd, J = 6.1, 3.9 Hz, 6H).< / annotation>< / semantics>< / com:Math> <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 168.3, 166.9, 165.0, 164.6, 164.3, 149.5, 149.2, 144.7, 143.5, 142.6, 142.2, 139.3, 135.6, 133.7, 132.8, 130.6, 130.3, 129.0, 128.5, 128.4, 128.0, 127.4, 127.2, 126.4, 124.2, 123.6, 119.0, 118.9, 118.7, 117.8, 117.8, 76.3, 74.3, 69.4, 64.8, 52.1, 38.0, 22.3. HRMS (ESI) calculated for C60H55N6O11 (M+H<com:Sup>+< / com:Sup>) 1035.3923, found 1035.3943. allyl (S)-4-(2-(allyloxy)-4-(4-(4-amino-2-(4-aminobenzamido)-4- oxobutanamido)benzamido)-3-isopropoxybenzamido)benzoate [Image disponible dans le document PDF, Image available in the PDF document] Zn dust (0.95 g; 15.5 mmol) was added portionwise over few minutes to a stirred solution of allyl (S)-4-(2-(allyloxy)-3-isopropoxy-4-(4-(2-(4-nitrobenzamido)-4-oxo-4-(tritylamino)- butanamido)benzamido)benzamido)benzoate (1.30 g; 1.26 mmol) in THF (6.0 mL), EtOH (4.8 mL) and AcOH (1.2 mL). Reaction stirred for 5 h, the mixture was filtered through celite, the solvent was reduced under vacuum. The crude was used in the next step without further purification. The residue was dissolved in DCM (18.7 mL), Tips (0.775 mL; 3.78 mmol) followed by TFA (6.3 mL) were added at 0 C. Reaction stirred 2 h at r.t. then solved removed under vacuum, residue take up and evaporated twice with DCM (15 mL) then triturated 3x with ice cold Pet. Et.. The crude thus obtained was purified on silica gel with a gradient 0-10% MeOH in DCM to give 1.02 g of a yellow solid (1.18 mmol; <com:Math><semantics>y=94%<annotation encoding="application / x-tex">y=94\%< / annotation>< / semantics>< / com:Math>). <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.59 (s, 1H), 10.38 (s, 1H), 9.52 (s, 1H), 8.23 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.98 (t, <com:Math><semantics>J=9.4<annotation encoding="application / x-tex">J = 9.4< / annotation>< / semantics>< / com:Math> Hz, 4H), 7.88 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.80 (dd, <com:Math><semantics>J=11.0<annotation encoding="application / x-tex">J = 11.0< / annotation>< / semantics>< / com:Math>, 8.7 Hz, 3H), 7.62 <com:Math><semantics>(d,J=8.7 Hz,2H),7.40(d,J=8.5 Hz,2H),6.97(s,1H),6.56(d,J=8.7 Hz,2H),6.11−<annotation encoding="application / x-tex">(d, J = 8.7 \text{ Hz}, 2H), 7.40 (d, J = 8.5 \text{ Hz}, 2H), 6.97 (s, 1H), 6.56 (d, J = 8.7 \text{ Hz}, 2H), 6.11 -< / annotation>< / semantics>< / com:Math> 5.97 (m, 2H), 5.68 (s, 2H), 5.44 – 5.35 (m, 2H), 5.31 - 5-18 (m, 2H), 4.85 (dd, <com:Math><semantics>J=14.1,7.1<annotation encoding="application / x-tex">J = 14.1, 7.1< / annotation>< / semantics>< / com:Math> Hz, 1H), 4.80 (d, <com:Math><semantics>J=5.3<annotation encoding="application / x-tex">J = 5.3< / annotation>< / semantics>< / com:Math> Hz, 2H), 4.61 (d, <com:Math><semantics>J=5.5<annotation encoding="application / x-tex">J = 5.5< / annotation>< / semantics>< / com:Math> Hz, 2H), 4.53 – 4.44 (m, 1H), 2.65 (d, <com:Math><semantics>J=<annotation encoding="application / x-tex">J =< / annotation>< / semantics>< / com:Math> 7.0 Hz, 2H), 1.26 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (126 MHz, DMSO) δ 171.5, 171.1, 166.4, 165.0, 164.7, 164.3, 151.9, 149.5, 143.5, 142.6, 142.5, 135.7, 133.7, 132.8, 130.4, 129.1, 128.4, 128.2, 127.1, 124.2, 123.6, 120.4, 119.0, 118.8, 117.8, 117.8, 116.0, 112.5, 76.3, 74.3, 64.9, 51.5, 40.1, 40.0, 39.9, 39.8, 39.8, 39.7, 39.6, 39.5, 39.3, 39.2, 39.0, 36.9, 22.3, 20.8. HRMS (ESI) calculated for C41H43N6O9 (M+H<com:Sup>+< / com:Sup>) 763.3086, found 763.3085. Marfey: 94.0% S enantiomer, 6.0% R enantiomer allyl (S)-4-(2-(allyloxy)-4-(4-(4-amino-2-(4-(4-nitrobenzamido)benzamido)-4- oxobutanamido)benzamido)-3-isopropoxybenzamido)benzoate [Image disponible dans le document PDF, Image available in the PDF document] See: Angew. Chem. Int. Ed. 2014, 53, <com:Math><semantics>1−6<annotation encoding="application / x-tex">1-6< / annotation>< / semantics>< / com:Math> Collidine (0.166 mL; 1.26 mmol) was added dropwise at 0 °C to a solution of 4-nitro benzoic acid (92 mg; 0.551 mmol) and Bis(trichloromethyl) carbonate (49 mg; 0.165 mmol) in THF (10 mL). Reaction stirred at r.t. for 20 min then added to a solution of allyl (S)-2-(allyloxy)-4- (2-(allyloxy)-4-(4-(2-(4-aminobenzamido)-3-cyanopropanamido)benzamido)-3- methoxybenzamido)-3-methoxybenzoate (120 mg; 0.157 mmol) and DiPEA (0.273 mL; 1.57 mmol) in THF (10 mL). Reaction stirred for 4 h then quenched with HCl 1 N and ice. Solvent partially reduced under vacuum, EA (40 mL) and HCl 1N (40 mL) were added, organic phase washed with NaHCO<com:Sub>3< / com:Sub> saturated solution (30 mL), brine (30 mL) and dried over sodium sulphate. The solvent was removed under reduced pressure, the residue was purified on silica gel with a gradient 0-10% MeOH in DCM to give 114 mg of a yellow residue (0.125 mmol; y= 80%). <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 10.79 (s, 1H), 10.58 (s, 1H), 10.45 (s, 1H), 9.52 (s, 1H), 8.68 <com:Math><semantics>(d,J=7.3 Hz,1H),8.41−8.36 (m, 2H),8.23−8.19 (m, 2H),8.00−7.95 (m, 4H),7.94 (m, 2H)<annotation encoding="application / x-tex">(d, J = 7.3 \text{ Hz}, 1\text{H}), 8.41 - 8.36 \text{ (m, 2H)}, 8.23 - 8.19 \text{ (m, 2H)}, 8.00 - 7.95 \text{ (m, 4H)}, 7.94 \text{ (m, 2H)}< / annotation>< / semantics>< / com:Math> 2H), 7.91 (m, 2H), 7.87 (d, <com:Math><semantics>J=8.6<annotation encoding="application / x-tex">J = 8.6< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.81 (m, 3H), 7.40 (d, <com:Math><semantics>J=8.4<annotation encoding="application / x-tex">J = 8.4< / annotation>< / semantics>< / com:Math> Hz, 2H), 6.99 (s, 1H), 6.04 (m, 2H), 5.39 (m, 2H), 5.28 (ddd, <com:Math><semantics>J=10.5<annotation encoding="application / x-tex">J = 10.5< / annotation>< / semantics>< / com:Math>, 2.9, 1.4 Hz, 1H), 5.20 (ddd, <com:Math><semantics>J=10.5<annotation encoding="application / x-tex">J = 10.5< / annotation>< / semantics>< / com:Math>, 2.9, 1.3 Hz, 1H), 4.92 (dd, <com:Math><semantics>J=14.0<annotation encoding="application / x-tex">J = 14.0< / annotation>< / semantics>< / com:Math>, 7.2 Hz, 1H), 4.79 (d, <com:Math><semantics>J=5.3<annotation encoding="application / x-tex">J = 5.3< / annotation>< / semantics>< / com:Math> Hz, 2H), 4.61 (d, <com:Math><semantics>J=5.5<annotation encoding="application / x-tex">J = 5.5< / annotation>< / semantics>< / com:Math> Hz, 2H), 4.49 (tt, <com:Math><semantics>J=12.2<annotation encoding="application / x-tex">J = 12.2< / annotation>< / semantics>< / com:Math>, 6.1 Hz, 1H), 2.69 (d, <com:Math><semantics>J=7.9<annotation encoding="application / x-tex">J = 7.9< / annotation>< / semantics>< / com:Math> Hz, 2H), 1.26 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 165.8, 164.9, 164.7, 164.3, 164.2, 149.5, 149.3, 143.5, 142.6, 142.4, 141.5, 140.3, 135.7, 133.7, 132.8, 130.3, 129.3, 129.2, 128.4, 128.3, 128.3, 127.1, 124.2, 123.6, 119.5, 119.0, 119.0, 118.8, 117.8, 117.8, 76.2, 74.3, 64.8, 51.6, 36.8, 22.3. HRMS (ESI) calculated for C48H46N7O12 (M+H<com:Sup>+< / com:Sup>) 912.3199, found 912.3196. (S)-4-(4-(4-(4-amino-2-(4-(4-nitrobenzamido)benzamido)-4-oxobutanamido)benzamido)- 2-hydroxy-3-isopropoxybenzamido)benzoic acid (28) [Image disponible dans le document PDF, Image available in the PDF document] Phenyl silane (0.012 mL; 0.099 mmol) followed by Palladium-tetrakis(triphenylphosphine (6.3 mg; 0.0055 mmol) was added to a solution of allyl (S)-4-(2-(allyloxy)-4-(4-(4-amino-2- (4-(4-nitrobenzamido)benzamido)-4-oxobutanamido)benzamido)-3- isopropoxybenzamido)benzoate (20 mg; 0.022 mmol) in THF (2.75 mL). Reaction stirred overnight and purified by preparative HPLC to afford to obtain 3.8 mg of a white material <com:Math><semantics>(0.0046 mmol;y=21%).<annotation encoding="application / x-tex">(0.0046 \text{ mmol}; y= 21\%).< / annotation>< / semantics>< / com:Math> According to the purification method used, the desired structure could be obtained either in its protonated form or as ammonium salt. Condition A: gradient 20-95% CH<com:Sub>3< / com:Sub>CN + 0.1% HCOOH in water + 0.1% HCOOH in 40 min. Condition B: gradient 10-95% CH<com:Sub>3< / com:Sub>CN in water 10 mM NH<com:Sub>4< / com:Sub>HCO<com:Sub>3< / com:Sub> in 40 min. Condition A: <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 12.82 (s, 1H), 12.29 (s, 1H), 10.79 (s, 1H), 10.60 (s, 1H), 10.46 (s, 1H), 9.40 (s, 1H), 8.68 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.41 – 8.35 (m, 2H), 8.24 – 8.18 (m, 2H), <com:Math><semantics>7.99−7.92<annotation encoding="application / x-tex">7.99 - 7.92< / annotation>< / semantics>< / com:Math> (m, 6H), <com:Math><semantics>7.90<annotation encoding="application / x-tex">7.90< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>7.85<annotation encoding="application / x-tex">7.85< / annotation>< / semantics>< / com:Math> (m, 3H), <com:Math><semantics>7.82<annotation encoding="application / x-tex">7.82< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>7.70<annotation encoding="application / x-tex">7.70< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.8 Hz<annotation encoding="application / x-tex">J = 8.8 \text{ Hz}< / annotation>< / semantics>< / com:Math>, 1H), 7.40 (s, 1H), 6.99 (s, 1H), 4.92 (dd, <com:Math><semantics>J=14.1<annotation encoding="application / x-tex">J = 14.1< / annotation>< / semantics>< / com:Math>, 7.2 Hz, 1H), 4.57 – 4.51 (m, 1H), 2.69 (d, <com:Math><semantics>J=7.6<annotation encoding="application / x-tex">J = 7.6< / annotation>< / semantics>< / com:Math> Hz, 2H), 1.26 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). (S)-4-(4-(4-(4-amino-2-(4-(4-nitrobenzamido)benzamido)-4-oxobutanamido)benzamido)- 2-hydroxy-3-isopropoxybenzamido)benzoic acid as ammonium salts [Image disponible dans le document PDF, Image available in the PDF document] Condition B: <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 15.41 (br, 1H), 10.80 (s, 1H), 10.46 (s, 1H), 8.87 (s, 1H), 8.72 <com:Math><semantics>(d,J=7.3 Hz,1H),8.41−8.35 (m, 2H),8.23−8.18 (m, 2H),7.96−7.92 (m, 2H),7.90 (d, J=7.3 Hz,1H)<annotation encoding="application / x-tex">(d, J = 7.3 \text{ Hz}, 1\text{H}), 8.41 - 8.35 \text{ (m, 2H)}, 8.23 - 8.18 \text{ (m, 2H)}, 7.96 - 7.92 \text{ (m, 2H)}, 7.90 \text{ (d, } J = 7.3 \text{ Hz}, 1\text{H})< / annotation>< / semantics>< / com:Math> <com:Math><semantics>=8.8 Hz,2H,7.84 (d, J=8.9 Hz,2H),7.81 (d, J=8.9 Hz,2H),7.76 (d, J=7.8 Hz,2H),<annotation encoding="application / x-tex">= 8.8 \text{ Hz}, 2\text{H}, 7.84 \text{ (d, } J = 8.9 \text{ Hz}, 2\text{H}), 7.81 \text{ (d, } J = 8.9 \text{ Hz}, 2\text{H}), 7.76 \text{ (d, } J = 7.8 \text{ Hz}, 2\text{H}),< / annotation>< / semantics>< / com:Math> 7.59 (br, 2H), 7.44 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.42 (s, 1H), 7.09 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 1H), 6.98 (s, 1H), <com:Math><semantics>5.06−4.99<annotation encoding="application / x-tex">5.06 - 4.99< / annotation>< / semantics>< / com:Math> (m, 1H), <com:Math><semantics>4.93<annotation encoding="application / x-tex">4.93< / annotation>< / semantics>< / com:Math> (q, <com:Math><semantics>J=7.1<annotation encoding="application / x-tex">J = 7.1< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>2.69<annotation encoding="application / x-tex">2.69< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=7.4<annotation encoding="application / x-tex">J = 7.4< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>1.19<annotation encoding="application / x-tex">1.19< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=6.2<annotation encoding="application / x-tex">J = 6.2< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.6, 166.9, 165.7, 165.3, 164.2, 163.1, 149.3, 142.0, 141.5, 140.3, 137.5, 129.5, 129.3, 129.3, 128.3, 127.6, 124.2, 123.7, 123.6, 119.5, 119.0, 117.7, 70.3, 51.6, 36.8, 22.7. HRMS (ESI) calculated for C42H38N7O12 (M+H<com:Sup>+< / com:Sup>) 832.2573, found 832.2580. Marfey: 91.2% S enantiomer, 8.8% R enantiomer d. Analogs synthesized modifying building block A1 Modifications of fragments A1 could give access to a series of derivatives, general synthetic scheme followed: [Image disponible dans le document PDF, Image available in the PDF document] In the above formulas, X and Y independently represent H or <com:Math><semantics>ℝ6<annotation encoding="application / x-tex">\mathbb{R}^6< / annotation>< / semantics>< / com:Math>. [Image disponible dans le document PDF, Image available in the PDF document] COCI, cat. DMF or BTC; Collidine [Image disponible dans le document PDF, Image available in the PDF document] In the above formulas, R represents H or <com:Math><semantics>ℝ6<annotation encoding="application / x-tex">\mathbb{R}^6< / annotation>< / semantics>< / com:Math>. Series of final compounds synthesized starting from amine 26: Coupling step, final deprotection and purification conditions are described in section 2.3b general procedures. Carbocylic acids employed in the coupling step with amine 26 were purchased or synthesized according to procedures described in section 2.2a. All compounds purified according to condition B, preparative HPLC gradient 10-95% CH<com:Sub>3< / com:Sub>CN in water 10 mM NH<com:Sub>4< / com:Sub>HCO<com:Sub>3< / com:Sub> in 40 min, were obtained as ammonium salts. (S)-4-(4-(4-(4-(4-(4-acetamidobenzamido)benzamido)-4-amino-4- oxobutanamido)benzamido)-2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (15 mg, 0.016 mmol) coupled with carboxylic acid 31 using coupling conditions C followed by final deprotection. Desired compound purified by preparative HPLC condition A, to obtain 1.1 mg of desired product as a white solid <com:Math><semantics>(0.0013 mmol,y=8%)<annotation encoding="application / x-tex">(0.0013 \text{ mmol}, y= 8\%)< / annotation>< / semantics>< / com:Math>. <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 12.78 (br, 1H), 12.29 (s, 1H), 10.60 (s, 1H), 10.45 (s, 1H), 10.33 (s, 1H), 10.23 (s, 1H), 9.40 (s, 1H), 8.63 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.95 (m, 6H), 7.92 – 7.87 (m, 3H), 7.85 (m, 3H), 7.82 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.71 (m, 3H), 7.39 (s, 1H), 7.35 (dd, <com:Math><semantics>J=8.0<annotation encoding="application / x-tex">J = 8.0< / annotation>< / semantics>< / com:Math>, 1.4 Hz, 1H), 6.99 (s, 1H), 4.92 (dd, <com:Math><semantics>J=14.0<annotation encoding="application / x-tex">J = 14.0< / annotation>< / semantics>< / com:Math>, 7.2 Hz, 1H), 4.54 (dt, <com:Math><semantics>J=12.3<annotation encoding="application / x-tex">J = 12.3< / annotation>< / semantics>< / com:Math>, 6.1 Hz, 1H), 2.69 <com:Math><semantics>(d,J=8.1 Hz,2H),2.09 (s, 3H),1.26 (d, J=6.1 Hz, 6H).<annotation encoding="application / x-tex">(d, J = 8.1 \text{ Hz}, 2H), 2.09 \text{ (s, 3H)}, 1.26 \text{ (d, } J = 6.1 \text{ Hz, 6H)}.< / annotation>< / semantics>< / com:Math> <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.8, 168.8, 168.5, 166.9, 165.8, 165.2, 164.2, 154.1, 142.5, 142.5, 142.2, 142.0, 137.0, 136.3, 133.9, 133.7, 130.2, 129.7, 128.7, 128.7, 128.5, 128.3, 128.2, 127.3, 126.3, 122.8, 120.7, 119.3, 119.0, 118.1, 112.4, 112.2, 74.9, 51.6, 36.8, 24.1, 22.3. (S)-4-(4-(4-(4-amino-4-oxo-2-(4-(4-(3-(trifluoromethyl)-3H-diazirin-3- yl)benzamido)benzamido)butanamido)benzamido)-2-hydroxy-3- isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (28 mg, 0.037 mmol) coupled with 4-(3-(trifluoromethyl)-3H-diazirin-3-yl)benzoic acid using coupling conditions A, intermediate purified on silica gel with a gradient 0-10% MeOH in DCM to give 25 mg (0.027 mmol, y= 70%) of allyl protected cystobactamid derivative. Followed final deprotection, desired compound purified by preparative HPLC condition A, to obtain 8.0 mg of desired product (0.009 mmol, y= 31%). Allyl protected intermediate [Image disponible dans le document PDF, Image available in the PDF document] <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 10.61 (s, 1H), 10.57 (s, 1H), 10.44 (s, 1H), 9.52 (s, 1H), 8.66 <com:Math><semantics>(d,J=7.3 Hz,1H),8.11−8.06 (m, 2H),7.98 (dd, J=8.7,6.8 Hz,4H),7.92 (d, J=8.9 Hz,4H)<annotation encoding="application / x-tex">(d, J = 7.3 \text{ Hz}, 1\text{H}), 8.11 - 8.06 \text{ (m, 2H)}, 7.98 \text{ (dd, } J = 8.7, 6.8 \text{ Hz}, 4\text{H}), 7.92 \text{ (d, } J = 8.9 \text{ Hz}, 4\text{H})< / annotation>< / semantics>< / com:Math> 2H), <com:Math><semantics>7.90−7.85<annotation encoding="application / x-tex">7.90 - 7.85< / annotation>< / semantics>< / com:Math> (m, 4H), <com:Math><semantics>7.81<annotation encoding="application / x-tex">7.81< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=8.6<annotation encoding="application / x-tex">J = 8.6< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>6.6<annotation encoding="application / x-tex">6.6< / annotation>< / semantics>< / com:Math> Hz, 3H), <com:Math><semantics>7.47<annotation encoding="application / x-tex">7.47< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.1<annotation encoding="application / x-tex">J = 8.1< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>7.40<annotation encoding="application / x-tex">7.40< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=<annotation encoding="application / x-tex">J =< / annotation>< / semantics>< / com:Math> 8.4 Hz, 2H), 6.99 (s, 1H), <com:Math><semantics>6.10−5.98<annotation encoding="application / x-tex">6.10 - 5.98< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>5.39<annotation encoding="application / x-tex">5.39< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>5.30−5.18<annotation encoding="application / x-tex">5.30 - 5.18< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>4.92<annotation encoding="application / x-tex">4.92< / annotation>< / semantics>< / com:Math> (dd, J = 14.0, 7.3 Hz, 1H), 4.79 (d, <com:Math><semantics>J=5.3<annotation encoding="application / x-tex">J = 5.3< / annotation>< / semantics>< / com:Math> Hz, 2H), 4.61 (d, <com:Math><semantics>J=5.5<annotation encoding="application / x-tex">J = 5.5< / annotation>< / semantics>< / com:Math> Hz, 2H), 4.52 – 4.45 (m, 1H), <com:Math><semantics>2.71−2.67<annotation encoding="application / x-tex">2.71 - 2.67< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>1.26<annotation encoding="application / x-tex">1.26< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 165.8, 165.0, 164.8, 164.7, 164.3, 149.5, 143.5, 142.6, 142.4, 141.7, 136.3, 135.7, 133.7, 132.8, 130.7, 130.3, 129.0, 128.7, 128.4, 128.3, 127.1, 126.5, 124.2, 123.6, 122.5, 121.0, 119.4, 119.0, 119.0, 118.8, 117.8, 117.8, 76.2, 74.3, 64.8, 51.6, 36.8, 22.3. Final compound (37): <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 12.81 (br, 1H), 12.29 (s, 1H), 10.61 (s, 2H), 10.46 (s, 1H), 9.39 (s, 1H), 8.66 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.09 (d, <com:Math><semantics>J=8.5<annotation encoding="application / x-tex">J = 8.5< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.96 (dd, <com:Math><semantics>J=12.4<annotation encoding="application / x-tex">J = 12.4< / annotation>< / semantics>< / com:Math>, 8.8 Hz, 3H), 7.90 (dd, <com:Math><semantics>J=26.1<annotation encoding="application / x-tex">J = 26.1< / annotation>< / semantics>< / com:Math>, 8.8 Hz, 4H), 7.87 – 7.83 (m, 3H), 7.82 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.70 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.70 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.70 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.70 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.70 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> H <com:Math><semantics>=8.7 Hz,2H,7.47 (d, J=8.1 Hz,2H),7.39 (s, 1H),6.99 (s, 1H),4.92 (dd, J=14.0,7.2 Hz,<annotation encoding="application / x-tex">= 8.7 \text{ Hz}, 2\text{H}, 7.47 \text{ (d, } J = 8.1 \text{ Hz}, 2\text{H}), 7.39 \text{ (s, 1H)}, 6.99 \text{ (s, 1H)}, 4.92 \text{ (dd, } J = 14.0, 7.2 \text{ Hz},< / annotation>< / semantics>< / com:Math> 1H), <com:Math><semantics>4.58−4.51<annotation encoding="application / x-tex">4.58 - 4.51< / annotation>< / semantics>< / com:Math> (m, 1H), <com:Math><semantics>2.69<annotation encoding="application / x-tex">2.69< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=7.6<annotation encoding="application / x-tex">J = 7.6< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>1.26<annotation encoding="application / x-tex">1.26< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=6.2<annotation encoding="application / x-tex">J = 6.2< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 168.5, 166.9, 165.8, 164.8, 164.2, 142.5, 141.7, 137.0, 136.3, 136.3, 130.7, 130.2, 129.6, 129.0, 128.7, 128.3, 126.5, 122.8, 122.5, 121.0, 120.7, 119.4, 118.9, 112.4, 74.8, 51.6, 36.8, 22.1. <com:Sup>19< / com:Sup>F NMR (471 MHz, DMSO) δ -64.40. HRMS (ESI) calculated for C44H36F3N8O10 (M-H) 893.2512, found 893.2506. (S)-4-(4-(4-(4-amino-2-(4-benzamidobenzamido)-4-oxobutanamido)benzamido)-2- hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (40 mg, 0.052 mmol) coupled with benzoic acid using coupling conditions A followed by final deprotection. Desired compound purified by preparative HPLC condition B, to obtain 13.8 mg of desired product as a white solid (0.018 mmol, <com:Math><semantics>y=34%<annotation encoding="application / x-tex">y=34\%< / annotation>< / semantics>< / com:Math>). <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 12.74 (br, 1H), 12.30 (br, 1H), 10.48 (s, 1H), 10.45 (s, 1H), 9.33 (br, 1H), 8.65 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>7.99−7.96<annotation encoding="application / x-tex">7.99 - 7.96< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>7.94<annotation encoding="application / x-tex">7.94< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=15.6<annotation encoding="application / x-tex">J = 15.6< / annotation>< / semantics>< / com:Math>, 6.5 Hz, 4H), <com:Math><semantics>7.92−7.89<annotation encoding="application / x-tex">7.92 - 7.89< / annotation>< / semantics>< / com:Math> (m, 4H), <com:Math><semantics>7.83<annotation encoding="application / x-tex">7.83< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=17.1<annotation encoding="application / x-tex">J = 17.1< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>8.7<annotation encoding="application / x-tex">8.7< / annotation>< / semantics>< / com:Math> Hz, 4H), <com:Math><semantics>7.79<annotation encoding="application / x-tex">7.79< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>7.61<annotation encoding="application / x-tex">7.61< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=11.6<annotation encoding="application / x-tex">J = 11.6< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>4.2<annotation encoding="application / x-tex">4.2< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.55 (t, <com:Math><semantics>J=7.6<annotation encoding="application / x-tex">J = 7.6< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.40 (s, 1H), 6.99 (s, 1H), 4.92 (dd, <com:Math><semantics>J=14.0<annotation encoding="application / x-tex">J = 14.0< / annotation>< / semantics>< / com:Math>, 7.2 Hz, 1H), 4.61 (s, 1H), 2.69 (d, <com:Math><semantics>J=7.9<annotation encoding="application / x-tex">J = 7.9< / annotation>< / semantics>< / com:Math> Hz, 2H), 1.25 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 168.3, 168.3, 166.9, 165.8, 164.0, 142.4, 142.1, 136.5, 134.7, 131.8, 130.2, 128.7, 128.4, 128.3, 128.2, 127.7, 127.4, 123.0, 120.4, 119.3, 118.9, 51.6, 36.8, 22.4. HRMS (ESI) calculated for C42H37N6O10 (M-H) 785.2577, found 785.2577. (S)-4-(4-(4-(4-amino-2-(4-(4-fluorobenzamido)benzamido)-4- oxobutanamido)benzamido)-2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (40 mg, 0.052 mmol) coupled with 4-fluorobenzoic acid using coupling conditions A followed by final deprotection. Desired compound purified by preparative HPLC condition B, to obtain 3.2 mg of desired product as a white solid (0.004 mmol, y= 8%). <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) δ 12.80 (br, 1H), 12.29 (br, 1H), 10.62 (br, 1H), 10.49 (s, 1H), 10.46 (s, 1H), 9.39 (s, 1H), 8.65 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>8.09−8.03<annotation encoding="application / x-tex">8.09 - 8.03< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>7.96<annotation encoding="application / x-tex">7.96< / annotation>< / semantics>< / com:Math> (t, <com:Math><semantics>J=8.4<annotation encoding="application / x-tex">J = 8.4< / annotation>< / semantics>< / com:Math> Hz, 4H), 7.90 (q, <com:Math><semantics>J=9.0<annotation encoding="application / x-tex">J = 9.0< / annotation>< / semantics>< / com:Math> Hz, 4H), 7.84 (dd, <com:Math><semantics>J=17.4<annotation encoding="application / x-tex">J = 17.4< / annotation>< / semantics>< / com:Math>, 8.8 Hz, 5H), 7.68 (d, <com:Math><semantics>J=8.6<annotation encoding="application / x-tex">J = 8.6< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.43 – 7.35 (m, 3H), 6.99 (s, 1H), 4.92 (dd, <com:Math><semantics>J=14.1<annotation encoding="application / x-tex">J = 14.1< / annotation>< / semantics>< / com:Math>, 7.1 Hz, 1H), 4.59 – 4.51 (m, 1H), 2.69 (d, <com:Math><semantics>J=14.1<annotation encoding="application / x-tex">J = 14.1< / annotation>< / semantics>< / com:Math>) 7.2 Hz, 2H), 1.26 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (126 MHz, DMSO) δ 171.3, 170.8, 168.4, 166.9, 165.8, 164.7, 164.2, 163.2, 142.5, 142.0, 136.4, 131.1, 130.6, 130.5, 130.2, 128.8, 128.3, 122.8, 120.6, 119.4, 118.9, 115.5, 115.3, 112.5, 74.8, 51.6, 36.8, 22.3. HRMS (ESI) calculated for C42H36FN6O10 (M-H) 803.2482, found 803.2498. (S)-4-(4-(4-(4-amino-2-(4-(4-aminobenzamido)benzamido)-4- oxobutanamido)benzamido)-2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Compound 40 was isolated as a by-product of the synthesis of 28, obtained 0.7 mg. <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 15.31 (s, 1H), 10.46 (s, 1H), 9.98 (s, 1H), 8.87 (s, 1H), 8.68 <com:Math><semantics>(d,J=7.0 Hz,1H),7.86(d,J=9.9 Hz,4H),7.82(dd,J=19.7,8.8 Hz,4H),7.75(dd,J=19.7,8.8 Hz,4H)<annotation encoding="application / x-tex">(d, J = 7.0 \text{ Hz}, 1\text{H}), 7.86 (d, J = 9.9 \text{ Hz}, 4\text{H}), 7.82 (dd, J = 19.7, 8.8 \text{ Hz}, 4\text{H}), 7.75 (dd, J = 19.7, 8.8 \text{ Hz}, 4\text{H})< / annotation>< / semantics>< / com:Math> 11.3, 8.6 Hz, 4H), 7.55 (d, <com:Math><semantics>J=8.5<annotation encoding="application / x-tex">J = 8.5< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.44 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.08 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 1H), 6.98 (s, 1H), 6.60 (d, <com:Math><semantics>J=8.6<annotation encoding="application / x-tex">J = 8.6< / annotation>< / semantics>< / com:Math> Hz, 2H), 5.80 (s, 2H), 5.02 (dt, <com:Math><semantics>J=12.4<annotation encoding="application / x-tex">J = 12.4< / annotation>< / semantics>< / com:Math>, 6.1 Hz, 1H), 4.91 (dd, <com:Math><semantics>J=12.4<annotation encoding="application / x-tex">J = 12.4< / annotation>< / semantics>< / com:Math>, 6.1 Hz, 1H), 4.91 (dd, <com:Math><semantics>J=12.4<annotation encoding="application / x-tex">J = 12.4< / annotation>< / semantics>< / com:Math>, 6.1 Hz, 1H), 4.91 (dd, <com:Math><semantics>J=12.4<annotation encoding="application / x-tex">J = 12.4< / annotation>< / semantics>< / com:Math>, 6.1 Hz, 1H), 4.91 (dd, <com:Math><semantics>J=12.4<annotation encoding="application / x-tex">J = 12.4< / annotation>< / semantics>< / com:Math>, 6.1 = 14.2, 7.2 Hz, 1H), 2.69 (d, <com:Math><semantics>J<annotation encoding="application / x-tex">J< / annotation>< / semantics>< / com:Math> = 7.0 Hz, 2H), 1.19 (d, <com:Math><semantics>J<annotation encoding="application / x-tex">J< / annotation>< / semantics>< / com:Math> = 6.1 Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 169.8, 166.8, 165.9, 165.5, 165.3, 163.1, 152.4, 142.7, 142.0, 141.5, 137.5, 134.0, 129.6, 129.5, 128.2, 127.9, 127.5, 123.7, 120.7, 119.0, 119.0, 117.5, 116.1, 112.5, 100.6, 70.3, 51.7, 36.9, 22.7. HRMS (ESI) calculated for C42H38N7O10 (M-H) 800.2686, found 800.2733. (S)-4-(4-(4-(4-amino-2-(4-(3-nitrobenzamido)benzamido)-4-oxobutanamido)benzamido)- 2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (40 mg, 0.052 mmol) coupled with 3-nitrobenzoic acid using coupling conditions A, intermediate purified on silica gel with a gradient 0-10% MeOH in DCM to give 45 mg (0.049 mmol, y= 95%) of allyl protected cystobactamid derivative. Followed final deprotection on 20 mg of intermediate (0.022 mmol), desired compound purified by preparative HPLC condition B, to obtain 6.8 mg of desired product (0.008 mmol, y= 31%) and 2.2 mg of compound 42, which was formed as a by-product of the reaction. Allyl protected intermediate: [Image disponible dans le document PDF, Image available in the PDF document] <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 10.80 (s, 1H), 10.58 (s, 1H), 10.45 (s, 1H), 9.52 (s, 1H), 8.82 <com:Math><semantics>(t,J=2.0 Hz,1H),8.68(d,J=7.3 Hz,1H),8.46(ddd,J=8.2,2.3,1.0 Hz,1H),8.44−8.41<annotation encoding="application / x-tex">(t, J = 2.0 \text{ Hz}, 1\text{H}), 8.68 (d, J = 7.3 \text{ Hz}, 1\text{H}), 8.46 (ddd, J = 8.2, 2.3, 1.0 \text{ Hz}, 1\text{H}), 8.44 - 8.41< / annotation>< / semantics>< / com:Math> (m, 1H), <com:Math><semantics>8.00−7.96<annotation encoding="application / x-tex">8.00 - 7.96< / annotation>< / semantics>< / com:Math> (m, 4H), <com:Math><semantics>7.96−7.93<annotation encoding="application / x-tex">7.96 - 7.93< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>7.93−7.89<annotation encoding="application / x-tex">7.93 - 7.89< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>7.86<annotation encoding="application / x-tex">7.86< / annotation>< / semantics>< / com:Math> (t, <com:Math><semantics>J=8.0<annotation encoding="application / x-tex">J = 8.0< / annotation>< / semantics>< / com:Math> Hz, 3H), <com:Math><semantics>7.83−7.79<annotation encoding="application / x-tex">7.83 - 7.79< / annotation>< / semantics>< / com:Math> (m, 3H), <com:Math><semantics>7.40<annotation encoding="application / x-tex">7.40< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.4<annotation encoding="application / x-tex">J = 8.4< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>6.99<annotation encoding="application / x-tex">6.99< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>6.08−5.99<annotation encoding="application / x-tex">6.08 - 5.99< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>5.39<annotation encoding="application / x-tex">5.39< / annotation>< / semantics>< / com:Math> (m, 2H), 5.24 (m, 2H), 4.93 (dd, <com:Math><semantics>J=14.0<annotation encoding="application / x-tex">J = 14.0< / annotation>< / semantics>< / com:Math>, 7.3 Hz, 1H), 4.79 (dd, <com:Math><semantics>J=3.9<annotation encoding="application / x-tex">J = 3.9< / annotation>< / semantics>< / com:Math>, 1.4 Hz, 2H), 4.61 (d, <com:Math><semantics>J=3.9<annotation encoding="application / x-tex">J = 3.9< / annotation>< / semantics>< / com:Math>), 5.24 (m, 2H), 4.93 (dd, <com:Math><semantics>J=3.9<annotation encoding="application / x-tex">J = 3.9< / annotation>< / semantics>< / com:Math>), 5.24 (m, 2H), 4.93 (dd, <com:Math><semantics>J=3.9<annotation encoding="application / x-tex">J = 3.9< / annotation>< / semantics>< / com:Math>), 5.24 (m, 2H), 4.93 (dd, <com:Math><semantics>J=3.9<annotation encoding="application / x-tex">J = 3.9< / annotation>< / semantics>< / com:Math>), 6.14 5.5 Hz, 2H), <com:Math><semantics>4.52−4.46<annotation encoding="application / x-tex">4.52 - 4.46< / annotation>< / semantics>< / com:Math> (m, 1H), <com:Math><semantics>2.71−2.68<annotation encoding="application / x-tex">2.71 - 2.68< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>1.26<annotation encoding="application / x-tex">1.26< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 165.8, 164.9, 164.7, 164.3, 163.6, 149.5, 147.8, 143.5, 142.6, 142.4, 141.5, 136.0, 135.7, 134.3, 133.7, 132.8, 130.3, 130.3, 129.2, 128.4, 128.3, 127.1, 126.4, 124.2, 123.6, 122.5, 119.6, 119.0, 118.8, 117.8, 117.8, 76.2, 74.3, 64.8, 51.6, 36.8, 22.3. Final compound 41: <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 12.79 (br, 1H), 12.29 (br, 1H), 10.80 (s, 1H), 10.62 (br, 1H), 10.46 (s, 1H), 9.36 (s, 1H), 8.82 (t, <com:Math><semantics>J=1.8<annotation encoding="application / x-tex">J = 1.8< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.68 (d, <com:Math><semantics>J=7.2<annotation encoding="application / x-tex">J = 7.2< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.46 (dd, <com:Math><semantics>J=<annotation encoding="application / x-tex">J =< / annotation>< / semantics>< / com:Math> 8.2, 1.5 Hz, 1H), 8.43 (d, <com:Math><semantics>J=7.9<annotation encoding="application / x-tex">J = 7.9< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>7.98−7.89<annotation encoding="application / x-tex">7.98 - 7.89< / annotation>< / semantics>< / com:Math> (m, 8H), <com:Math><semantics>7.86<annotation encoding="application / x-tex">7.86< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=15.4<annotation encoding="application / x-tex">J = 15.4< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>7.9<annotation encoding="application / x-tex">7.9< / annotation>< / semantics>< / com:Math> Hz, 3H), 7.82 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 3H), 7.66 (br, 1H), 7.40 (s, 1H), 6.99 (s, 1H), 4.93 (dd, <com:Math><semantics>J=14.1<annotation encoding="application / x-tex">J = 14.1< / annotation>< / semantics>< / com:Math>, 7.2 Hz, 1H), 4.58 (s, 1H), 2.70 (d, <com:Math><semantics>J=7.5<annotation encoding="application / x-tex">J = 7.5< / annotation>< / semantics>< / com:Math> Hz, 2H), 1.26 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 168.4, 166.9, 165.8, 164.1, 163.6, 147.8, 142.5, 141.5, 136.4, 136.0, 134.3, 130.3, 130.2, 129.2, 128.3, 128.3, 126.4, 122.9, 122.5, 120.6, 119.6, 118.9, 74.5, 51.6, 36.8, 22.3. HRMS (ESI) calculated for C42H38N7O12 (M+H) 832.2573, found 832.2565. (S)-4-(4-(4-(4-amino-2-(4-(3-aminobenzamido)benzamido)-4- oxobutanamido)benzamido)-2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 15.86 (br, 1H), 12.45 (br, 1H), 10.43 (s, 1H), 10.30 (s, 1H), 8.94 (br, 1H), 8.62 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>7.91−7.83<annotation encoding="application / x-tex">7.91 - 7.83< / annotation>< / semantics>< / com:Math> (m, 9H), <com:Math><semantics>7.79<annotation encoding="application / x-tex">7.79< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=20.6<annotation encoding="application / x-tex">J = 20.6< / annotation>< / semantics>< / com:Math>, 8.7 Hz, 4H), 7.49 (br, 1H), 7.40 (s, 1H), 7.16 (t, <com:Math><semantics>J=7.8<annotation encoding="application / x-tex">J = 7.8< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.10 (d, <com:Math><semantics>J=1.8<annotation encoding="application / x-tex">J = 1.8< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.08 (d, <com:Math><semantics>J=7.8<annotation encoding="application / x-tex">J = 7.8< / annotation>< / semantics>< / com:Math> Hz, 1H), 6.98 (s, 1H), 6.76 (dd, <com:Math><semantics>J=7.9<annotation encoding="application / x-tex">J = 7.9< / annotation>< / semantics>< / com:Math>, 1.5 Hz, 1H), 5.33 (s, 2H), 4.95 (br, 1H), 4.92 (dd, <com:Math><semantics>J=<annotation encoding="application / x-tex">J =< / annotation>< / semantics>< / com:Math> 14.0, 7.3 Hz, 1H), <com:Math><semantics>2.71−2.66<annotation encoding="application / x-tex">2.71 - 2.66< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>1.20<annotation encoding="application / x-tex">1.20< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 167.5, 167.2, 166.6, 165.9, 163.3, 148.8, 142.3, 142.1, 135.6, 130.4, 128.8, 128.5, 128.2, 127.7, 123.6, 119.2, 119.0, 117.0, 114.8, 113.0, 51.6, 36.8, 22.6. HRMS (ESI) calculated for C42H38N7O10 (M-H) 800.2686, found 800.2691. (S)-4-(4-(4-(4-amino-2-(4-(2-nitrobenzamido)benzamido)-4-oxobutanamido)benzamido)- 2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (20 mg, 0.026 mmol) coupled with 2-nitrobenzoic acid using coupling conditions B followed by final deprotection. Desired compound purified by preparative HPLC condition B, to obtain 2.4 mg of desired product as a white solid (0.003 mmol, y= 11%). <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 12.72 (br, 1H), 12.30 (br, 1H), 10.91 (s, 1H), 10.45 (s, 1H), 9.29 (br, 1H), 8.67 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.17 (dd, <com:Math><semantics>J=8.2<annotation encoding="application / x-tex">J = 8.2< / annotation>< / semantics>< / com:Math>, 0.8 Hz, 1H), 7.93 (t, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 6H), 7.89 (td, <com:Math><semantics>J=7.5<annotation encoding="application / x-tex">J = 7.5< / annotation>< / semantics>< / com:Math>, 0.9 Hz, 1H), <com:Math><semantics>7.85−7.80<annotation encoding="application / x-tex">7.85 - 7.80< / annotation>< / semantics>< / com:Math> (m, 6H), <com:Math><semantics>7.80−7.75<annotation encoding="application / x-tex">7.80 - 7.75< / annotation>< / semantics>< / com:Math> (m, 4H), <com:Math><semantics>7.40<annotation encoding="application / x-tex">7.40< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>6.99<annotation encoding="application / x-tex">6.99< / annotation>< / semantics>< / com:Math> (s, 1H), 4.92 (dd, <com:Math><semantics>J=13.9<annotation encoding="application / x-tex">J = 13.9< / annotation>< / semantics>< / com:Math>, 7.3 Hz, 1H), 4.64 (br, 1H), 2.69 (dd, <com:Math><semantics>J=6.8<annotation encoding="application / x-tex">J = 6.8< / annotation>< / semantics>< / com:Math>, 3.4 Hz, 2H), 1.25 (d, <com:Math><semantics>J=<annotation encoding="application / x-tex">J =< / annotation>< / semantics>< / com:Math> 6.1 Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 168.2, 166.9, 165.7, 164.4, 164.0, 146.4, 142.4, 141.6, 136.6, 134.2, 132.4, 131.1, 130.3, 129.3, 129.0, 128.5, 128.1, 124.3, 123.0, 118.9, 118.7, 51.6, 36.8, 22.4. HRMS (ESI) calculated for C42H36N7O12 (M-H) 830.2427, found 830.2439. (S)-4-(4-(4-(4-amino-2-(4-(4-cyanobenzamido)benzamido)-4- oxobutanamido)benzamido)-2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (25 mg, 0.033 mmol) coupled with 4-cyanobenzoic acid using coupling conditions A, intermediate purified on silica gel with a gradient 0-10% MeOH in DCM to give 18 mg (0.02 mmol, y= 61%) of allyl protected cystobactamid derivative. Final deprotection afforded the desired compound, which was purified by preparative HPLC condition B, to obtain 3.3 mg of desired product (0.004 mmol, y= 20%). Allyl protected intermediate: [Image disponible dans le document PDF, Image available in the PDF document] <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 10.70 (s, 1H), 10.57 (s, 1H), 10.45 (s, 1H), 9.52 (s, 1H), 8.68 <com:Math><semantics>(d,J=7.3 Hz,1H),8.13(d,J=8.4 Hz,2H),8.05(d,J=8.4 Hz,2H),7.98(dd,J=8.7,6.9)<annotation encoding="application / x-tex">(d, J = 7.3 \text{ Hz}, 1\text{H}), 8.13 (d, J = 8.4 \text{ Hz}, 2\text{H}), 8.05 (d, J = 8.4 \text{ Hz}, 2\text{H}), 7.98 (dd, J = 8.7, 6.9)< / annotation>< / semantics>< / com:Math> Hz, 4H), 7.93 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.88 (dd, <com:Math><semantics>J=15.2<annotation encoding="application / x-tex">J = 15.2< / annotation>< / semantics>< / com:Math>, 8.7 Hz, 4H), 7.81 (dd, <com:Math><semantics>J=8.6<annotation encoding="application / x-tex">J = 8.6< / annotation>< / semantics>< / com:Math>, 5.6 Hz, 3H), 7.40 (d, <com:Math><semantics>J=8.4<annotation encoding="application / x-tex">J = 8.4< / annotation>< / semantics>< / com:Math> Hz, 2H), 6.99 (s, 1H), 6.09 – 5.98 (m, 2H), 5.43 – 5.34 (m, 2H), 5.30 – <com:Math><semantics>5.18<annotation encoding="application / x-tex">5.18< / annotation>< / semantics>< / com:Math> (m, <com:Math><semantics>2H<annotation encoding="application / x-tex">2H< / annotation>< / semantics>< / com:Math>), <com:Math><semantics>4.92<annotation encoding="application / x-tex">4.92< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=14.1<annotation encoding="application / x-tex">J = 14.1< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>7.2<annotation encoding="application / x-tex">7.2< / annotation>< / semantics>< / com:Math> Hz, <com:Math><semantics>1H<annotation encoding="application / x-tex">1H< / annotation>< / semantics>< / com:Math>), <com:Math><semantics>4.79<annotation encoding="application / x-tex">4.79< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=5.3<annotation encoding="application / x-tex">J = 5.3< / annotation>< / semantics>< / com:Math> Hz, <com:Math><semantics>2H<annotation encoding="application / x-tex">2H< / annotation>< / semantics>< / com:Math>), <com:Math><semantics>4.61<annotation encoding="application / x-tex">4.61< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=5.4<annotation encoding="application / x-tex">J = 5.4< / annotation>< / semantics>< / com:Math> Hz, 2H), 4.49 (dt, <com:Math><semantics>J=12.3<annotation encoding="application / x-tex">J = 12.3< / annotation>< / semantics>< / com:Math>, 6.1 Hz, 1H), 2.69 (d, <com:Math><semantics>J=7.5<annotation encoding="application / x-tex">J = 7.5< / annotation>< / semantics>< / com:Math> Hz, 2H), 1.26 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 165.8, 165.0, 164.7, 164.5, 164.3, 149.5, 143.5, 142.6, 142.4, 141.6, 138.7, 135.7, 133.7, 132.8, 132.5, 130.3, 129.1, 128.6, 128.4, 128.3, 127.1, 124.2, 123.6, 119.5, 119.0, 118.8, 117.8, 117.8, 114.0, 76.3, 74.3, 64.8, 51.6, 36.8, 22.3. Final compound 44: <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) δ 12.81 (br, 1H), 12.29 (br, 1H), 10.70 (s, 1H), 10.61 (br, 1H), 10.46 (s, 1H), 9.37 (br, 1H), 8.67 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>8.15−8.10<annotation encoding="application / x-tex">8.15 - 8.10< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>8.07−8.03<annotation encoding="application / x-tex">8.07 - 8.03< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>7.98−7.93<annotation encoding="application / x-tex">7.98 - 7.93< / annotation>< / semantics>< / com:Math> (m, 4H), <com:Math><semantics>7.93−7.87<annotation encoding="application / x-tex">7.93 - 7.87< / annotation>< / semantics>< / com:Math> (m, 4H), <com:Math><semantics>7.83<annotation encoding="application / x-tex">7.83< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=16.0<annotation encoding="application / x-tex">J = 16.0< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>8.8<annotation encoding="application / x-tex">8.8< / annotation>< / semantics>< / com:Math> Hz, 5H), <com:Math><semantics>7.67<annotation encoding="application / x-tex">7.67< / annotation>< / semantics>< / com:Math> (br, 1H), 7.40 (s, 1H), 6.99 (s, 1H), 4.92 (q, <com:Math><semantics>J=7.1<annotation encoding="application / x-tex">J = 7.1< / annotation>< / semantics>< / com:Math> Hz, 1H), 4.56 (br, 1H), 2.69 (d, <com:Math><semantics>J=7.2<annotation encoding="application / x-tex">J = 7.2< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>1.26<annotation encoding="application / x-tex">1.26< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 168.4, 166.9, 165.8, 164.5, 164.1, 142.5, 141.6, 138.7, 136.4, 132.5, 130.2, 129.1, 128.6, 128.3, 128.3, 122.9, 120.6, 119.5, 118.9, 118.3, 114.0, 74.8, 51.6, 36.8, 22.3. HRMS (ESI) calculated for C43H36N7O10 (M-H) 810.2529, found 810.2538. <com:Math><semantics>(S)−4−(4−(4−(4−amino−4−oxo−2−(4−(4−4−amino−4−oxo−2−(4−(4−4−4−4−4−4−4−4−4−4−4−4−4−4−4−4−4<annotation encoding="application / x-tex">(S)-4-(4-(4-(4-amino-4-oxo-2-(4-(4-4-amino-4-oxo-2-(4-(4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4< / annotation>< / semantics>< / com:Math> (trifluoromethyl)benzamido)benzamido)butanamido)benzamido)-2-hydroxy-3- isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (15 mg, 0.020 mmol) coupled with 4-trifluoromethyl benzoic acid using coupling conditions A followed by final deprotection. Desired compound purified by preparative HPLC condition B, to obtain 5.3 mg of desired product as a white solid (0.0062 mmol, y= 31%). <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 12.80 (br, 1H), 12.29 (br, 1H), 10.69 (s, 1H), 10.62 (br, 1H), 10.46 (s, 1H), 9.37 (br, 1H), 8.67 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.17 (d, <com:Math><semantics>J=8.1<annotation encoding="application / x-tex">J = 8.1< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.98 – 7.92 (m, 8H), 7.90 (d, <com:Math><semantics>J=8.9<annotation encoding="application / x-tex">J = 8.9< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.85 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.82 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 3H), 7.67 (br, 1H), 7.40 (s, 1H), 6.99 (s, 1H), 4.92 (q, <com:Math><semantics>J=7.2<annotation encoding="application / x-tex">J = 7.2< / annotation>< / semantics>< / com:Math> Hz, 1H), 4.57 (br, 1H), 2.69 (d, <com:Math><semantics>J=7.6<annotation encoding="application / x-tex">J = 7.6< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>1.26(d,J=6.1Hz,6H).<annotation encoding="application / x-tex">1.26 (d, J = 6.1 Hz, 6H).< / annotation>< / semantics>< / com:Math> <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 168.4, 166.9, 165.8, 164.7, 164.1, 142.5, 141.7, 138.5, 136.9, 136.4, 131.6, 131.4, 130.2, 129.1, 128.7, 128.3, 128.3, 125.4, 125.4, 124.7, 123.1, 122.9, 120.6, 119.5, 118.9, 74.7, 51.6, 36.8, 22.3. HRMS (ESI) calculated for C43H36F3N6O10 (M-H) 853.2450, found 853.2438. (S)-4-(4-(4-(4-amino-4-oxo-2-(4-(4- ureidobenzamido)benzamido)butanamido)benzamido)-2-hydroxy-3- isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (20 mg, 0.026 mmol) coupled with carboxylic acid 32 using coupling conditions C followed by final deprotection. Desired compound purified by preparative HPLC condition B, to obtain 6.2 mg of desired product as a white solid <com:Math><semantics>(0.0073 mmol,y=28%)<annotation encoding="application / x-tex">(0.0073 \text{ mmol}, y= 28\%)< / annotation>< / semantics>< / com:Math>. <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 12.55 (br, 1H), 10.44 (s, 1H), 10.26 (s, 1H), 9.15 (br, 1H), 8.89 (s, 1H), 8.63 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>7.93−7.87<annotation encoding="application / x-tex">7.93 - 7.87< / annotation>< / semantics>< / com:Math> (m, 10H), <com:Math><semantics>7.81<annotation encoding="application / x-tex">7.81< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 4H), <com:Math><semantics>7.66<annotation encoding="application / x-tex">7.66< / annotation>< / semantics>< / com:Math> (br, 1H), <com:Math><semantics>7.56−7.52<annotation encoding="application / x-tex">7.56 - 7.52< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>7.39<annotation encoding="application / x-tex">7.39< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>6.99<annotation encoding="application / x-tex">6.99< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>6.01<annotation encoding="application / x-tex">6.01< / annotation>< / semantics>< / com:Math> (s, 2H), <com:Math><semantics>4.92<annotation encoding="application / x-tex">4.92< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=14.0<annotation encoding="application / x-tex">J = 14.0< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>7.3<annotation encoding="application / x-tex">7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), 4.77 (br, 1H), 2.69 (d, <com:Math><semantics>J=8.2<annotation encoding="application / x-tex">J = 8.2< / annotation>< / semantics>< / com:Math> Hz, 2H), 1.23 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Math><semantics>13<annotation encoding="application / x-tex">^{13}< / annotation>< / semantics>< / com:Math>C NMR (176 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 171.3, 170.7, 167.9, 167.0, 165.9, 165.3, 163.8, 155.7, 144.0, 142.3, 142.3, 130.3, 128.8, 128.4, 128.2, 128.0, 126.6, 123.2, 119.2, 119.0, 116.6, 51.6, 36.8, 22.5. HRMS (ESI) calculated for C43H39N8O11 (M-H) 843.2744, found 843.2759. (S)-4-(4-(4-(4-amino-2-(4-(4-(4-nitrobenzamido)benzamido)benzamido)-4- oxobutanamido)benzamido)-2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (15 mg, 0.020 mmol) coupled with carboxylic acid 29 using coupling conditions C followed by final deprotection. Desired compound purified by preparative HPLC condition B, to obtain 3.9 mg of desired product as a white solid (0.0041 mmol, y= 20%). <com:Math><semantics>1H NMR<annotation encoding="application / x-tex">^{1}\text{H NMR}< / annotation>< / semantics>< / com:Math> (700 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 12.61 (br, 1H), 12.32 (br, 1H), 10.84 (s, 1H), 10.44 (s, 1H), 10.41 (s, 1H), 9.16 (br, 1H), 8.65 (d, <com:Math><semantics>J=7.2<annotation encoding="application / x-tex">J = 7.2< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.42 <com:Math><semantics>−8.37<annotation encoding="application / x-tex">- 8.37< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>8.25−8.19<annotation encoding="application / x-tex">8.25 - 8.19< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>8.04<annotation encoding="application / x-tex">8.04< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>7.96<annotation encoding="application / x-tex">7.96< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>7.94−7.86<annotation encoding="application / x-tex">7.94 - 7.86< / annotation>< / semantics>< / com:Math> (m, 9H), <com:Math><semantics>7.82<annotation encoding="application / x-tex">7.82< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 4H), 7.67 (br, 1H), 7.40 (s, 1H), 6.99 (s, 1H), 4.93 (dd, <com:Math><semantics>J=14.1<annotation encoding="application / x-tex">J = 14.1< / annotation>< / semantics>< / com:Math>, 7.2 Hz, 1H), 4.76 (br, 1H), 2.69 (d, <com:Math><semantics>J=7.7<annotation encoding="application / x-tex">J = 7.7< / annotation>< / semantics>< / com:Math> Hz, 2H), 1.23 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Math><semantics>13C NMR<annotation encoding="application / x-tex">^{13}\text{C NMR}< / annotation>< / semantics>< / com:Math> (176 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 171.3, 170.7, 167.0, 165.8, 165.1, 164.3, 163.7, 149.3, 142.3, 142.1, 141.9, 140.3, 130.3, 129.8, 129.3, 128.7, 128.6, 128.3, 128.0, 123.6, 123.2, 119.6, 119.3, 119.0, 51.6, 36.8, 22.5. HRMS (ESI) calculated for C49H41N8O13 (M-H) 949.2799, found 949.2848. (S)-4-(4-(4-(4-amino-2-(4-(2-hydroxy-3-isopropoxy-4-nitrobenzamido)benzamido)-4- oxobutanamido)benzamido)-2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (40 mg, 0.052 mmol) coupled with carboxylic acid (see section 2.2c) using coupling conditions A, intermediate purified on silica gel with a gradient 0-10% MeOH in DCM to give 40 mg (0.095 mmol, y= 87%) of allyl protected cystobactamid derivative. Followed final deprotection on 15 mg of intermediate (0.015 mmol), desired compound purified by preparative HPLC condition B, to obtain 2.5 mg of desired product (0.0028 mmol, y= 18%) and 1.2 mg of compound 49, which was formed as a by-product of the reaction. Allyl protected intermediate: [Image disponible dans le document PDF, Image available in the PDF document] <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 10.66 (s, 1H), 10.58 (s, 1H), 10.44 (s, 1H), 9.52 (s, 1H), 8.66 <Formule mathématique disponible dans le document PDF, Math available in the PDF document>(d, J = 7.3 \text{ Hz}, 1\text{H}), 7.98 \text{ } (dd, J = 8.7, 6.6 \text{ Hz}, 4\text{H}), 7.92 \text{ } (d, J = 8.8 \text{ Hz}, 2\text{H}), 7.87 \text{ } (d, J = 8.6 \text{ Hz}, 2\text{H}), 7.87 \text{ } (d, J = 8.6 \text{ Hz}, 2\text{H}), 7.87 \text{ } (d, J = 8.6 \text{ Hz}, 2\text{H Hz, 2H), <com:Math><semantics>7.83−7.76<annotation encoding="application / x-tex">7.83 - 7.76< / annotation>< / semantics>< / com:Math> (m, 5H), <com:Math><semantics>7.72<annotation encoding="application / x-tex">7.72< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.4<annotation encoding="application / x-tex">J = 8.4< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>7.46<annotation encoding="application / x-tex">7.46< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.4<annotation encoding="application / x-tex">J = 8.4< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>7.40<annotation encoding="application / x-tex">7.40< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.4<annotation encoding="application / x-tex">J = 8.4< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>7.40<annotation encoding="application / x-tex">7.40< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.4<annotation encoding="application / x-tex">J = 8.4< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>7.40<annotation encoding="application / x-tex">7.40< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.4<annotation encoding="application / x-tex">J = 8.4< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>7.40<annotation encoding="application / x-tex">7.40< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.4<annotation encoding="application / x-tex">J = 8.4< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>7.40<annotation encoding="application / x-tex">7.40< / annotation>< / semantics>< / com:Math> (d 8.4 Hz, 2H), 6.99 (s, 1H), 6.09 – 5.93 (m, 3H), 5.43 - 5.36 (m, 2H), 5.36 - 5.26 (m, 2H), 5.22 <com:Math><semantics>−5.16<annotation encoding="application / x-tex">-5.16< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>4.92<annotation encoding="application / x-tex">4.92< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=13.9<annotation encoding="application / x-tex">J = 13.9< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>7.4<annotation encoding="application / x-tex">7.4< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>4.81−4.78<annotation encoding="application / x-tex">4.81 - 4.78< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>4.70−4.65<annotation encoding="application / x-tex">4.70 - 4.65< / annotation>< / semantics>< / com:Math> (m, 1H), <com:Math><semantics>4.62−4.59<annotation encoding="application / x-tex">4.62 - 4.59< / annotation>< / semantics>< / com:Math> (m, 4H), <com:Math><semantics>4.52−4.46<annotation encoding="application / x-tex">4.52 - 4.46< / annotation>< / semantics>< / com:Math> (m, 1H), <com:Math><semantics>2.71−2.67<annotation encoding="application / x-tex">2.71 - 2.67< / annotation>< / semantics>< / com:Math> (m, 1H), <com:Math><semantics>1.26<annotation encoding="application / x-tex">1.26< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H), <com:Math><semantics>1.24<annotation encoding="application / x-tex">1.24< / annotation>< / semantics>< / com:Math> <com:Math><semantics>(d,J=6.1 Hz,6H).<annotation encoding="application / x-tex">(d, J = 6.1 \text{ Hz}, 6H).< / annotation>< / semantics>< / com:Math> <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 165.7, 164.9, 164.7, 164.3, 163.7, 149.9, 149.5, 146.8, 143.5, 143.4, 142.6, 142.4, 141.4, 136.1, 135.7, 133.7, 133.1, 132.8, 130.3, 129.1, 128.5, 128.4, 128.3, 127.1, 124.2, 123.6, 123.2, 119.2, 119.0, 118.8, 118.8, 118.3, 117.8, 117.8, 77.2, 76.2, 74.6, 74.3, 64.8, 51.6, 36.8, 22.3, 22.1. Final compound 48: <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 12.82 (br, 1H), 12.29 (br, 1H), 10.61 (br, 1H), 10.43 (s, 1H), 9.40 (s, 1H), 8.60 (d, <com:Math><semantics>J=7.2<annotation encoding="application / x-tex">J = 7.2< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.96 (dd, <com:Math><semantics>J=14.7<annotation encoding="application / x-tex">J = 14.7< / annotation>< / semantics>< / com:Math>, 8.7 Hz, 4H), 7.91-7.75 (m, 9H), 7.69 <com:Math><semantics>(d,J=8.7 Hz,1H),7.59(d,J=8.3 Hz,1H),7.40(s,1H),6.98(s,1H),6.48(br,1H),5.10<annotation encoding="application / x-tex">(d, J = 8.7 \text{ Hz}, 1\text{H}), 7.59 (d, J = 8.3 \text{ Hz}, 1\text{H}), 7.40 (s, 1\text{H}), 6.98 (s, 1\text{H}), 6.48 (br, 1\text{H}), 5.10< / annotation>< / semantics>< / com:Math> (br, 1H), 4.91 (dd, <com:Math><semantics>J=13.9<annotation encoding="application / x-tex">J = 13.9< / annotation>< / semantics>< / com:Math>, 7.2 Hz, 1H), 4.54 (dt, <com:Math><semantics>J=11.9<annotation encoding="application / x-tex">J = 11.9< / annotation>< / semantics>< / com:Math>, 5.9 Hz, 1H), 2.69 (dd, <com:Math><semantics>J=6.7<annotation encoding="application / x-tex">J = 6.7< / annotation>< / semantics>< / com:Math>, 3.2 Hz, 2H), 1.26 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H), 1.14 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.8, 168.5, 166.3, 166.0, 164.2, 154.1, 147.2, 142.5, 137.0, 136.4, 130.2, 128.5, 128.3, 123.4, 122.8, 120.9, 120.7, 118.9, 118.8, 112.5, 112.2, 74.8, 51.6, 36.8, 22.3, 22.2. HRMS (ESI) calculated for C45H44N7O14 (M+H) 906.2941, found 906.2940. (S)-4-(4-(4-(4-amino-2-(4-(4-amino-2-hydroxy-3-isopropoxybenzamido)benzamido)-4- oxobutanamido)benzamido)-2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 12.82 (br, 1H), 12.63 (s, 1H), 12.28 (br, 1H), 10.61 (br, 1H), 10.45 (s, 1H), 10.11 (s, 1H), 9.39 (s, 1H), 8.65 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.95 (dd, <com:Math><semantics>J=12.0<annotation encoding="application / x-tex">J = 12.0< / annotation>< / semantics>< / com:Math>, 8.7 Hz, 4H), 7.89 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.83 (dd, <com:Math><semantics>J=24.7<annotation encoding="application / x-tex">J = 24.7< / annotation>< / semantics>< / com:Math>, 8.7 Hz, 4H), 7.78 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.68 (br, 2H), 7.59 (d, <com:Math><semantics>J=9.0<annotation encoding="application / x-tex">J = 9.0< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.40 (s, 1H), 6.99 (s, 1H), 6.26 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 1H), 5.63 (s, 2H), <com:Math><semantics>4.92<annotation encoding="application / x-tex">4.92< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=14.0<annotation encoding="application / x-tex">J = 14.0< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>7.3<annotation encoding="application / x-tex">7.3< / annotation>< / semantics>< / com:Math> Hz, <com:Math><semantics>1H<annotation encoding="application / x-tex">1H< / annotation>< / semantics>< / com:Math>), <com:Math><semantics>4.55<annotation encoding="application / x-tex">4.55< / annotation>< / semantics>< / com:Math> (br, <com:Math><semantics>1H<annotation encoding="application / x-tex">1H< / annotation>< / semantics>< / com:Math>), <com:Math><semantics>4.46<annotation encoding="application / x-tex">4.46< / annotation>< / semantics>< / com:Math> (dt, <com:Math><semantics>J=12.3<annotation encoding="application / x-tex">J = 12.3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>6.1<annotation encoding="application / x-tex">6.1< / annotation>< / semantics>< / com:Math> Hz, <com:Math><semantics>1H<annotation encoding="application / x-tex">1H< / annotation>< / semantics>< / com:Math>), <com:Math><semantics>2.70−2.67<annotation encoding="application / x-tex">2.70 - 2.67< / annotation>< / semantics>< / com:Math> (m, 2H), 1.26 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H), 1.22 (d, <com:Math><semantics>J=6.2<annotation encoding="application / x-tex">J = 6.2< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 169.4, 168.4, 166.9, 165.9, 164.2, 155.7, 148.1, 142.5, 142.0, 141.3, 137.0, 136.4, 130.2, 129.6, 128.8, 128.3, 128.3, 128.2, 123.6, 122.9, 120.6, 120.3, 118.9, 105.3, 103.4, 72.8, 51.6, 36.8, 22.3, 22.2. HRMS (ESI) calculated for C45H46N7O12 (M+H) 876.3199, found 876.3200. (S)-4-(4-(4-(4-amino-2-(4-(4-cyano-2-methylbenzamido)benzamido)-4- oxobutanamido)benzamido)-2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (20 mg, 0.026 mmol) coupled with 4-Cyano-2-methylbenzoic acid using coupling conditions A followed by final deprotection. Desired compound purified by preparative HPLC condition B, to obtain 4.5 mg of desired product as a white solid <com:Math><semantics>(0.005 mmol,y=21%)<annotation encoding="application / x-tex">(0.005 \text{ mmol}, y= 21\%)< / annotation>< / semantics>< / com:Math>. <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 12.75 (br, 1H), 12.29 (br, 1H), 10.73 (s, 1H), 10.46 (s, 1H), 9.31 (br, 1H), 8.66 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.93 (m, 6H), 7.82 (m, 7H), 7.78 (br, 1H), 7.69 (d, <com:Math><semantics>J=<annotation encoding="application / x-tex">J =< / annotation>< / semantics>< / com:Math> 7.9 Hz, 1H), <com:Math><semantics>7.65−7.55<annotation encoding="application / x-tex">7.65 - 7.55< / annotation>< / semantics>< / com:Math> (br, 2H), <com:Math><semantics>7.39<annotation encoding="application / x-tex">7.39< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>6.99<annotation encoding="application / x-tex">6.99< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>4.92<annotation encoding="application / x-tex">4.92< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=14.1<annotation encoding="application / x-tex">J = 14.1< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>7.2<annotation encoding="application / x-tex">7.2< / annotation>< / semantics>< / com:Math> Hz, 1H), 4.63 (br, 1H), 2.69 (d, <com:Math><semantics>J=8.1<annotation encoding="application / x-tex">J = 8.1< / annotation>< / semantics>< / com:Math> Hz, 2H), 2.42 (s, 3H), 1.25 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 168.3, 166.9, 166.6, 165.7, 164.0, 142.4, 141.6, 141.1, 136.8, 136.5, 134.0, 130.2, 129.7, 129.0, 128.4, 128.2, 123.0, 120.3, 118.9, 118.9, 118.4, 112.3, 51.6, 36.8, 22.4, 18.8. HRMS (ESI) calculated for C44H38N7O10 (M-H) 824.2686, found 824.2705. (S)-4-(4-(4-(4-amino-2-(4-(4-cyano-3-fluorobenzamido)benzamido)-4- oxobutanamido)benzamido)-2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (20 mg, 0.026 mmol) coupled with 4-Cyano-3-fluorobenzoic acid using coupling conditions A followed by final deprotection. Desired compound purified by preparative HPLC condition B, to obtain 5.7 mg of desired product as a white solid (0.007 mmol, <com:Math><semantics>y=27%<annotation encoding="application / x-tex">y=27\%< / annotation>< / semantics>< / com:Math>). <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) δ 12.78 (br, 1H), 12.29 (br, 1H), 10.74 (s, 1H), 10.46 (s, 1H), 9.35 (br, 1H), 8.68 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.15 (dd, <com:Math><semantics>J=8.0<annotation encoding="application / x-tex">J = 8.0< / annotation>< / semantics>< / com:Math>, 6.7 Hz, 1H), 8.08 (dd, <com:Math><semantics>J=10.1<annotation encoding="application / x-tex">J = 10.1< / annotation>< / semantics>< / com:Math>, 1.5 Hz, 1H), 7.97 (m, 2H), 7.94 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 5H), 7.88 (d, <com:Math><semantics>J=8.9<annotation encoding="application / x-tex">J = 8.9< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.83 (dd, <com:Math><semantics>J=15.2<annotation encoding="application / x-tex">J = 15.2< / annotation>< / semantics>< / com:Math>, 8.8 Hz, 5H), 7.64 (br, 1H), 7.40 (s, 1H), 6.99 (s, 1H), 4.92 (dd, <com:Math><semantics>J=14.1<annotation encoding="application / x-tex">J = 14.1< / annotation>< / semantics>< / com:Math>, 7.1 Hz, 1H), 4.59 (br, 1H), 2.69 (d, <com:Math><semantics>J=7.2<annotation encoding="application / x-tex">J = 7.2< / annotation>< / semantics>< / com:Math> Hz, 2H), 1.26 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.2, 170.7, 168.4, 166.9, 165.7, 164.1, 161.5, 142.5, 141.5, 141.5, 141.3, 136.4, 134.3, 129.3, 128.4, 128.2, 124.7, 124.7, 122.9, 120.5, 119.6, 118.9, 115.8, 115.7, 113.6, 102.9, 102.8, 51.6, 36.8, 22.3. <com:Sup>19< / com:Sup>F NMR (471 MHz, DMSO) δ -107.68 (dd, <com:Math><semantics>J=9.8<annotation encoding="application / x-tex">J = 9.8< / annotation>< / semantics>< / com:Math>, 6.8 Hz). HRMS (ESI) calculated for C43H35FN7O10 (M-H) 828.2435, found 28.2447. (S)-4-(4-(4-(4-amino-2-(4-(4-cyano-3-methylbenzamido)benzamido)-4- oxobutanamido)benzamido)-2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (20 mg, 0.026 mmol) coupled with 4-Cyano-3-methylbenzoic acid using coupling conditions A followed by final deprotection. Desired compound purified by preparative HPLC condition B, to obtain 5.2 mg of desired product as a white solid (0.006 mmol, y= 24%). <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 12.77 (br, 1H), 12.29 (br, 1H), 10.66 (s, 1H), 10.46 (s, 1H), 9.34 (br, 1H), 8.67 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.02 (s, 1H), <com:Math><semantics>7.98−7.90<annotation encoding="application / x-tex">7.98 - 7.90< / annotation>< / semantics>< / com:Math> (m, 8H), <com:Math><semantics>7.90−7.87<annotation encoding="application / x-tex">7.90 - 7.87< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>7.87−7.76<annotation encoding="application / x-tex">7.87 - 7.76< / annotation>< / semantics>< / com:Math> (m, 5H), <com:Math><semantics>7.67−7.58<annotation encoding="application / x-tex">7.67 - 7.58< / annotation>< / semantics>< / com:Math> (br, 1H), <com:Math><semantics>7.40<annotation encoding="application / x-tex">7.40< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>6.99<annotation encoding="application / x-tex">6.99< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>4.92<annotation encoding="application / x-tex">4.92< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=14.1,7.2<annotation encoding="application / x-tex">J = 14.1, 7.2< / annotation>< / semantics>< / com:Math> Hz, 1H), 4.60 (br, 1H), 2.69 (d, <com:Math><semantics>J=7.5<annotation encoding="application / x-tex">J = 7.5< / annotation>< / semantics>< / com:Math> Hz, 2H), 2.59 (s, 3H), 1.25 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 168.3, 166.9, 165.8, 164.6, 164.1, 142.4, 141.9, 141.6, 138.6, 136.5, 132.8, 132.6, 130.2, 129.4, 129.2, 129.1, 128.3, 128.2, 125.8, 125.4, 122.9, 120.4, 119.5, 118.9, 117.5, 114.4, 51.6, 36.8, 22.3, 20.0. HRMS (ESI) calculated for C44H38N7O10 (M-H) 824.2686, found 824.2694. (S,E)-4-(4-(4-(4-amino-2-(4-(3-(4-hydroxyphenyl)-2-methylacrylamido)benzamido)-4- oxobutanamido)benzamido)-2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (40 mg, 0.052 mmol) coupled with carboxylic acid 30 coupling conditions A, intermediate purified on silica gel with a gradient 0-10% MeOH in DCM to give 50 mg (0.052 mmol, y= q.) of allyl protected cystobactamid derivative. Followed final deprotection on 15 mg of intermediate (0.016 mmol), desired compound purified by preparative HPLC condition B, to obtain 1.0 mg of desired product (0.0012 mmol, <com:Math><semantics>y=7%<annotation encoding="application / x-tex">y=7\%< / annotation>< / semantics>< / com:Math>). Allyl protected intermediate: [Image disponible dans le document PDF, Image available in the PDF document] <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 10.58 (s, 1H), 10.44 (s, 1H), 10.12 (s, 1H), 9.52 (s, 1H), 8.62 <com:Math><semantics>(d,J=7.3 Hz,1H),7.98(dd,J=8.8,7.0 Hz,4H),7.90−7.85(m,4H),7.85−7.79(m,5H),<annotation encoding="application / x-tex">(d, J = 7.3 \text{ Hz}, 1\text{H}), 7.98 (dd, J = 8.8, 7.0 \text{ Hz}, 4\text{H}), 7.90 - 7.85 (m, 4\text{H}), 7.85 - 7.79 (m, 5\text{H}),< / annotation>< / semantics>< / com:Math> <com:Math><semantics>7.45<annotation encoding="application / x-tex">7.45< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>7.40<annotation encoding="application / x-tex">7.40< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.4<annotation encoding="application / x-tex">J = 8.4< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>7.30<annotation encoding="application / x-tex">7.30< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>7.06−7.01<annotation encoding="application / x-tex">7.06 - 7.01< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>6.99<annotation encoding="application / x-tex">6.99< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>6.09−5.98<annotation encoding="application / x-tex">6.09 - 5.98< / annotation>< / semantics>< / com:Math> (m, 3H), <com:Math><semantics>5.44−5.35<annotation encoding="application / x-tex">5.44 - 5.35< / annotation>< / semantics>< / com:Math> (m, 3H), <com:Math><semantics>5.28<annotation encoding="application / x-tex">5.28< / annotation>< / semantics>< / com:Math> (dq, <com:Math><semantics>J=10.5<annotation encoding="application / x-tex">J = 10.5< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>1.4<annotation encoding="application / x-tex">1.4< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>5.20<annotation encoding="application / x-tex">5.20< / annotation>< / semantics>< / com:Math> (ddd, <com:Math><semantics>J=10.5<annotation encoding="application / x-tex">J = 10.5< / annotation>< / semantics>< / com:Math>), <com:Math><semantics>5.20<annotation encoding="application / x-tex">5.20< / annotation>< / semantics>< / com:Math> (ddd, <com:Math><semantics>J=10.5<annotation encoding="application / x-tex">J = 10.5< / annotation>< / semantics>< / com:Math>), <com:Math><semantics>5.20<annotation encoding="application / x-tex">5.20< / annotation>< / semantics>< / com:Math> (ddd, <com:Math><semantics>J=10.5<annotation encoding="application / x-tex">J = 10.5< / annotation>< / semantics>< / com:Math>), <com:Math><semantics>5.20<annotation encoding="application / x-tex">5.20< / annotation>< / semantics>< / com:Math> (ddd, <com:Math><semantics>J=10.5<annotation encoding="application / x-tex">J = 10.5< / annotation>< / semantics>< / com:Math>), <com:Math><semantics>5.20<annotation encoding="application / x-tex">5.20< / annotation>< / semantics>< / com:Math> (ddd, <com:Math><semantics>J=10.5<annotation encoding="application / x-tex">J = 10.5< / annotation>< / semantics>< / com:Math>), 10.5, 2.9, 1.3 Hz, 1H), 4.91 (dd, <com:Math><semantics>J=14.0<annotation encoding="application / x-tex">J = 14.0< / annotation>< / semantics>< / com:Math>, 7.2 Hz, 1H), 4.79 (dd, <com:Math><semantics>J=4.0<annotation encoding="application / x-tex">J = 4.0< / annotation>< / semantics>< / com:Math>, 1.4 Hz, 2H), 4.63 - <com:Math><semantics>4.60 (m, 4H),4.49 (dt, J=12.3,6.2 Hz, 1H),3.85−3.73 (m, 1H),2.69 (d, J=7.8 Hz, 2H),<annotation encoding="application / x-tex">4.60 \text{ (m, 4H)}, 4.49 \text{ (dt, } J = 12.3, 6.2 \text{ Hz, 1H)}, 3.85 - 3.73 \text{ (m, 1H)}, 2.69 \text{ (d, } J = 7.8 \text{ Hz, 2H)},< / annotation>< / semantics>< / com:Math> <com:Math><semantics>2.12(d,J=1.3Hz,3H),1.26(d,J=6.1Hz,6H).<annotation encoding="application / x-tex">2.12 (d, J = 1.3 Hz, 3H), 1.26 (d, J = 6.1 Hz, 6H).< / annotation>< / semantics>< / com:Math> <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.8, 168.7, 165.9, 165.0, 164.7, 164.3, 158.0, 149.5, 143.5, 142.6, 142.4, 142.3, 135.7, 133.7, 133.6, 133.3, 132.8, 131.1, 130.7, 130.3, 128.4, 128.3, 128.2, 127.1, 124.2, 123.6, 119.1, 119.0, 118.8, 117.8, 117.8, 117.6, 114.7, 107.0, 97.2, 76.3, 74.3, 68.2, 64.8, 51.6, 36.8, 22.3, 14.5. Final compound 53: <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 12.79 (br, 1H), 12.29 (br, 1H), 10.60 (br, 1H), 10.45 (s, 1H), <com:Math><semantics>10.08<annotation encoding="application / x-tex">10.08< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>9.76<annotation encoding="application / x-tex">9.76< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>9.38<annotation encoding="application / x-tex">9.38< / annotation>< / semantics>< / com:Math> (br, 1H), <com:Math><semantics>8.61<annotation encoding="application / x-tex">8.61< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=7.2<annotation encoding="application / x-tex">J = 7.2< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>7.98−7.90<annotation encoding="application / x-tex">7.98 - 7.90< / annotation>< / semantics>< / com:Math> (m, 4H), <com:Math><semantics>7.90−<annotation encoding="application / x-tex">7.90 -< / annotation>< / semantics>< / com:Math> 7.76 (m, 10H), 7.39 (s, 1H), 7.35 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.26 (s, 1H), 6.99 (s, 1H), 6.84 (d, <com:Math><semantics>J=<annotation encoding="application / x-tex">J =< / annotation>< / semantics>< / com:Math> 8.6 Hz, 2H), 4.91 (dd, <com:Math><semantics>J=14.1<annotation encoding="application / x-tex">J = 14.1< / annotation>< / semantics>< / com:Math>, 7.2 Hz, 1H), 4.56 (br, 1H), 2.68 (d, <com:Math><semantics>J=7.5<annotation encoding="application / x-tex">J = 7.5< / annotation>< / semantics>< / com:Math> Hz, 2H), 2.11 (d, <com:Math><semantics>J=14.1<annotation encoding="application / x-tex">J = 14.1< / annotation>< / semantics>< / com:Math>, 7.2 Hz, 1H), 4.56 (br, 1H), 2.68 (d, <com:Math><semantics>J=14.1<annotation encoding="application / x-tex">J = 14.1< / annotation>< / semantics>< / com:Math>, 2H), 2.11 (d, <com:Math><semantics>J=14.1<annotation encoding="application / x-tex">J = 14.1< / annotation>< / semantics>< / com:Math>), 4.56 (br, 1H), 2.68 (d, <com:Math><semantics>J=14.1<annotation encoding="application / x-tex">J = 14.1< / annotation>< / semantics>< / com:Math> <com:Math><semantics>=1.2 Hz,3H),1.26 (d, J=6.1 Hz,6H).<annotation encoding="application / x-tex">= 1.2 \text{ Hz}, 3\text{H}), 1.26 \text{ (d, } J = 6.1 \text{ Hz}, 6\text{H}).< / annotation>< / semantics>< / com:Math> <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.8, 168.8, 166.9, 165.9, 164.1, 162.3, 162.2, 157.5, 142.4, 133.8, 131.3, 130.2, 129.5, 128.2, 127.3, 126.6, 122.8, 120.6, 119.0, 118.9, 115.4, 51.6, 36.8, 22.3, 14.5. HRMS (ESI) calculated for C45H41N6O11 (M-H) 841,2839, found 841,2844. 4-(4-(4-((2S)-4-amino-4-oxo-2-(4-(2- phenoxypropanamido)benzamido)butanamido)benzamido)-2-hydroxy-3- isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (40 mg, 0.052 mmol) coupled with 2-phenoxypropanoic acid using coupling conditions A, intermediate purified on silica gel with a gradient 0-10% MeOH in DCM to give 30 mg (0.033 mmol, y= 63%) of allyl protected cystobactamid derivative. Followed final deprotection on 15 mg of intermediate (0.016 mmol), desired compound purified by preparative HPLC condition B, to obtain 7.5 mg of desired product (0.009 mmol, <com:Math><semantics>y=56%<annotation encoding="application / x-tex">y = 56\%< / annotation>< / semantics>< / com:Math>). Allyl protected intermediate: [Image disponible dans le document PDF, Image available in the PDF document] <com:Math><semantics>1H NMR<annotation encoding="application / x-tex">^{1}\text{H NMR}< / annotation>< / semantics>< / com:Math> (500 MHz, Acetone) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 10.25 (s, 1H), 10.02 (s, 1H), 9.52 (s, 1H), 8.99 (s, 1H), 8.40 <com:Math><semantics>(dd,J=8.8,2.3 Hz,1H),8.37(d,J=7.5 Hz,1H),8.08−8.03(m,2H),8.00−7.96(m,2H),<annotation encoding="application / x-tex">(dd, J = 8.8, 2.3 \text{ Hz}, 1\text{H}), 8.37 (d, J = 7.5 \text{ Hz}, 1\text{H}), 8.08 - 8.03 (m, 2\text{H}), 8.00 - 7.96 (m, 2\text{H}),< / annotation>< / semantics>< / com:Math> <com:Math><semantics>7.94−7.88<annotation encoding="application / x-tex">7.94 - 7.88< / annotation>< / semantics>< / com:Math> (m, 4H), <com:Math><semantics>7.88−7.82<annotation encoding="application / x-tex">7.88 - 7.82< / annotation>< / semantics>< / com:Math> (m, 5H), <com:Math><semantics>7.34−7.29<annotation encoding="application / x-tex">7.34 - 7.29< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>7.15<annotation encoding="application / x-tex">7.15< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>7.05−7.01<annotation encoding="application / x-tex">7.05 - 7.01< / annotation>< / semantics>< / com:Math> (m, 2H), 6.99 (tt, <com:Math><semantics>J=7.4<annotation encoding="application / x-tex">J = 7.4< / annotation>< / semantics>< / com:Math>, 1.0 Hz, 1H), 6.54 (s, 1H), 6.27 - 6.17 (m, 1H), 6.14 - 6.04 (m, 1H), 5.50 (m, 2H), <com:Math><semantics>5.32<annotation encoding="application / x-tex">5.32< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>5.10−5.05<annotation encoding="application / x-tex">5.10 - 5.05< / annotation>< / semantics>< / com:Math> (m, 1H), <com:Math><semantics>4.89<annotation encoding="application / x-tex">4.89< / annotation>< / semantics>< / com:Math> (q, <com:Math><semantics>J=6.7<annotation encoding="application / x-tex">J = 6.7< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>4.83−4.76<annotation encoding="application / x-tex">4.83 - 4.76< / annotation>< / semantics>< / com:Math> (m, 5H), <com:Math><semantics>2.93 (qd, J=15.9,6.0 Hz, 2H),1.61 (d, J=6.7 Hz, 3H),1.39 (d, J=6.2 Hz, 6H).<annotation encoding="application / x-tex">2.93 \text{ (qd, } J = 15.9, 6.0 \text{ Hz, } 2\text{H)}, 1.61 \text{ (d, } J = 6.7 \text{ Hz, } 3\text{H)}, 1.39 \text{ (d, } J = 6.2 \text{ Hz, } 6\text{H)}.< / annotation>< / semantics>< / com:Math> <com:Sup>13< / com:Sup>C NMR (176 MHz, Acetone) δ 173.7, 171.5, 171.0, 167.2, 166.0, 165.0, 163.9, 158.3, 150.7, 144.4, 143.6, 142.6, 140.8, 138.6, 138.3, 134.1, 133.9, 131.5, 130.6, 130.4, 130.2, 130.1, 129.2, 126.9, 126.2, 123.8, 122.7, 122.0, 120.2, 120.1, 120.0, 119.6, 118.1, 116.7, 116.6, 116.6, 115.9, 77.5, 75.9, 75.6, 65.9, 52.5, 37.1, 22.9, 18.8. Final compound 54: <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 12.76 (br, 1H), 12.29 (br, 1H), 10.71 (br, 1H), 10.44 (s, 1H), 10.36 (s, 1H), 9.33 (br, 1H), 8.62 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.94 (dd, <com:Math><semantics>J=15.5<annotation encoding="application / x-tex">J = 15.5< / annotation>< / semantics>< / com:Math>, 8.6 Hz, 4H), 7.85 <com:Math><semantics>(dd,J=16.2,8.7 Hz,4H),7.80(d,J=8.7 Hz,3H),7.74(d,J=8.8 Hz,2H),7.62(br,1H),<annotation encoding="application / x-tex">(dd, J = 16.2, 8.7 \text{ Hz}, 4H), 7.80 (d, J = 8.7 \text{ Hz}, 3H), 7.74 (d, J = 8.8 \text{ Hz}, 2H), 7.62 (br, 1H),< / annotation>< / semantics>< / com:Math> 7.38 (s, 1H), 7.30 (dd, <com:Math><semantics>J=8.6<annotation encoding="application / x-tex">J = 8.6< / annotation>< / semantics>< / com:Math>, 7.4 Hz, 2H), 6.96 (dd, <com:Math><semantics>J=13.2<annotation encoding="application / x-tex">J = 13.2< / annotation>< / semantics>< / com:Math>, 7.6 Hz, 4H), 4.93 – 4.87 (m, 2H), <com:Math><semantics>4.60<annotation encoding="application / x-tex">4.60< / annotation>< / semantics>< / com:Math> (br, 1H), <com:Math><semantics>2.69−2.65<annotation encoding="application / x-tex">2.69 - 2.65< / annotation>< / semantics>< / com:Math> (m, 2H), <com:Math><semantics>1.56<annotation encoding="application / x-tex">1.56< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=6.6<annotation encoding="application / x-tex">J = 6.6< / annotation>< / semantics>< / com:Math> Hz, 3H), <com:Math><semantics>1.25<annotation encoding="application / x-tex">1.25< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 170.9, 170.3, 170.1, 168.0, 166.6, 165.3, 163.7, 156.8, 142.1, 140.9, 136.1, 129.9, 129.2, 128.4, 128.0, 127.8, 122.6, 120.9, 120.0, 118.5, 118.4, 114.7, 73.3, 51.2, 36.4, 22.0, 18.2. HRMS (ESI) calculated for C44H41N6O11 (M-H) 829.2839, found 829.2830. (S)-4-(4-(4-(4-amino-2-(4-(isonicotinamido)benzamido)-4-oxobutanamido)benzamido)-2- hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (25 mg, 0.032 mmol) coupled with isonicotinic acid using coupling conditions A followed by final deprotection. Desired compound purified by preparative HPLC condition B, to obtain 5.5 mg of desired product as a white solid (0.007 mmol, y= 22%). <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 15.70 (br, 1H), 12.48 (br, 1H), 10.73 (s, 1H), 10.46 (s, 1H), 8.88 (s, 1H), 8.80 (d, <com:Math><semantics>J=5.8<annotation encoding="application / x-tex">J = 5.8< / annotation>< / semantics>< / com:Math> Hz, 2H), 8.73 (d, <com:Math><semantics>J=7.0<annotation encoding="application / x-tex">J = 7.0< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.94 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.91 <com:Math><semantics>−7.86<annotation encoding="application / x-tex">-7.86< / annotation>< / semantics>< / com:Math> (m, 4H), <com:Math><semantics>7.86−7.77<annotation encoding="application / x-tex">7.86 - 7.77< / annotation>< / semantics>< / com:Math> (m, 6H), <com:Math><semantics>7.70<annotation encoding="application / x-tex">7.70< / annotation>< / semantics>< / com:Math> (br, 2H), <com:Math><semantics>7.45<annotation encoding="application / x-tex">7.45< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>7.42<annotation encoding="application / x-tex">7.42< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>7.10<annotation encoding="application / x-tex">7.10< / annotation>< / semantics>< / com:Math> <com:Math><semantics>(d,J=8.7 Hz,1H),6.98 (s, 1H),5.01 (dt, J=12.2,6.0 Hz,1H),4.92 (q, J=7.1 Hz,1H),2.69<annotation encoding="application / x-tex">(d, J = 8.7 \text{ Hz}, 1\text{H}), 6.98 \text{ (s, 1H)}, 5.01 \text{ (dt, } J = 12.2, 6.0 \text{ Hz}, 1\text{H}), 4.92 \text{ (q, } J = 7.1 \text{ Hz}, 1\text{H}), 2.69< / annotation>< / semantics>< / com:Math> <com:Math><semantics>(d,J=7.0 Hz,2H),1.20(d,J=6.1 Hz,6H).<annotation encoding="application / x-tex">(d, J = 7.0 \text{ Hz}, 2H), 1.20 (d, J = 6.1 \text{ Hz}, 6H).< / annotation>< / semantics>< / com:Math> <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 167.1, 165.7, 165.3, 164.3, 163.2, 150.3, 142.0, 141.7, 141.4, 137.5, 134.2, 130.0, 129.5, 129.3, 128.3, 127.6, 124.2, 123.7, 121.6, 119.5, 119.0, 117.9, 115.7, 100.9, 70.4, 51.7, 36.8, 22.7. HRMS (ESI) calculated for C41H38N7O10 (M-H) 788.2675, found 788.2659. (S)-4-(4-(4-(4-amino-2-(4-(4-(methylsulfonyl)benzamido)benzamido)-4- oxobutanamido)benzamido)-2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (25 mg, 0.032 mmol) coupled with 4-(methylsulfonyl)benzoic acid using coupling conditions A followed by final deprotection. Desired compound purified by preparative HPLC condition B, to obtain 8.6 mg of desired product as a white solid (0.010 mmol, y= 31%). <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 15.35 (s, 1H), 10.76 (s, 1H), 10.57 (s, 1H), 8.90 (s, 1H), 8.87 (s, 1H), 8.21 (d, <com:Math><semantics>J=8.1<annotation encoding="application / x-tex">J = 8.1< / annotation>< / semantics>< / com:Math> Hz, 2H), 8.09 (d, <com:Math><semantics>J=8.1<annotation encoding="application / x-tex">J = 8.1< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.96 (d, <com:Math><semantics>J=8.5<annotation encoding="application / x-tex">J = 8.5< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.90 (d, <com:Math><semantics>J=8.1<annotation encoding="application / x-tex">J = 8.1< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.90 (d, <com:Math><semantics>J=8.5<annotation encoding="application / x-tex">J = 8.5< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.90 (d, <com:Math><semantics>J=8.5<annotation encoding="application / x-tex">J = 8.5< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.90 (d, <com:Math><semantics>J=8.5<annotation encoding="application / x-tex">J = 8.5< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.90 (d, <com:Math><semantics>J=8.<annotation encoding="application / x-tex">J = 8.< / annotation>< / semantics>< / com:Math> <com:Math><semantics>=8.4 Hz,2H),7.83 (s, 4H),7.79 (d, J=8.0 Hz, 2H),7.58 (d, J=8.0 Hz, 2H),7.51 (s, 1H),<annotation encoding="application / x-tex">= 8.4 \text{ Hz}, 2\text{H}), 7.83 \text{ (s, 4H)}, 7.79 \text{ (d, } J = 8.0 \text{ Hz, 2H)}, 7.58 \text{ (d, } J = 8.0 \text{ Hz, 2H)}, 7.51 \text{ (s, 1H)},< / annotation>< / semantics>< / com:Math> 7.45 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.08 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 1H), 6.98 (s, 1H), 5.02 (dt, <com:Math><semantics>J=12.0<annotation encoding="application / x-tex">J = 12.0< / annotation>< / semantics>< / com:Math>, 5.9 Hz, 1H), 4.92 (dd, <com:Math><semantics>J=13.4<annotation encoding="application / x-tex">J = 13.4< / annotation>< / semantics>< / com:Math>, 7.2 Hz, 1H), 3.30 (s, 3H), 2.73 (dd, <com:Math><semantics>J=14.8<annotation encoding="application / x-tex">J = 14.8< / annotation>< / semantics>< / com:Math>, 8.7 Hz, 1H), 2.68 (dd, <com:Math><semantics>J=14.8<annotation encoding="application / x-tex">J = 14.8< / annotation>< / semantics>< / com:Math>) 14.8, 5.1 Hz, 1H), 1.20 (d, <com:Math><semantics>J=5.7<annotation encoding="application / x-tex">J = 5.7< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 166.9, 165.7, 165.3, 164.6, 163.1, 143.3, 142.0, 141.8, 141.6, 139.2, 137.5, 134.0, 133.4, 129.7, 129.5, 129.2, 128.8, 128.4, 128.3, 127.6, 127.1, 127.0, 126.8, 123.7, 119.5, 119.0, 117.6, 116.0, 100.6, 70.3, 51.9, 43.3, 36.9, 22.7. HRMS (ESI) calculated for C43H39N6O12S (M-H) 863.2352, found 863.2364. (S)-4-(4-(4-(4-amino-4-oxo-2-(4-(1-oxo-1,3-dihydroisobenzofuran-5- carboxamido)benzamido)butanamido)benzamido)-2-hydroxy-3- isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (25 mg, 0.032 mmol) coupled with 1-oxo-1,3-dihydroisobenzofuran-5-carboxylic acid using coupling conditions A followed by final deprotection. Desired compound purified by preparative HPLC condition B, to obtain 4.9 mg of desired product as a white solid (0.0058 mmol, y= 18%). <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 15.33 (s, 1H), 10.81 (s, 1H), 10.56 (s, 1H), 8.87 (s, 2H), 8.23 (s, 1H), 8.14 (d, <com:Math><semantics>J=8.1<annotation encoding="application / x-tex">J = 8.1< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.01 (d, <com:Math><semantics>J=8.0<annotation encoding="application / x-tex">J = 8.0< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.95 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.91 (d, <com:Math><semantics>J=8.1<annotation encoding="application / x-tex">J = 8.1< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.01 (d, <com:Math><semantics>J=8.0<annotation encoding="application / x-tex">J = 8.0< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.95 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 2H), 7.91 (d, <com:Math><semantics>J=8.0<annotation encoding="application / x-tex">J = 8.0< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.95 (d, <com:Math><semantics>J=8.<annotation encoding="application / x-tex">J = 8.< / annotation>< / semantics>< / com:Math> <com:Math><semantics>=8.7 Hz,2H),7.83 (q, J=9.1 Hz,4H),7.77 (d, J=8.4 Hz,2H),7.56 (d, J=8.5 Hz,2H),<annotation encoding="application / x-tex">= 8.7 \text{ Hz}, 2\text{H}), 7.83 \text{ (q, } J = 9.1 \text{ Hz}, 4\text{H}), 7.77 \text{ (d, } J = 8.4 \text{ Hz}, 2\text{H}), 7.56 \text{ (d, } J = 8.5 \text{ Hz}, 2\text{H}),< / annotation>< / semantics>< / com:Math> 7.51 (s, 1H), 7.44 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.08 (d, <com:Math><semantics>J=8.7<annotation encoding="application / x-tex">J = 8.7< / annotation>< / semantics>< / com:Math> Hz, 1H), 6.98 (s, 1H), 5.51 (s, 2H), 5.05 <com:Math><semantics>−5.00<annotation encoding="application / x-tex">-5.00< / annotation>< / semantics>< / com:Math> (m, 1H), 4.92 (dd, <com:Math><semantics>J=13.9<annotation encoding="application / x-tex">J = 13.9< / annotation>< / semantics>< / com:Math>, 7.6 Hz, 1H), 2.73 (dd, <com:Math><semantics>J=15.1<annotation encoding="application / x-tex">J = 15.1< / annotation>< / semantics>< / com:Math>, 8.6 Hz, 1H), 2.68 (dd, <com:Math><semantics>J=15.1<annotation encoding="application / x-tex">J = 15.1< / annotation>< / semantics>< / com:Math>) 15.1, 5.5 Hz, 1H), 1.19 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 170.0, 166.8, 165.7, 165.3, 165.0, 163.1, 147.4, 142.0, 141.6, 140.0, 137.5, 134.0, 133.4, 131.2, 129.7, 129.5, 129.1, 128.5, 128.3, 128.1, 127.5, 127.4, 127.1, 125.0, 124.2, 123.7, 122.5, 120.0, 119.5, 119.0, 117.5, 116.0, 100.6, 70.3, 70.1, 51.9, 36.9, 22.7. HRMS (ESI) calculated for C44H37N6O12 (M-H) 841.2475, found 841.2478. (S,E)-4-(4-(4-(4-amino-2-(4-(3-(4-cyanophenyl)-2-methylacrylamido)benzamido)-4- oxobutanamido)benzamido)-2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (25 mg, 0.032 mmol) coupled with carboxylic acid 35 using coupling conditions A followed by final deprotection. Desired compound purified by preparative HPLC condition B, to obtain 6.4 mg of desired product as a white solid (0.0075 mmol, <com:Math><semantics>y=24%<annotation encoding="application / x-tex">y=24\%< / annotation>< / semantics>< / com:Math>). <com:Sup>1< / com:Sup>H NMR (700 MHz, DMSO) δ 12.80 (br, 1H), 12.29 (br, 1H), 10.65 (br, 1H), 10.47 (s, 1H), <com:Math><semantics>10.26<annotation encoding="application / x-tex">10.26< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>9.37<annotation encoding="application / x-tex">9.37< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>8.64<annotation encoding="application / x-tex">8.64< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=7.2<annotation encoding="application / x-tex">J = 7.2< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>7.95<annotation encoding="application / x-tex">7.95< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=11.5<annotation encoding="application / x-tex">J = 11.5< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>8.8<annotation encoding="application / x-tex">8.8< / annotation>< / semantics>< / com:Math> Hz, 4H), <com:Math><semantics>7.91<annotation encoding="application / x-tex">7.91< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=10.4,8.6 Hz,4H),7.88−7.80 (m, 7H),7.67 (d, J=8.3 Hz, 3H),7.40 (s, 1H),7.37 (s, 1H),<annotation encoding="application / x-tex">J = 10.4, 8.6 \text{ Hz}, 4\text{H}), 7.88 - 7.80 \text{ (m, 7H)}, 7.67 \text{ (d, } J = 8.3 \text{ Hz, 3H)}, 7.40 \text{ (s, 1H)}, 7.37 \text{ (s, 1H)},< / annotation>< / semantics>< / com:Math> <com:Math><semantics>6.99<annotation encoding="application / x-tex">6.99< / annotation>< / semantics>< / com:Math> (s, 1H), <com:Math><semantics>4.92<annotation encoding="application / x-tex">4.92< / annotation>< / semantics>< / com:Math> (q, <com:Math><semantics>J=7.1<annotation encoding="application / x-tex">J = 7.1< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>4.59−4.53<annotation encoding="application / x-tex">4.59 - 4.53< / annotation>< / semantics>< / com:Math> (m, 1H), <com:Math><semantics>2.69<annotation encoding="application / x-tex">2.69< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=7.0<annotation encoding="application / x-tex">J = 7.0< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>1.26<annotation encoding="application / x-tex">1.26< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=7.0<annotation encoding="application / x-tex">J = 7.0< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>1.26<annotation encoding="application / x-tex">1.26< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=7.0<annotation encoding="application / x-tex">J = 7.0< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>1.26<annotation encoding="application / x-tex">1.26< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=7.0<annotation encoding="application / x-tex">J = 7.0< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>1.26<annotation encoding="application / x-tex">1.26< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=7.0<annotation encoding="application / x-tex">J = 7.0< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>1<annotation encoding="application / x-tex">1< / annotation>< / semantics>< / com:Math> <com:Math><semantics>=6.1 Hz,6H<annotation encoding="application / x-tex">= 6.1 \text{ Hz}, 6\text{H}< / annotation>< / semantics>< / com:Math>). <com:Math><semantics>13C NMR<annotation encoding="application / x-tex">^{13}\text{C NMR}< / annotation>< / semantics>< / com:Math> (176 MHz, DMSO) <com:Math><semantics>δ<annotation encoding="application / x-tex">\delta< / annotation>< / semantics>< / com:Math> 171.3, 170.8, 168.4, 168.1, 166.9, 165.8, 164.1, 142.5, 142.1, 142.0, 140.6, 136.9, 136.4, 135.8, 132.4, 132.0, 131.7, 130.2, 130.1, 128.6, 128.3, 126.9, 126.1, 122.9, 120.6, 119.2, 118.9, 118.7, 112.5, 110.3, 74.7, 51.6, 36.8, 22.3, 14.6. HRMS (ESI) calculated for C46H41N7NaO10 (M+Na<com:Sup>+< / com:Sup>) 874.2807, found 874.2814. (S)-4-(4-(4-(4-amino-2-(4-(6-cyanonicotinamido)benzamido)-4- oxobutanamido)benzamido)-2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] • • Amine 26 (25 mg, 0.033 mmol) coupled with 6-cyanonicotinic acid using coupling conditions A followed by final deprotection. Desired compound purified by preparative HPLC condition B, to obtain 4.6 mg of desired product <com:Math><semantics>(0.0057 mmol,y=17%)<annotation encoding="application / x-tex">(0.0057 \text{ mmol}, y= 17\%)< / annotation>< / semantics>< / com:Math>. <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) δ 12.76 (br, 1H), 12.31 (br, 1H), 10.87 (s, 1H), 10.47 (s, 1H), 9.34 (br, 1H), <com:Math><semantics>9.26−9.22<annotation encoding="application / x-tex">9.26 - 9.22< / annotation>< / semantics>< / com:Math> (m, 1H), <com:Math><semantics>8.69<annotation encoding="application / x-tex">8.69< / annotation>< / semantics>< / com:Math> (d, <com:Math><semantics>J=7.2<annotation encoding="application / x-tex">J = 7.2< / annotation>< / semantics>< / com:Math> Hz, 1H), <com:Math><semantics>8.54<annotation encoding="application / x-tex">8.54< / annotation>< / semantics>< / com:Math> (dd, <com:Math><semantics>J=8.1<annotation encoding="application / x-tex">J = 8.1< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>2.2<annotation encoding="application / x-tex">2.2< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.26 (d, <com:Math><semantics>J=8.1<annotation encoding="application / x-tex">J = 8.1< / annotation>< / semantics>< / com:Math> Hz, 1H), 7.95 (dt, <com:Math><semantics>J=6.7<annotation encoding="application / x-tex">J = 6.7< / annotation>< / semantics>< / com:Math>, 3.2 Hz, 6H), 7.91 – 7.74 (m, 7H), 7.63 (br, 1H), 7.40 (s, 1H), 6.99 (s, 1H), 4.92 (dd, <com:Math><semantics>J=14.1<annotation encoding="application / x-tex">J = 14.1< / annotation>< / semantics>< / com:Math>, 7.1 Hz, 1H), 4.60 (s, 1H), 2.69 (d, <com:Math><semantics>J=7.0<annotation encoding="application / x-tex">J = 7.0< / annotation>< / semantics>< / com:Math> Hz, 2H), 1.25 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.2, 170.7, 168.3, 166.9, 165.7, 164.1, 163.0, 150.2, 142.4, 141.3, 137.3, 136.5, 134.5, 133.4, 130.2, 129.4, 128.8, 128.4, 128.2, 122.9, 120.4, 119.5, 118.9, 117.1, 74.4, 51.6, 36.8, 22.3. HRMS (ESI) calculated for C42H35N8O10 (M-H) 811.2482, found 811.2480. (S)-4-(4-(4-(4-amino-2-(4-(5-cyanopicolinamido)benzamido)-4- oxobutanamido)benzamido)-2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (25 mg, 0.033 mmol) coupled with 5-cyanopicolinic acid using coupling conditions A followed by final deprotection. Desired compound purified by preparative HPLC condition B, to obtain 2.5 mg of desired product <com:Math><semantics>(0.0031 mmol,y=9%)<annotation encoding="application / x-tex">(0.0031 \text{ mmol}, y= 9\%)< / annotation>< / semantics>< / com:Math>. <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) δ 12.76 (br, 1H), 12.30 (br, 1H), 11.03 (s, 1H), 10.46 (s, 1H), 9.33 (br, 1H), 9.22 (d, <com:Math><semantics>J=1.3<annotation encoding="application / x-tex">J = 1.3< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.68 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.60 (dd, <com:Math><semantics>J=8.2<annotation encoding="application / x-tex">J = 8.2< / annotation>< / semantics>< / com:Math>, 2.0 Hz, 1H), 8.31 (d, <com:Math><semantics>J=8.1<annotation encoding="application / x-tex">J = 8.1< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.05 (d, <com:Math><semantics>J=8.8<annotation encoding="application / x-tex">J = 8.8< / annotation>< / semantics>< / com:Math> Hz, 2H), <com:Math><semantics>8.00−7.89<annotation encoding="application / x-tex">8.00 - 7.89< / annotation>< / semantics>< / com:Math> (m, 6H), 7.83 (dd, <com:Math><semantics>J=<annotation encoding="application / x-tex">J =< / annotation>< / semantics>< / com:Math> 13.2, 8.8 Hz, 5H), 7.62 (s, 1H), 7.40 (s, 1H), 6.99 (s, 1H), 4.92 (dd, <com:Math><semantics>J=14.1<annotation encoding="application / x-tex">J = 14.1< / annotation>< / semantics>< / com:Math>, 7.2 Hz, 1H), 4.60 (br, 1H), 2.69 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 2H), 1.25 (d, <com:Math><semantics>J=6.1<annotation encoding="application / x-tex">J = 6.1< / annotation>< / semantics>< / com:Math> Hz, 6H). <com:Sup>13< / com:Sup>C NMR (176 MHz, DMSO) δ 171.3, 170.7, 168.3, 166.9, 165.8, 164.0, 161.6, 152.3, 151.5, 142.4, 142.3, 140.9, 136.5, 130.2, 129.4, 128.3, 128.2, 122.9, 122.5, 120.3, 119.7, 118.9, 116.6, 111.7, 51.6, 36.8, 22.4. HRMS (ESI) calculated for C42H35N8O10 (M-H) 811.2482, found 811.2461. (S)-4-(4-(4-(4-amino-2-(4-(3-chloro-4-cyanobenzamido)benzamido)-4- oxobutanamido)benzamido)-2-hydroxy-3-isopropoxybenzamido)benzoic acid [Image disponible dans le document PDF, Image available in the PDF document] Amine 26 (25 mg, 0.033 mmol) coupled with 3-chloro-4-cyanobenzoic acid using coupling conditions A followed by final deprotection. Desired compound purified by preparative HPLC condition B, to obtain 4.5 mg of desired product <com:Math><semantics>(0.0053 mmol,y=16%)<annotation encoding="application / x-tex">(0.0053 \text{ mmol}, y= 16\%)< / annotation>< / semantics>< / com:Math>. <com:Sup>1< / com:Sup>H NMR (500 MHz, DMSO) δ 12.78 (br, 1H), 12.30 (br, 1H), 10.76 (s, 1H), 10.46 (s, 1H), 9.36 (br, 1H), 8.68 (d, <com:Math><semantics>J=7.3<annotation encoding="application / x-tex">J = 7.3< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.29 (d, <com:Math><semantics>J=1.6<annotation encoding="application / x-tex">J = 1.6< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.19 (d, <com:Math><semantics>J=8.1<annotation encoding="application / x-tex">J = 8.1< / annotation>< / semantics>< / com:Math> Hz, 1H), 8.07 &...

Claims

CLAIMS:

1. A compound of formula (Ib): [Image disponible dans le document PDF, Image available in the PDF document] (Ib) wherein <com:Math><semantics>R1<annotation encoding="application / x-tex">R^1< / annotation>< / semantics>< / com:Math> is a hydrogen atom or a group of formula -<com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl; <com:Math><semantics>R2<annotation encoding="application / x-tex">R^2< / annotation>< / semantics>< / com:Math> is a hydrogen atom, an OH group or a group of formula -O-C<com:Sub>1-6< / com:Sub> alkyl; A is an alkynyl, a cycloalkyl, heterocycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, aryl, heteroaryl, aralkyl or heteroaralkyl group, all of which may optionally be substituted; Q is a group of formula -C(=O)-NH-, wherein the NH-group is bound to the phenyl group carrying R<com:Sup>2< / com:Sup>; Ar is a phenylene group which may optionally be substituted; Ar<com:Sup>1< / com:Sup> is a phenylene group which may optionally be substituted; E is a group of formula -L-C(=O)-NH-* or a group of formula -C(=O)-NH-(CH<com:Sub>2< / com:Sub>)<com:Sub>m< / com:Sub>-*, wherein * denotes the point of attachment to group Ar and wherein L is a bond or a - NH-, a <com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkylene or a heteroalkylene group containing from 1 to 6 carbon atoms and 1, 2 or 3 heteroatoms selected from O, S and N, and wherein m is an integer of from 1 to 4; G is a phenyl group or a heteroaryl group containing 5 or 6 to 10 ring atoms selected from O, S, N and C or a heterocycloalkyl group containing 5 or 6 ring atoms selected from O, S, N and C; all of which groups are substituted by 1, 2, 3, 4 or 5 groups R<com:Sup>6< / com:Sup>; the groups R<com:Sup>6< / com:Sup> are independently from each other selected from a halogen atom, NO<com:Sub>2< / com:Sub>, N<com:Sub>3< / com:Sub>, OH, NH<com:Sub>2< / com:Sub>, SH, CN or an alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, hetero- cycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, aryl, heteroaryl, aralkyl or hetero- aralkyl group, all of which groups may optionally be substituted; or two groups R<com:Sup>6< / com:Sup> are linked together via an alkylene, alkenylene or heteroalkylene group, all of which may optionally be substituted; wherein at least one group <com:Math><semantics>R6<annotation encoding="application / x-tex">R^6< / annotation>< / semantics>< / com:Math> is a -CN group; R<com:Sup>7< / com:Sup> is a hydrogen atom; and <com:Math><semantics>R8<annotation encoding="application / x-tex">R^8< / annotation>< / semantics>< / com:Math> is a group of formula -C(=O)-NH<com:Sub>2< / com:Sub>; or a pharmaceutically acceptable salt, solvate or hydrate thereof.

2. A compound according to claim 1, wherein Ar is an unsubstituted phenylene group.

3. A compound according to claim 1 having the following formula (II): [Image disponible dans le document PDF, Image available in the PDF document] (II) • 4. A compound according to any one of claims 1 to 3, wherein <com:Math><semantics>R1<annotation encoding="application / x-tex">R^1< / annotation>< / semantics>< / com:Math> is a <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> alkyl group and wherein <com:Math><semantics>R2<annotation encoding="application / x-tex">R^2< / annotation>< / semantics>< / com:Math> is an OH group.

5. A compound according to any one of claims 1 to 4, wherein A is an optionally substituted phenyl group; an optionally substituted heteroaryl group containing 5 or 6 ring atoms selected from O, S, N and C; an optionally substituted cycloalkyl group containing from 3 to 7 ring atoms; or an optionally substituted heterocycloalkyl group containing from 3 to 7 ring atoms selected from O, S, N and C; or an optionally substituted acetylenyl group.

6. A compound according to any one of claims 1 to 5, wherein A is a group of the following formula: [Image disponible dans le document PDF, Image available in the PDF document] wherein R<com:Sup>3< / com:Sup> is a hydrogen atom, a halogen atom, an OH group, a C<com:Sub>1-6< / com:Sub> alkyl group or a group of formula -O-C<com:Sub>1-6< / com:Sub> alkyl; R<com:Sup>4< / com:Sup> is a hydrogen atom, a halogen atom, an OH group, a C<com:Sub>1-6< / com:Sub> alkyl group or a group of formula -O-C<com:Sub>1-6< / com:Sub> alkyl; and R<com:Sup>5< / com:Sup> is an OH group or a NH<com:Sub>2< / com:Sub> group.

7. A compound according to any one of claims 1 to 6, wherein E is selected from the following groups: -C(=O)-NH-*, -O-CH(CH<com:Sub>3< / com:Sub>)-C(=O)-NH-*, -S-CH(CH<com:Sub>3< / com:Sub>)-C(=O)-NH- *, -CH<com:Sub>2< / com:Sub>-C(=O)-NH-*, -CH<com:Sub>2< / com:Sub>-CH<com:Sub>2< / com:Sub>-C(=O)-NH-*, -C(=O)-NH-CH<com:Sub>2< / com:Sub>-*, and -C(=O)-NH- CH<com:Sub>2< / com:Sub>-CH<com:Sub>2< / com:Sub>-*, wherein * denotes the point of attachment to group Ar.

8. A compound according to any one of claims 1 to 7, wherein E is a group of formula: - C(=O)-NH-*, wherein * denotes the point of attachment to group Ar.

9. A compound according to any one of claims 1 to 8, wherein G is a substituted phenyl group or a substituted heteroaryl group containing 5 or 6 ring atoms selected from C, N, O and S.

10. A compound according to any one of claims 1 to 9, wherein G is a phenyl group which is substituted by 1, 2 or 3 groups R<com:Sup>6< / com:Sup>; and wherein at least one group R<com:Sup>6< / com:Sup> is a -CN group.

11. A compound according to any one of claims 1 to 10, wherein G is a group of the following formula: [Image disponible dans le document PDF, Image available in the PDF document] wherein R<com:Sup>6a< / com:Sup> is -CN; R<com:Sup>6b< / com:Sup> is -H, -NO<com:Sub>2< / com:Sub>, -OMe, -Cl, -Br, -NH<com:Sub>2< / com:Sub>, -O-CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -F or -Me; and <com:Math><semantics>R6c<annotation encoding="application / x-tex">R^{6c}< / annotation>< / semantics>< / com:Math> is -H, -F, -NO<com:Sub>2< / com:Sub>, -NH<com:Sub>2< / com:Sub>, -OH or -Me.

12. A compound according to any one of claims 1 to 6, wherein G-E together are selected from the following groups: [Image disponible dans le document PDF, Image available in the PDF document] 13. A compound according to claim 1 of formula (III): [Image disponible dans le document PDF, Image available in the PDF document] (III) wherein <com:Math><semantics>R1<annotation encoding="application / x-tex">R^1< / annotation>< / semantics>< / com:Math> is a hydrogen atom or a group of formula -<com:Math><semantics>C1−6<annotation encoding="application / x-tex">C_{1-6}< / annotation>< / semantics>< / com:Math> alkyl; <com:Math><semantics>R2<annotation encoding="application / x-tex">R^2< / annotation>< / semantics>< / com:Math> is a hydrogen atom, an OH group or a group of formula -O-C<com:Sub>1-6< / com:Sub> alkyl; R<com:Sup>3< / com:Sup> is a hydrogen atom, a halogen atom, an OH group, a C<com:Sub>1-6< / com:Sub> alkyl group or a group of formula -O-C<com:Sub>1-6< / com:Sub> alkyl; R<com:Sup>4< / com:Sup> is a hydrogen atom, a halogen atom, an OH group, a C<com:Sub>1-6< / com:Sub> alkyl group or a group of formula -O-C<com:Sub>1-6< / com:Sub> alkyl; R<com:Sup>5< / com:Sup> is an OH group or a NH<com:Sub>2< / com:Sub> group; the groups R<com:Sup>6< / com:Sup> are independently from each other selected from -F, -NO<com:Sub>2< / com:Sub>, -OH, -O-C<com:Sub>1-6< / com:Sub> alkyl, -NH<com:Sub>2< / com:Sub>, -CN, -Me, -CF<com:Sub>3< / com:Sub>, NHAc, -NHCONH<com:Sub>2< / com:Sub> and -SO<com:Sub>2< / com:Sub>Me; or wherein two groups <com:Math><semantics>R6<annotation encoding="application / x-tex">R^6< / annotation>< / semantics>< / com:Math> together form a group of the formula -CH<com:Sub>2< / com:Sub>-O-C(=O)-; wherein one group <com:Math><semantics>R6<annotation encoding="application / x-tex">R^6< / annotation>< / semantics>< / com:Math> is a CN group; a is 1, 2 or 3; and L is a bond or a -NH-, a C<com:Sub>1-6< / com:Sub> alkylene or a heteroalkylene group containing from 1 to 6 carbon atoms and 1, 2 or 3 heteroatoms selected from O, S and N; or a pharmaceutically acceptable salt, solvate or hydrate thereof.

14. A compound according to claim 1 of formula (IV): [Image disponible dans le document PDF, Image available in the PDF document] (IV) wherein <com:Math><semantics>R1<annotation encoding="application / x-tex">R^1< / annotation>< / semantics>< / com:Math> is a <com:Math><semantics>C1−4<annotation encoding="application / x-tex">C_{1-4}< / annotation>< / semantics>< / com:Math> alkyl group; R<com:Sup>3< / com:Sup> is hydrogen or a -O-C<com:Sub>1-4< / com:Sub> alkyl group; R<com:Sup>4< / com:Sup> is hydrogen or an OH group; and G and E are defined as in claim 1; or a pharmaceutically acceptable salt, solvate or hydrate thereof.

15. A compound of claim 14, wherein G-E are selected from the following groups: [Image disponible dans le document PDF, Image available in the PDF document] 16. A compound according to claim 1 or 2, wherein Ar<com:Sup>1< / com:Sup> is an optionally substituted 1,4 phenylene group.

17. A pharmaceutical composition comprising a compound according to any one of claims 1 to 16, and one or more carrier substances and / or one or more adjuvants.

18. A compound according to anyone of claims 1 to 16 or a pharmaceutical composition according to claim 17, for use in the treatment or prophylaxis of bacterial infections.